GNW 10-Q Quarterly Report Sept. 30, 2025

GENWORTH FINANCIAL INC

10-Ks and 10-Qs

10-Q	Quarter ended Sept. 30, 2025
10-Q	Quarter ended June 30, 2025
10-Q	Quarter ended March 31, 2025
10-K	Fiscal year ended Dec. 31, 2024
10-Q	Quarter ended Sept. 30, 2024
10-Q	Quarter ended June 30, 2024
10-Q	Quarter ended March 31, 2024
10-K	Fiscal year ended Dec. 31, 2023
10-Q	Quarter ended Sept. 30, 2023
10-Q	Quarter ended June 30, 2023
10-Q	Quarter ended March 31, 2023
10-K	Fiscal year ended Dec. 31, 2022
10-Q	Quarter ended Sept. 30, 2022
10-Q	Quarter ended June 30, 2022
10-Q	Quarter ended March 31, 2022
10-K	Fiscal year ended Dec. 31, 2021
10-Q	Quarter ended Sept. 30, 2021
10-Q	Quarter ended June 30, 2021
10-Q	Quarter ended March 31, 2021
10-K	Fiscal year ended Dec. 31, 2020
10-Q	Quarter ended Sept. 30, 2020
10-Q	Quarter ended June 30, 2020
10-Q	Quarter ended March 31, 2020
10-K	Fiscal year ended Dec. 31, 2019
10-Q	Quarter ended Sept. 30, 2019
10-Q	Quarter ended June 30, 2019
10-Q	Quarter ended March 31, 2019
10-K	Fiscal year ended Dec. 31, 2018
10-Q	Quarter ended Sept. 30, 2018
10-Q	Quarter ended June 30, 2018
10-Q	Quarter ended March 31, 2018
10-K	Fiscal year ended Dec. 31, 2017
10-Q	Quarter ended Sept. 30, 2017
10-Q	Quarter ended June 30, 2017
10-Q	Quarter ended March 31, 2017
10-K	Fiscal year ended Dec. 31, 2016
10-Q	Quarter ended Sept. 30, 2016
10-Q	Quarter ended June 30, 2016
10-Q	Quarter ended March 31, 2016
10-K	Fiscal year ended Dec. 31, 2015
10-Q	Quarter ended Sept. 30, 2015
10-Q	Quarter ended June 30, 2015
10-Q	Quarter ended March 31, 2015
10-K	Fiscal year ended Dec. 31, 2014
10-Q	Quarter ended Sept. 30, 2014
10-Q	Quarter ended June 30, 2014
10-Q	Quarter ended March 31, 2014
10-K	Fiscal year ended Dec. 31, 2013
10-Q	Quarter ended Sept. 30, 2013
10-Q	Quarter ended June 30, 2013
10-Q	Quarter ended March 31, 2013
10-K	Fiscal year ended Dec. 31, 2012
10-Q	Quarter ended Sept. 30, 2012
10-Q	Quarter ended June 30, 2012
10-Q	Quarter ended March 31, 2012
10-K	Fiscal year ended Dec. 31, 2011
10-Q	Quarter ended Sept. 30, 2011
10-Q	Quarter ended June 30, 2011
10-Q	Quarter ended March 31, 2011
10-K	Fiscal year ended Dec. 31, 2010
10-Q	Quarter ended Sept. 30, 2010
10-Q	Quarter ended June 30, 2010
10-Q	Quarter ended March 31, 2010
10-K	Fiscal year ended Dec. 31, 2009

PROXIES

DEF 14A	Filed on May 23, 2024
DEF 14A	Filed on April 8, 2024
DEF 14A	Filed on April 1, 2021
DEF 14A	Filed on Oct. 28, 2020
DEF 14A	Filed on Nov. 1, 2019
DEF 14A	Filed on Nov. 1, 2018
DEF 14A	Filed on Nov. 3, 2017
DEF 14A	Filed on April 1, 2016
DEF 14A	Filed on April 2, 2015
DEF 14A	Filed on April 4, 2014
DEF 14A	Filed on April 11, 2013
DEF 14A	Filed on April 4, 2012
DEF 14A	Filed on April 4, 2011
DEF 14A	Filed on April 1, 2010

gnw-20250930

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________

FORM 10-Q

___________________________


x			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2025


o			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number 001-32195

___________________________

GENWORTH FINANCIAL, INC.

(Exact name of registrant as specified in its charter)

___________________________


Delaware			80-0873306
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification Number)

11011 West Broad Street Glen Allen , Virginia			23060
(Address of principal executive offices)			(Zip Code)

( 804 ) 281-6000

(Registrant’s telephone number, including area code)

___________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading
Symbol

Name of each exchange
on which registered

Common Stock, par value $.001 per share

GNW

New York Stock Exchange

___________________________

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a l arge accelerated filer , an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	x	Accelerated filer	o

Non-accelerated filer	o	Smaller reporting company	o

		Emerging growth company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of October 31, 2025, 399,380,567 shares of Common Stock, par value $0.001 per share, were outstanding.

TABLE OF CONTENTS


			Page
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements			3
Condensed Consolidated Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024			3
Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2025 and 202 4 (Unaudited)			4
Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and 202 4 (Unaudited)			5
Condensed Consolidated Statements of Changes in Equity for the three and nine months ended September 30, 2025 and 202 4 (Unaudited)			6
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 202 4 (Unaudited)			8
Notes to Condensed Consolidated Financial Statements (Unaudited)			9
Note 1 — Business and Basis of Presentation			9
Note 2 — Accounting Changes			10
Note 3 — Earnings (Loss) Per Share			11
Note 4 — Investments			12
Note 5 — Derivative Instruments			28
Note 6 — Fair Value of Financial Instruments			34
Note 7 — Deferred Acquisition Costs			55
Note 8 — Future Policy Benefits			56
Note 9 — Policyholder Account Balances			61
Note 10 — Additional Insurance Liabilities			64
Note 11 — Market Risk Benefits			65
Note 12 — Separate Accounts			68
Note 13 — Liability for Policy and Contract Claims			68
Note 14 — Income Taxes			70
Note 15 — Segment Information			71
Note 16 — Commitments and Contingencies			74
Note 17 — Changes in Accumulated Other Comprehensive Income (Loss)			79
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			82
Item 3. Quantitative and Qualitative Disclosures About Market Risk			128
Item 4. Controls and Procedures			128
PART II—OTHER INFORMATION
Item 1. Legal Proceedings			130
Item 1A. Risk Factors			130
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			130
Item 5. Other Information			130
Item 6. Exhibits			131
Signatures			132

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

GENWORTH FINANCIAL, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in millions, except par value and share amounts)




	September 30, 2025		December 31, 2024
	(Unaudited)
Assets
Investments:
Fixed maturity securities available-for-sale, at fair value (amortized cost of $ 48,379 and $ 48,720 , respectively, and allowance for credit losses of $ 28 and $ 10 , respectively)	$	46,110	$	44,902
Equity securities, at fair value	546		515
Commercial mortgage loans	6,374		6,450
Less: Allowance for credit losses	( 59 )		( 39 )
Commercial mortgage loans, net	6,315		6,411
Policy loans	2,311		2,310
Limited partnerships	3,473		3,142
Other invested assets	658		648
Total investments	59,413		57,928
Cash, cash equivalents and restricted cash	2,036		2,048
Accrued investment income	589		607
Deferred acquisition costs	1,632		1,779
Intangible assets	184		197
Reinsurance recoverable	17,935		17,679
Less: Allowance for credit losses	( 23 )		( 24 )
Reinsurance recoverable, net	17,912		17,655
Other assets	421		444
Deferred tax asset	1,788		1,718
Market risk benefit assets	62		57
Separate account assets	4,449		4,438
Total assets	$	88,486	$	86,871
Liabilities and equity
Liabilities:
Future policy benefits	$	55,364	$	53,610
Policyholder account balances	14,039		14,594
Market risk benefit liabilities	429		465
Liability for policy and contract claims	710		670
Unearned premiums	96		115
Other liabilities	2,056		2,026
Long-term borrowings	1,520		1,518
Separate account liabilities	4,449		4,438
Liabilities related to discontinued operations	2		4
Total liabilities	78,665		77,440
Commitments and contingencies (Note 16)
Equity:
Common stock, $ 0.001 par value; 1,500,000,000 shares authorized; 607,393,280 and 606,314,179 shares issued, respectively; 402,682,970 and 421,419,484 shares outstanding, respectively	1		1
Additional paid-in capital	11,879		11,875
Accumulated other comprehensive income (loss)	( 1,395 )		( 1,642 )
Retained earnings	1,731		1,511
Treasury stock, at cost ( 204,710,310 and 184,894,695 shares, respectively)	( 3,404 )		( 3,251 )
Total Genworth Financial, Inc.’s stockholders’ equity	8,812		8,494
Noncontrolling interests	1,009		937
Total equity	9,821		9,431
Total liabilities and equity	$	88,486	$	86,871

See Notes to Condensed Consolidated Financial Statements

Table of Contents

GENWORTH FINANCIAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Amounts in millions, except per share amounts)

(Unaudited)


	Three months ended September 30,				Nine months ended September 30,
	2025		2024		2025		2024
Revenues:
Premiums	$	886	$	874	$	2,613	$	2,604
Net investment income	799		777		2,340		2,367
Net investment gains (losses)	99		66		98		54
Policy fees and other income	151		163		466		488
Total revenues	1,935		1,880		5,517		5,513
Benefits and expenses:
Benefits and other changes in policy reserves	1,227		1,213		3,639		3,567
Liability remeasurement (gains) losses	106		34		170		65
Changes in fair value of market risk benefits and associated hedges	( 1 )		21		7		( 10 )
Interest credited	96		102		289		352
Acquisition and operating expenses, net of deferrals	259		259		744		724
Amortization of deferred acquisition costs and intangibles	57		62		174		187
Interest expense	27		28		79		88
Total benefits and expenses	1,771		1,719		5,102		4,973
Income from continuing operations before income taxes	164		161		415		540
Provision for income taxes	9		40		80		138
Income from continuing operations	155		121		335		402
Loss from discontinued operations, net of taxes	( 8 )		( 3 )		( 20 )		( 5 )
Net income	147		118		315		397
Less: net income attributable to noncontrolling interests	31		33		94		97
Net income available to Genworth Financial, Inc.’s common stockholders	$	116	$	85	$	221	$	300
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share:
Basic	$	0.30	$	0.20	$	0.58	$	0.70
Diluted	$	0.30	$	0.20	$	0.58	$	0.69
Net income available to Genworth Financial, Inc.’s common stockholders per share:
Basic	$	0.29	$	0.20	$	0.54	$	0.69
Diluted	$	0.28	$	0.19	$	0.53	$	0.68
Weighted-average common shares outstanding:
Basic	408.0		430.8		413.2		436.7
Diluted	413.3		435.8		417.9		442.3

See Notes to Condensed Consolidated Financial Statements

Table of Contents

GENWORTH FINANCIAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Amounts in millions)

(Unaudited)


	Three months ended September 30,				Nine months ended September 30,
	2025		2024		2025		2024
Net income	$	147	$	118	$	315	$	397
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses	643		1,662		1,278		749
Net unrealized gains (losses) on securities with an allowance for credit losses	—		—		5		—
Derivatives qualifying as hedges	( 27 )		141		( 139 )		( 139 )
Change in the discount rate used to measure future policy benefits	( 627 )		( 1,965 )		( 880 )		98
Change in instrument-specific credit risk of market risk benefits	1		—		1		2
Foreign currency translation and other adjustments	( 1 )		3		13		( 2 )
Total other comprehensive income (loss)	( 11 )		( 159 )		278		708
Total comprehensive income (loss)	136		( 41 )		593		1,105
Less: comprehensive income attributable to noncontrolling interests	43		58		125		121
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders	$	93	$	( 99 )	$	468	$	984

See Notes to Condensed Consolidated Financial Statements

Table of Contents

GENWORTH FINANCIAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Amounts in millions)

(Unaudited)


	Three months ended September 30, 2025
	Common stock		Additional paid-in capital		Accumulated other comprehensive income (loss)		Retained earnings		Treasury stock, at cost		Total Genworth Financial, Inc.’s stockholders’ equity		Noncontrolling interests		Total equity
Balances as of June 30, 2025	$	1	$	11,871	$	( 1,372 )	$	1,615	$	( 3,327 )	$	8,788	$	991	$	9,779
Repurchase of subsidiary shares	—		—		—		—		—		—		( 20 )		( 20 )
Comprehensive income:
Net income	—		—		—		116		—		116		31		147
Other comprehensive income (loss), net of taxes	—		—		( 23 )		—		—		( 23 )		12		( 11 )
Total comprehensive income											93		43		136
Treasury stock acquired in connection with share repurchases	—		—		—		—		( 77 )		( 77 )		—		( 77 )
Dividends to noncontrolling interests	—		—		—		—		—		—		( 6 )		( 6 )
Stock-based compensation expense and exercises and other	—		8		—		—		—		8		1		9
Balances as of September 30, 2025	$	1	$	11,879	$	( 1,395 )	$	1,731	$	( 3,404 )	$	8,812	$	1,009	$	9,821


	Three months ended September 30, 2024
	Common stock		Additional paid-in capital		Accumulated other comprehensive income (loss)		Retained earnings		Treasury stock, at cost		Total Genworth Financial, Inc.’s stockholders’ equity		Noncontrolling interests		Total equity
Balances as of June 30, 2024	$	1	$	11,880	$	( 1,687 )	$	1,428	$	( 3,163 )	$	8,459	$	894	$	9,353
Repurchase of subsidiary shares	—		—		—		—		—		—		( 14 )		( 14 )
Comprehensive income (loss):
Net income	—		—		—		85		—		85		33		118
Other comprehensive income (loss), net of taxes	—		—		( 184 )		—		—		( 184 )		25		( 159 )
Total comprehensive income (loss)											( 99 )		58		( 41 )
Treasury stock acquired in connection with share repurchases	—		—		—		—		( 36 )		( 36 )		—		( 36 )
Dividends to noncontrolling interests	—		—		—		—		—		—		( 5 )		( 5 )
Stock-based compensation expense and exercises and other	—		( 12 )		—		( 1 )		—		( 13 )		11		( 2 )
Balances as of September 30, 2024	$	1	$	11,868	$	( 1,871 )	$	1,512	$	( 3,199 )	$	8,311	$	944	$	9,255

See Notes to Condensed Consolidated Financial Statements

Table of Contents

GENWORTH FINANCIAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY, CONTINUED

(Amounts in millions)

(Unaudited)


	Nine months ended September 30, 2025
	Common stock		Additional paid-in capital		Accumulated other comprehensive income (loss)		Retained earnings		Treasury stock, at cost		Total Genworth Financial, Inc.’s stockholders’ equity		Noncontrolling interests		Total equity
Balances as of December 31, 2024	$	1	$	11,875	$	( 1,642 )	$	1,511	$	( 3,251 )	$	8,494	$	937	$	9,431
Repurchase of subsidiary shares	—		—		—		—		—		—		( 48 )		( 48 )
Comprehensive income:
Net income	—		—		—		221		—		221		94		315
Other comprehensive income, net of taxes	—		—		247		—		—		247		31		278
Total comprehensive income											468		125		593
Treasury stock acquired in connection with share repurchases	—		—		—		—		( 153 )		( 153 )		—		( 153 )
Dividends to noncontrolling interests	—		—		—		—		—		—		( 17 )		( 17 )
Stock-based compensation expense and exercises and other	—		4		—		( 1 )		—		3		12		15
Balances as of September 30, 2025	$	1	$	11,879	$	( 1,395 )	$	1,731	$	( 3,404 )	$	8,812	$	1,009	$	9,821


	Nine months ended September 30, 2024
	Common stock		Additional paid-in capital		Accumulated other comprehensive income (loss)		Retained earnings		Treasury stock, at cost		Total Genworth Financial, Inc.’s stockholders’ equity		Noncontrolling interests		Total equity
Balances as of December 31, 2023	$	1	$	11,884	$	( 2,555 )	$	1,213	$	( 3,063 )	$	7,480	$	855	$	8,335
Repurchase of subsidiary shares	—		—		—		—		—		—		( 32 )		( 32 )
Comprehensive income:
Net income	—		—		—		300		—		300		97		397
Other comprehensive income, net of taxes	—		—		684		—		—		684		24		708
Total comprehensive income											984		121		1,105
Treasury stock acquired in connection with share repurchases	—		—		—		—		( 136 )		( 136 )		—		( 136 )
Dividends to noncontrolling interests	—		—		—		—		—		—		( 15 )		( 15 )
Stock-based compensation expense and exercises and other	—		( 16 )		—		( 1 )		—		( 17 )		15		( 2 )
Balances as of September 30, 2024	$	1	$	11,868	$	( 1,871 )	$	1,512	$	( 3,199 )	$	8,311	$	944	$	9,255

See Notes to Condensed Consolidated Financial Statements

Table of Contents

GENWORTH FINANCIAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in millions)

(Unaudited)


	Nine months ended September 30,
		2025		2024
Cash flows from (used by) operating activities:
Net income		$	315	$	397
Less loss from discontinued operations, net of taxes		20		5
Adjustments to reconcile net income to net cash from (used by) operating activities:
Amortization of fixed maturity securities discounts and premiums		( 105 )		( 91 )
Net investment (gains) losses		( 98 )		( 54 )
Changes in fair value of market risk benefits and associated hedges		7		( 10 )
Charges assessed to policyholders		( 409 )		( 429 )
Amortization of deferred acquisition costs and intangibles		174		187
Deferred income taxes		( 29 )		( 57 )
Derivative instruments, limited partnerships and other		( 268 )		( 343 )
Long-term incentive compensation expense		42		37
Change in certain assets and liabilities:
Accrued investment income and other assets		( 60 )		( 88 )
Insurance reserves		588		490
Current tax liabilities		( 3 )		108
Other liabilities, policy and contract claims and other policy-related balances		( 19 )		( 91 )
Cash used by operating activities—discontinued operations		( 28 )		—
Net cash from (used by) operating activities		127		61
Cash flows from (used by) investing activities:
Proceeds from maturities and repayments of investments:
Fixed maturity securities		1,981		1,870
Commercial mortgage loans		486		431
Limited partnerships and other invested assets		173		158
Proceeds from sales of investments:
Fixed maturity and equity securities		1,459		2,139
Purchases and originations of investments:
Fixed maturity and equity securities		( 2,933 )		( 3,423 )
Commercial mortgage loans		( 415 )		( 171 )
Limited partnerships and other invested assets		( 330 )		( 413 )
Short-term investments, net		( 21 )		26
Policy loans, net		93		69
Other		( 25 )		( 45 )
Net cash from (used by) investing activities		468		641
Cash flows from (used by) financing activities:
Deposits to universal life and investment contracts		383		407
Withdrawals from universal life and investment contracts		( 773 )		( 963 )
Proceeds from issuance of long-term debt		—		750
Debt issuance costs		—		( 7 )
Repayment and repurchase of long-term debt		—		( 793 )
Repurchase of subsidiary shares		( 48 )		( 32 )
Treasury stock acquired in connection with share repurchases		( 151 )		( 135 )
Dividends paid to noncontrolling interests		( 17 )		( 15 )
Other, net		( 1 )		( 72 )
Net cash from (used by) financing activities		( 607 )		( 860 )

Net change in cash, cash equivalents and restricted cash		( 12 )		( 158 )
Cash, cash equivalents and restricted cash at beginning of period		2,048		2,215
Cash, cash equivalents and restricted cash at end of period		$	2,036	$	2,057

See Notes to Condensed Consolidated Financial Statements

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(1) Business and Basis of Presentation

Genworth Holdings, Inc. (“Genworth Holdings”) (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an initial public offering of its common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100 % owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, and was renamed Genworth Financial, Inc. (“Genworth Financial”) upon the completion of the reorganization.

The accompanying unaudited condensed financial statements include on a consolidated basis the accounts of Genworth Financial and its affiliate companies in which it holds a majority voting interest or power to direct activities of certain variable interest entities, which on a consolidated basis is referred to as “Genworth,” the “Company,” “we,” “us” or “our” unless the context otherwise requires. All intercompany accounts and transactions have been eliminated in consolidation. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries.

We manage our business through the following three reportable segments:

• Enact . Enact Holdings, Inc. (“Enact Holdings”) comprises our Enact segment. Through Enact Holdings’ mortgage insurance subsidiaries, we offer private mortgage insurance products predominantly insuring prime-based, individually underwritten residential mortgage loans at specified coverage percentages (“primary mortgage insurance”). Enact Holdings also selectively enters into insurance transactions with lenders and investors, under which it insures a portfolio of loans at or after origination (“pool mortgage insurance”).

• Long-Term Care Insurance. Through our principal U.S. life insurance subsidiaries, we offer long-term care insurance products in the United States. Long-term care insurance products are intended to protect against the significant and escalating costs of long-term care services provided in the insured’s home or assisted living or nursing facilities.

• Life and Annuities. We service a variety of protection and retirement income products through our principal U.S. life insurance subsidiaries that are not actively marketed or sold. These products include traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), fixed annuities and variable annuities.

In addition to our three reportable segments, we also have Corporate and Other, which includes debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, and eliminations of inter-segment transactions. Corporate and Other also includes the results of other businesses that are not individually reportable, such as start-up results of our CareScout business (“CareScout”) related to our aging care growth initiatives and certain international businesses.

The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and rules and regulations of the U.S. Securities and Exchange Commission. Preparing financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ from those estimates. These unaudited condensed consolidated financial statements include all adjustments (including normal recurring adjustments) considered necessary by management to present a fair statement of the financial position, results of operations and cash flows for the periods presented. The results reported in these unaudited condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for the entire year. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and related notes contained in our 2024 Annual Report on Form 10-K.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

common stock at an average price of $ 7.62 per share for a total cost of $ 153 million , including excise taxes and other costs paid in connection with acquiring the shares. The repurchased shares were recorded at cost and presented as treasury stock in a separate caption in equity in our condensed consolidated balance sheets. On September 18, 2025, Genworth Financial announced that its Board of Directors had authorized a new share repurchase program under which Genworth Financial may purchase up to $ 350 million of its outstanding common stock. Under the new program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.

(2) Accounting Changes

Accounting Pronouncements Not Yet Adopted

In September 2025, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance to refine the scope of derivative accounting. The guidance added a scope exception for certain contracts that are not exchange-traded and have underlying variables based on the operations or activities of one of the parties to the contract. This guidance is effective for us on January 1, 2027 using the prospective or modified retrospective method, with early adoption permitted. We are currently evaluating the impact the guidance may have on our processes.

In September 2025, the FASB issued new accounting guidance related to accounting for internal-use software co sts. The new guidance modified the cost capitalization threshold by removing project development stages and adding new capitalization considerations. Under the new standard, eligible costs are capitalized when management has authorized and committed funds to the project, and it is probable that the project will be completed and the software will be used for its intended purpose, commonly referred to as “the probable-to-complete threshold.” Additional disclosure will be required of internal-use software and related amortization regardless of how the internal-use software is classified on the balance sheet. This guidance is ef fective for us for interim and annual reporting periods beginning on January 1, 2028 using the prospective, modified retrospective or retrospective method, with early adoption permitted. We are currently evaluating the impact the guidance may have on our processes, controls and disclosures.

In November 2024, the FASB issued new accounting guidance to require disaggregated disclosures in the notes to the financial statements of certain categories of expenses included in our consolidated statements of income, including employee compensation, depreciation and intangible asset amortization. This guidance is effective for us for annual reporting periods beginning on January 1, 2027 and interim periods beginning on January 1, 2028 using the prospective or retrospective method, with early adoption permitted. We are currently evaluating the impact the guidance may have on our processes, controls and disclosures.

In December 2023, the FASB issued new accounting guidance to improve income tax disclosures. The guidance requires annual disclosure of specific categories in the income tax rate reconciliation, separate disclosure of additional information related to reconciling items that meet a quantitative threshold and additional disclosures about income taxes paid, among other qualitative and quantitative disclosure improvements. The guidance will have no impact on our consolidated financial statements but will expand our disclosures effective for annual reporting periods beginning on January 1, 2025 and will be adopted using the retrospective method. We are finalizing the required disclosures in accordance with the new guidance, which will be reflected in the notes contained in our 2025 Annual Report on Form 10-K.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(3) Earnings (Loss) Per Share

Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted common shares outstanding for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions, except per share amounts)	2025		2024		2025		2024
Weighted-average common shares used in basic earnings (loss) per share calculations	408.0		430.8		413.2		436.7
Potentially dilutive securities:
Performance stock units, restricted stock units and other equity-based awards	5.3		5.0		4.7		5.6
Weighted-average common shares used in diluted earnings (loss) per share calculations	413.3		435.8		417.9		442.3
Income from continuing operations:
Income from continuing operations	$	155	$	121	$	335	$	402
Less: net income from continuing operations attributable to noncontrolling interests	31		33		94		97
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders	$	124	$	88	$	241	$	305
Basic per share	$	0.30	$	0.20	$	0.58	$	0.70
Diluted per share	$	0.30	$	0.20	$	0.58	$	0.69
Loss from discontinued operations:
Loss from discontinued operations, net of taxes	$	( 8 )	$	( 3 )	$	( 20 )	$	( 5 )
Basic per share	$	( 0.02 )	$	( 0.01 )	$	( 0.05 )	$	( 0.01 )
Diluted per share	$	( 0.02 )	$	( 0.01 )	$	( 0.05 )	$	( 0.01 )
Net income:
Income from continuing operations	$	155	$	121	$	335	$	402
Loss from discontinued operations, net of taxes	( 8 )		( 3 )		( 20 )		( 5 )
Net income	147		118		315		397
Less: net income attributable to noncontrolling interests	31		33		94		97
Net income available to Genworth Financial, Inc.’s common stockholders	$	116	$	85	$	221	$	300
Basic per share (1)	$	0.29	$	0.20	$	0.54	$	0.69
Diluted per share	$	0.28	$	0.19	$	0.53	$	0.68

_____________

(1) May not total due to whole number calculation.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(4) Investments

(a) Net Investment Income

Sources of net investment income were as follows for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Fixed maturity securities—taxable	$	565	$	557	$	1,694	$	1,682
Fixed maturity securities—non-taxable	1		—		1		1
Equity securities	3		3		9		8
Commercial mortgage loans	74		74		219		224
Policy loans	39		38		107		152
Limited partnerships	62		36		139		92
Other invested assets (1)	64		70		187		205
Cash, cash equivalents, restricted cash and short-term investments	18		24		59		76
Gross investment income before expenses and fees	826		802		2,415		2,440
Expenses and fees	( 27 )		( 25 )		( 75 )		( 73 )
Net investment income	$	799	$	777	$	2,340	$	2,367

_____________

(1) Includes amounts related to derivative instruments. See note 5 for additional information.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(b) Net Investment Gains (Losses)

The following table sets forth net investment gains (losses) for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Realized investment gains (losses):
Available-for-sale fixed maturity securities:
Realized gains	$	3	$	7	$	14	$	35
Realized losses	( 13 )		( 14 )		( 46 )		( 83 )
Net realized gains (losses) on available-for-sale fixed maturity securities	( 10 )		( 7 )		( 32 )		( 48 )
Net realized gains (losses) on equity securities sold	—		—		5		—
Total net realized investment gains (losses)	( 10 )		( 7 )		( 27 )		( 48 )
Net change in allowance for credit losses on available-for-sale fixed maturity securities	( 3 )		—		( 18 )		7
Write-down of available-for-sale fixed maturity securities (1)	—		—		( 4 )		—
Net unrealized gains (losses) on equity securities still held	30		22		48		66
Net unrealized gains (losses) on limited partnerships	66		55		129		46
Commercial mortgage loans	( 3 )		( 8 )		( 20 )		( 11 )
Derivative instruments (2)	17		10		( 13 )		3
Other	2		( 6 )		3		( 9 )
Net investment gains (losses)	$	99	$	66	$	98	$	54

_____________________

(1) Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis.

(2) See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses).

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

See Note 2—Summary of Significant Accounting Policies included in the Notes to Consolidated Financial Statements in our 2024 Annual Report on Form 10-K for a discussion of our policy for evaluating and measuring the allowance for credit losses related to our available-for-sale fixed maturity securities. The following table represents the allowance for credit losses aggregated by security type for available-for-sale fixed maturity securities as of and for the three months ended September 30, 2025:



(Amounts in millions)	Beginning balance		Increase from securities without allowance in previous periods		Increase (decrease) from securities with allowance in previous periods		Securities sold		Decrease due to change in intent or requirement to sell		Write-offs		Recoveries		Ending balance
Fixed maturity securities:
U.S. corporate	$	10	$	—	$	( 1 )	$	—	$	—	$	—	$	—	$	9
Non-U.S. corporate	10		—		4		—		—		—		—		14
Commercial mortgage-backed	5		—		—		—		—		—		—		5
Total available-for-sale fixed maturity securities	$	25	$	—	$	3	$	—	$	—	$	—	$	—	$	28

There was no allowance for credit losses related to our available-for-sale fixed maturity securities as of and for the three months ended September 30, 2024.

Th e following table represents the allowance for credit losses aggregated by security type for available-for-sale fixed maturity securities as of and for the nine months ended September 30, 2025:



(Amounts in millions)	Beginning balance		Increase from securities without allowance in previous periods		Increase (decrease) from securities with allowance in previous periods		Securities sold		Decrease due to change in intent or requirement to sell		Write-offs		Recoveries		Ending balance
Fixed maturity securities:
U.S. corporate	$	4	$	10	$	( 1 )	$	( 4 )	$	—	$	—	$	—	$	9
Non-U.S. corporate	3		12		—		—		( 1 )		—		—		14
Commercial mortgage-backed	3		1		1		—		—		—		—		5
Total available-for-sale fixed maturity securities	$	10	$	23	$	—	$	( 4 )	$	( 1 )	$	—	$	—	$	28

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table represents the allowance for credit losses aggregated by security type for available-for-sale fixed maturity securities as of and for the nine months ended September 30, 2024:



(Amounts in millions)	Beginning balance		Increase from securities without allowance in previous periods		Increase (decrease) from securities with allowance in previous periods		Securities sold		Decrease due to change in intent or requirement to sell		Write-offs		Recoveries		Ending balance
Fixed maturity securities:


Commercial mortgage-backed	$	7	$	—	$	—	$	( 7 )	$	—	$	—	$	—	$	—
Total available-for-sale fixed maturity securities	$	7	$	—	$	—	$	( 7 )	$	—	$	—	$	—	$	—

Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of the dates indicated:



(Amounts in millions)	September 30, 2025		December 31, 2024
Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses	$	( 2,241 )	$	( 3,801 )
Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses	—		( 7 )
Adjustments to policyholder contract balances	63		83
Income taxes, net	266		530
Net unrealized investment gains (losses)	( 1,912 )		( 3,195 )
Less: net unrealized investment gains (losses) attributable to noncontrolling interests	( 7 )		( 39 )
Net unrealized investment gains (losses) attributable to Genworth Financial, Inc.	$	( 1,905 )	$	( 3,156 )

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The change in net unrealized gains (losses) on available-for-sale investment securities reported in accumulated other comprehensive income (loss) was as follows as of and for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Beginning balance	$	( 2,536 )	$	( 3,042 )	$	( 3,156 )	$	( 2,130 )
Unrealized gains (losses) arising during the period:
Unrealized gains (losses) on fixed maturity securities	736		2,140		1,535		911
Adjustments to policyholder contract balances	( 11 )		( 34 )		( 20 )		( 7 )
Provision for income taxes	( 90 )		( 450 )		( 257 )		( 193 )
Change in unrealized gains (losses) on investment securities	635		1,656		1,258		711
Reclassification adjustments to net investment (gains) losses (1)	8		6		25		38
Change in net unrealized investment gains (losses)	643		1,662		1,283		749
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests	12		25		32		24
Ending balance	$	( 1,905 )	$	( 1,405 )	$	( 1,905 )	$	( 1,405 )

_____________

(1) Net of taxes of $( 2 ) million and $( 1 ) million during the three months ended September 30, 2025 and 2024, respectively, and $( 7 ) million and $( 10 ) million during the nine months ended September 30, 2025 and 2024, respectively.

Amounts reclassified out of accumulated other comprehensive income (loss) to net investment gains (losses) include realized gains (losses) on sales of securities, which are determined on a specific identification basis.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(d) Fixed Maturity Securities

As of September 30, 2025, the amortized cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows:


(Amounts in millions)	Amortized cost		Gross unrealized gains		Gross unrealized losses		Allowance for credit losses		Fair value
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises	$	3,857	$	66	$	( 330 )	$	—	$	3,593
State and political subdivisions	2,387		14		( 256 )		—		2,145
Non-U.S. government	1,244		38		( 79 )		—		1,203
U.S. corporate:
Utilities	4,797		104		( 355 )		( 3 )		4,543
Energy	2,470		67		( 122 )		—		2,415
Finance and insurance	7,460		115		( 478 )		( 2 )		7,095
Consumer—non-cyclical	4,662		102		( 278 )		( 4 )		4,482
Technology and communications	2,984		65		( 233 )		—		2,816
Industrial	1,101		16		( 82 )		—		1,035
Capital goods	2,349		67		( 102 )		—		2,314
Consumer—cyclical	1,408		22		( 72 )		—		1,358
Transportation	1,091		43		( 70 )		—		1,064
Other	276		4		( 11 )		—		269
Total U.S. corporate	28,598		605		( 1,803 )		( 9 )		27,391
Non-U.S. corporate:
Utilities	691		4		( 37 )		( 3 )		655
Energy	1,011		30		( 33 )		( 5 )		1,003
Finance and insurance	1,743		43		( 78 )		—		1,708
Consumer—non-cyclical	629		6		( 62 )		—		573
Technology and communications	781		9		( 57 )		—		733
Industrial	774		21		( 27 )		( 6 )		762
Capital goods	714		14		( 30 )		—		698
Consumer—cyclical	250		4		( 9 )		—		245
Transportation	448		15		( 19 )		—		444
Other	489		12		( 21 )		—		480
Total non-U.S. corporate	7,530		158		( 373 )		( 14 )		7,301
Residential mortgage-backed	1,080		15		( 36 )		—		1,059
Commercial mortgage-backed	1,607		2		( 244 )		( 5 )		1,360
Other asset-backed	2,076		13		( 31 )		—		2,058
Total available-for-sale fixed maturity securities	$	48,379	$	911	$	( 3,152 )	$	( 28 )	$	46,110

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

As of December 31, 2024, the amortized cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows:


(Amounts in millions)	Amortized cost		Gross unrealized gains		Gross unrealized losses		Allowance for credit losses		Fair value
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises	$	3,847	$	24	$	( 378 )	$	—	$	3,493
State and political subdivisions	2,452		8		( 311 )		—		2,149
Non-U.S. government	1,021		5		( 117 )		—		909
U.S. corporate:
Utilities	4,685		47		( 450 )		—		4,282
Energy	2,444		38		( 170 )		—		2,312
Finance and insurance	7,533		57		( 675 )		( 4 )		6,911
Consumer—non-cyclical	4,728		51		( 392 )		—		4,387
Technology and communications	2,992		42		( 311 )		—		2,723
Industrial	1,166		11		( 105 )		—		1,072
Capital goods	2,360		37		( 154 )		—		2,243
Consumer—cyclical	1,602		13		( 118 )		—		1,497
Transportation	1,135		30		( 91 )		—		1,074
Other	283		2		( 15 )		—		270
Total U.S. corporate	28,928		328		( 2,481 )		( 4 )		26,771
Non-U.S. corporate:
Utilities	750		1		( 55 )		( 3 )		693
Energy	1,046		16		( 56 )		—		1,006
Finance and insurance	1,877		20		( 123 )		—		1,774
Consumer—non-cyclical	632		3		( 79 )		—		556
Technology and communications	801		5		( 80 )		—		726
Industrial	805		7		( 46 )		—		766
Capital goods	633		4		( 46 )		—		591
Consumer—cyclical	245		1		( 16 )		—		230
Transportation	454		11		( 29 )		—		436
Other	587		5		( 43 )		—		549
Total non-U.S. corporate	7,830		73		( 573 )		( 3 )		7,327
Residential mortgage-backed	862		4		( 55 )		—		811
Commercial mortgage-backed	1,591		1		( 288 )		( 3 )		1,301
Other asset-backed	2,189		9		( 57 )		—		2,141
Total available-for-sale fixed maturity securities	$	48,720	$	452	$	( 4,260 )	$	( 10 )	$	44,902

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of September 30, 2025:


	Less than 12 months					12 months or more					Total
(Dollar amounts in millions)	Fair value		Gross unrealized losses		Number of securities	Fair value		Gross unrealized losses		Number of securities	Fair value		Gross unrealized losses		Number of securities
Description of Securities
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises	$	544	$	( 23 )	27	$	1,342	$	( 307 )	45	$	1,886	$	( 330 )	72
State and political subdivisions	166		( 8 )		36	1,520		( 248 )		247	1,686		( 256 )		283
Non-U.S. government	58		( 1 )		22	416		( 78 )		59	474		( 79 )		81
U.S. corporate	1,735		( 61 )		358	13,892		( 1,742 )		1,758	15,627		( 1,803 )		2,116
Non-U.S. corporate	228		( 11 )		42	3,611		( 362 )		442	3,839		( 373 )		484
Residential mortgage-backed	—		—		—	397		( 36 )		142	397		( 36 )		142
Commercial mortgage-backed	—		—		—	1,220		( 244 )		195	1,220		( 244 )		195
Other asset-backed	165		( 1 )		52	725		( 30 )		144	890		( 31 )		196
Total for fixed maturity securities in an unrealized loss position	$	2,896	$	( 105 )	537	$	23,123	$	( 3,047 )	3,032	$	26,019	$	( 3,152 )	3,569
% Below cost:
<20% Below cost	$	2,856	$	( 91 )	528	$	20,150	$	( 1,964 )	2,596	$	23,006	$	( 2,055 )	3,124
20%-50% Below cost	40		( 14 )		9	2,973		( 1,083 )		436	3,013		( 1,097 )		445

Total for fixed maturity securities in an unrealized loss position	$	2,896	$	( 105 )	537	$	23,123	$	( 3,047 )	3,032	$	26,019	$	( 3,152 )	3,569
Investment grade	$	2,835	$	( 96 )	518	$	22,514	$	( 2,992 )	2,947	$	25,349	$	( 3,088 )	3,465
Below investment grade	61		( 9 )		19	609		( 55 )		85	670		( 64 )		104
Total for fixed maturity securities in an unrealized loss position	$	2,896	$	( 105 )	537	$	23,123	$	( 3,047 )	3,032	$	26,019	$	( 3,152 )	3,569

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses had not been recorded, aggregated by investment type and length of time that individual investment securities had been in a continuous unrealized loss position, based on industry, as of September 30, 2025:


	Less than 12 months					12 months or more					Total
(Dollar amounts in millions)	Fair value		Gross unrealized losses		Number of securities	Fair value		Gross unrealized losses		Number of securities	Fair value		Gross unrealized losses		Number of securities
Description of Securities
U.S. corporate:
Utilities	$	334	$	( 11 )	55	$	1,951	$	( 344 )	288	$	2,285	$	( 355 )	343
Energy	147		( 4 )		32	1,039		( 118 )		136	1,186		( 122 )		168
Finance and insurance	332		( 7 )		78	4,190		( 471 )		512	4,522		( 478 )		590
Consumer—non-cyclical	339		( 8 )		63	2,238		( 270 )		252	2,577		( 278 )		315
Technology and communications	231		( 15 )		49	1,590		( 218 )		181	1,821		( 233 )		230
Industrial	128		( 2 )		24	554		( 80 )		80	682		( 82 )		104
Capital goods	69		( 1 )		21	995		( 101 )		123	1,064		( 102 )		144
Consumer—cyclical	31		( 1 )		12	786		( 71 )		112	817		( 72 )		124
Transportation	102		( 9 )		19	464		( 61 )		62	566		( 70 )		81
Other	22		( 3 )		5	85		( 8 )		12	107		( 11 )		17
Subtotal, U.S. corporate securities	1,735		( 61 )		358	13,892		( 1,742 )		1,758	15,627		( 1,803 )		2,116
Non-U.S. corporate:
Utilities	—		—		—	430		( 37 )		47	430		( 37 )		47
Energy	87		( 5 )		15	351		( 28 )		37	438		( 33 )		52
Finance and insurance	—		—		—	898		( 78 )		122	898		( 78 )		122
Consumer—non-cyclical	58		( 1 )		10	368		( 61 )		38	426		( 62 )		48
Technology and communications	48		( 3 )		11	431		( 54 )		47	479		( 57 )		58
Industrial	—		—		—	279		( 27 )		37	279		( 27 )		37
Capital goods	35		( 2 )		6	311		( 28 )		40	346		( 30 )		46
Consumer—cyclical	—		—		—	118		( 9 )		17	118		( 9 )		17
Transportation	—		—		—	221		( 19 )		29	221		( 19 )		29
Other	—		—		—	204		( 21 )		28	204		( 21 )		28
Subtotal, non-U.S. corporate securities	228		( 11 )		42	3,611		( 362 )		442	3,839		( 373 )		484
Total for corporate securities in an unrealized loss position	$	1,963	$	( 72 )	400	$	17,503	$	( 2,104 )	2,200	$	19,466	$	( 2,176 )	2,600

We did not recognize an allowance for credit losses on securities in an unrealized loss position included in the tables above. Based on a qualitative and quantitative review of the issuers of the securities, we believe the decline in fair value was largely due to increased interest rates since purchase and was not indicative of credit losses. The issuers continue to make timely principal and interest payments. For all securities in an unrealized loss position without an allowance for credit losses, we expect to recover the amortized cost based on our estimate of the amount and timing of cash flows to be collected. We do not intend to sell nor do we expect that we will be required to sell these securities prior to recovering our amortized cost.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Less than 12 months					12 months or more					Total
(Dollar amounts in millions)	Fair value		Gross unrealized losses		Number of securities	Fair value		Gross unrealized losses		Number of securities	Fair value		Gross unrealized losses		Number of securities
Description of Securities
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises	$	1,013	$	( 43 )	67	$	1,270	$	( 335 )	47	$	2,283	$	( 378 )	114
State and political subdivisions	432		( 15 )		69	1,406		( 296 )		256	1,838		( 311 )		325
Non-U.S. government	438		( 18 )		130	386		( 99 )		60	824		( 117 )		190
U.S. corporate	5,001		( 173 )		894	14,626		( 2,302 )		1,997	19,627		( 2,475 )		2,891
Non-U.S. corporate	1,359		( 34 )		238	4,126		( 538 )		553	5,485		( 572 )		791
Residential mortgage-backed	151		( 3 )		69	409		( 52 )		147	560		( 55 )		216
Commercial mortgage-backed	—		—		—	1,244		( 288 )		206	1,244		( 288 )		206
Other asset-backed	182		( 3 )		56	971		( 54 )		194	1,153		( 57 )		250
Total for fixed maturity securities in an unrealized loss position	$	8,576	$	( 289 )	1,523	$	24,438	$	( 3,964 )	3,460	$	33,014	$	( 4,253 )	4,983
% Below cost:
<20% Below cost	$	8,505	$	( 266 )	1,511	$	19,956	$	( 2,322 )	2,794	$	28,461	$	( 2,588 )	4,305
20%-50% Below cost	71		( 23 )		12	4,481		( 1,641 )		664	4,552		( 1,664 )		676
>50% Below cost	—		—		—	1		( 1 )		2	1		( 1 )		2
Total for fixed maturity securities in an unrealized loss position	$	8,576	$	( 289 )	1,523	$	24,438	$	( 3,964 )	3,460	$	33,014	$	( 4,253 )	4,983
Investment grade	$	8,337	$	( 282 )	1,469	$	23,621	$	( 3,857 )	3,335	$	31,958	$	( 4,139 )	4,804
Below investment grade	239		( 7 )		54	817		( 107 )		125	1,056		( 114 )		179
Total for fixed maturity securities in an unrealized loss position	$	8,576	$	( 289 )	1,523	$	24,438	$	( 3,964 )	3,460	$	33,014	$	( 4,253 )	4,983

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Less than 12 months					12 months or more					Total
(Dollar amounts in millions)	Fair value		Gross unrealized losses		Number of securities	Fair value		Gross unrealized losses		Number of securities	Fair value		Gross unrealized losses		Number of securities
Description of Securities
U.S. corporate:
Utilities	$	1,005	$	( 26 )	151	$	1,968	$	( 424 )	303	$	2,973	$	( 450 )	454
Energy	491		( 25 )		107	1,051		( 145 )		137	1,542		( 170 )		244
Finance and insurance	917		( 26 )		172	4,472		( 643 )		584	5,389		( 669 )		756
Consumer—non-cyclical	917		( 34 )		160	2,267		( 358 )		289	3,184		( 392 )		449
Technology and communications	454		( 16 )		86	1,772		( 295 )		235	2,226		( 311 )		321
Industrial	220		( 8 )		34	565		( 97 )		90	785		( 105 )		124
Capital goods	464		( 21 )		81	1,009		( 133 )		144	1,473		( 154 )		225
Consumer—cyclical	277		( 10 )		58	883		( 108 )		126	1,160		( 118 )		184
Transportation	187		( 6 )		37	529		( 85 )		73	716		( 91 )		110
Other	69		( 1 )		8	110		( 14 )		16	179		( 15 )		24
Subtotal, U.S. corporate securities	5,001		( 173 )		894	14,626		( 2,302 )		1,997	19,627		( 2,475 )		2,891
Non-U.S. corporate:
Utilities	152		( 3 )		23	455		( 51 )		51	607		( 54 )		74
Energy	223		( 7 )		33	435		( 49 )		48	658		( 56 )		81
Finance and insurance	270		( 4 )		58	1,116		( 119 )		157	1,386		( 123 )		215
Consumer—non-cyclical	110		( 7 )		24	365		( 72 )		48	475		( 79 )		72
Technology and communications	114		( 4 )		18	489		( 76 )		65	603		( 80 )		83
Industrial	152		( 2 )		33	340		( 44 )		51	492		( 46 )		84
Capital goods	118		( 3 )		18	313		( 43 )		43	431		( 46 )		61
Consumer—cyclical	52		( 1 )		8	117		( 15 )		20	169		( 16 )		28
Transportation	34		( 1 )		4	247		( 28 )		34	281		( 29 )		38
Other	134		( 2 )		19	249		( 41 )		36	383		( 43 )		55
Subtotal, non-U.S. corporate securities	1,359		( 34 )		238	4,126		( 538 )		553	5,485		( 572 )		791
Total for corporate securities in an unrealized loss position	$	6,360	$	( 207 )	1,132	$	18,752	$	( 2,840 )	2,550	$	25,112	$	( 3,047 )	3,682

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The scheduled maturity distribution of fixed maturity securities as of September 30, 2025 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties.


(Amounts in millions)	Amortized cost		Fair value
Due one year or less	$	1,656	$	1,648
Due after one year through five years	8,381		8,309
Due after five years through ten years	11,293		11,230
Due after ten years	22,286		20,446
Subtotal	43,616		41,633
Residential mortgage-backed	1,080		1,059
Commercial mortgage-backed	1,607		1,360
Other asset-backed	2,076		2,058
Total	$	48,379	$	46,110

As of September 30, 2025, securities issued by finance and insurance, utilities, consumer—non-cyclical and technology and communications industry groups represented approximately 25 %, 15 %, 15 % and 10 %, respectively, of our domestic and foreign corporate fixed maturity securities portfolio. No other industry group comprised more than 10 % of our investment portfolio.

As of September 30, 2025, we did not hold any fixed maturity securities in any single issuer, other than securities issued or guaranteed by the U.S. government, which exceeded 10 % of stockholders’ equity.

(e) Commercial Mortgage Loans

Our mortgage loans are collateralized by commercial properties, including multi-family residential buildings. The carrying value of commercial mortgage loans is stated at original cost net of principal payments, amortization and allowance for credit losses.

We diversify our commercial mortgage loans by both property type and geographic region. The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of the dates indicated:



	September 30, 2025				December 31, 2024
(Amounts in millions)	Carrying value		% of total		Carrying value		% of total
Property type:
Retail	$	2,618	41	%	$	2,716	42	%
Industrial	1,441		23		1,331		21
Office	1,319		21		1,391		22
Apartments	502		8		498		7
Mixed use	348		5		360		6
Other	146		2		154		2
Subtotal	6,374		100	%	6,450		100	%
Allowance for credit losses	( 59 )				( 39 )
Total	$	6,315			$	6,411

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)



	September 30, 2025				December 31, 2024
(Amounts in millions)	Carrying value		% of total		Carrying value		% of total
Geographic region:
South Atlantic	$	1,726	27	%	$	1,750	27	%
Pacific	1,172		19		1,157		18
Mountain	986		16		971		15
Middle Atlantic	845		13		871		13
West South Central	522		8		539		8
East North Central	430		7		431		7
West North Central	342		5		372		6
East South Central	194		3		190		3
New England	157		2		169		3
Subtotal	6,374		100	%	6,450		100	%
Allowance for credit losses	( 59 )				( 39 )
Total	$	6,315			$	6,411

As of September 30, 2025, we had no commercial mortgage loans past due or on non-accrual status. As of December 31, 2024, we had one commercial mortgage loan in the industrial property type with an amortized cost of $ 7 million that was more than 90 days past due and on non-accrual status. This loan did not have an allowance for credit losses as of December 31, 2024. During the second quarter of 2025, we foreclosed on this commercial mortgage loan and recorded the property as real estate owned assets in other invested assets in our condensed consolidated balance sheet. For a discussion of our policy related to placing commercial mortgage loans on non-accrual status, see Note 2—Summary of Significant Accounting Policies included in the Notes to Consolidated Financial Statements in our 2024 Annual Report on Form 10-K.

Occasionally, we may make modifications of interest rate reductions, term extensions and/or principal forgiveness related to commercial mortgage loans. An assessment of whether a borrower is experiencing financial difficulty is made on the date of a modification. As the effect of most modifications made to borrowers experiencing financial difficulty is already included in the allowance for credit losses as a result of the measurement methodologies used to estimate the allowance, a change to the allowance for credit losses is generally not recorded upon modification.

During the three months ended September 30, 2025, we did not modify any commercial mortgage loans where the borrower was determined to be experiencing financial difficulty. During the nine months ended September 30, 2025 and the three and nine months ended September 30, 2024, we modified one commercial mortgage loan in each period where the borrower was determined to be experiencing financial difficulty. These loans were included in the office property type with an amortized cost of $ 9 million and $ 35 million as of September 30, 2025 and 2024, respectively, which represented 1 % and 2 %, respectively, of the total asset class. The modification during the nine months ended September 30, 2025 extended the contractual term of the loan by two years , with the option to extend by one additional year up to three times, and resulted in an increase to the interest rate. The modification during the three and nine months ended September 30, 2024 extended the contractual term of the loan by ten years and changed the loan from interest-only to amortizing, which resulted in an increase to the interest rate. We continue to account for these modified loans as existing loans. As of September 30, 2025, all loans previously modified during the 12 months prior remained current.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table sets forth the allowance for credit losses related to commercial mortgage loans as of and for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Allowance for credit losses:
Beginning balance	$	56	$	30	$	39	$	27
Provision	3		8		20		11
Write-offs	—		—		—		—
Recoveries	—		—		—		—
Ending balance	$	59	$	38	$	59	$	38

During the nine months ended September 30, 2025, we increased the provision for credit losses primarily as a result of updates to the analytical model used to determine the adequacy of the allowance for credit losses.

In evaluating the credit quality of commercial mortgage loans, we assess the performance of the underlying loans using both quantitative and qualitative criteria. Certain risks associated with commercial mortgage loans can be evaluated by reviewing both the debt-to-value and debt service coverage ratio to understand both the probability of the borrower not being able to make the necessary loan payments as well as the ability to sell the underlying property for an amount that would enable us to recover our unpaid principal balance in the event of default by the borrower. The average debt-to-value ratio is based on our most recent estimate of the fair value for the underlying property which is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A lower debt-to-value indicates that our loan value is more likely to be recovered in the event of default by the borrower if the property were sold. The debt service coverage ratio is based on “normalized” annual income of the property compared to the payments required under the terms of the loan. Normalization allows for the removal of annual one-time events such as capital expenditures, prepaid or late real estate tax payments or non-recurring third-party fees (such as legal, consulting or contract fees). This ratio is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A higher debt service coverage ratio indicates the borrower is less likely to default on the loan. The debt service coverage ratio is not used without considering other factors associated with the borrower, such as the borrower’s liquidity or access to other resources that may result in our expectation that the borrower will continue to make the future scheduled payments.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables set forth commercial mortgage loans by year of origination and credit quality indicator as of September 30, 2025:


(Amounts in millions)	2025		2024		2023		2022		2021		2020 and prior		Total
Debt-to-value:
0% - 50%	$	82	$	36	$	78	$	130	$	176	$	1,944	$	2,446
51% - 60%	91		52		46		185		248		651		1,273
61% - 75%	242		111		140		497		398		968		2,356
76% - 100%	—		—		—		43		25		206		274
Greater than 100%	—		—		—		—		—		25		25
Total amortized cost	$	415	$	199	$	264	$	855	$	847	$	3,794	$	6,374
Debt service coverage ratio:
Less than 1.00	$	—	$	—	$	—	$	34	$	23	$	263	$	320
1.00 - 1.25	34		16		12		41		35		299		437
1.26 - 1.50	134		77		97		120		63		505		996
1.51 - 2.00	130		69		78		398		360		1,207		2,242
Greater than 2.00	117		37		77		262		366		1,520		2,379
Total amortized cost	$	415	$	199	$	264	$	855	$	847	$	3,794	$	6,374

The following tables set forth the debt-to-value of commercial mortgage loans by property type as of the dates indicated:



	September 30, 2025
(Amounts in millions)	0% - 50%			51% - 60%			61% - 75%			76% - 100%			Greater than 100%			Total
Property type:
Retail	$	1,195		$	577		$	840		$	6		$	—		$	2,618
Industrial	640			285			516			—			—			1,441
Office	266			200			615			238			—			1,319
Apartments	193			119			190			—			—			502
Mixed use	75			63			158			27			25			348
Other	77			29			37			3			—			146
Total amortized cost	$	2,446		$	1,273		$	2,356		$	274		$	25		$	6,374
% of total	39		%	20		%	37		%	4		%	—		%	100		%
Weighted-average debt service coverage ratio	2.52			1.89			1.54			1.07			0.81			1.96

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)



	December 31, 2024
(Amounts in millions)	0% - 50%			51% - 60%			61% - 75%			76% - 100%			Greater than 100%			Total
Property type:
Retail	$	1,108		$	689		$	917		$	2		$	—		$	2,716
Industrial	596			226			498			4			7			1,331
Office	269			220			639			263			—			1,391
Apartments	181			96			205			16			—			498
Mixed use	70			32			218			15			25			360
Other	83			45			26			—			—			154
Total amortized cost	$	2,307		$	1,308		$	2,503		$	300		$	32		$	6,450
% of total	36		%	20		%	39		%	5		%	—		%	100		%
Weighted-average debt service coverage ratio	2.38			1.87			1.60			1.37			1.01			1.92

The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by property type as of the dates indicated:



	September 30, 2025
(Amounts in millions)	Less than 1.00			1.00 - 1.25			1.26 - 1.50			1.51 - 2.00			Greater than 2.00			Total
Property type:
Retail	$	25		$	91		$	449		$	1,127		$	926		$	2,618
Industrial	50			64			225			419			683			1,441
Office	177			201			191			347			403			1,319
Apartments	17			25			88			165			207			502
Mixed use	43			45			27			127			106			348
Other	8			11			16			57			54			146
Total amortized cost	$	320		$	437		$	996		$	2,242		$	2,379		$	6,374
% of total	5		%	7		%	16		%	35		%	37		%	100		%
Weighted-average debt-to-value	75		%	70		%	64		%	57		%	43		%	54		%



	December 31, 2024
(Amounts in millions)	Less than 1.00			1.00 - 1.25			1.26 - 1.50			1.51 - 2.00			Greater than 2.00			Total
Property type:
Retail	$	35		$	98		$	469		$	1,215		$	899		$	2,716
Industrial	33			70			202			486			540			1,331
Office	124			114			207			499			447			1,391
Apartments	14			37			99			148			200			498
Mixed use	50			39			41			172			58			360
Other	9			33			16			13			83			154
Total amortized cost	$	265		$	391		$	1,034		$	2,533		$	2,227		$	6,450
% of total	4		%	6		%	16		%	39		%	35		%	100		%
Weighted-average debt-to-value	74		%	67		%	65		%	58		%	45		%	56		%

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(5) Derivative Instruments

Our business activities routinely deal with fluctuations in interest rates, equity prices, currency exchange rates and other asset and liability prices. We use derivative instruments to mitigate or reduce some of these risks. We have established policies for managing each of these risks, including prohibitions on derivatives market-making and other speculative derivatives activities. These policies require the use of derivative instruments in concert with other techniques to reduce or mitigate these risks. While we use derivatives to mitigate or reduce risks, certain derivatives do not meet the accounting requirements to be designated as hedging instruments and are denoted as “derivatives not designated as hedges” in the following disclosures. For derivatives that meet the accounting requirements to be designated as hedges, the following disclosures for these derivatives are denoted as “derivatives designated as hedges,” which include cash flow hedges.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table sets forth our positions in derivative instruments as of the dates indicated:


	Derivative assets					Derivative liabilities
		Fair value					Fair value
(Amounts in millions)	Balance sheet classification	September 30, 2025		December 31, 2024		Balance sheet classification	September 30, 2025		December 31, 2024
Derivatives designated as hedges
Cash flow hedges:
Interest rate swaps	Other invested assets	$	17	$	18	Other liabilities	$	750	$	749
Foreign currency swaps	Other invested assets	5		13		Other liabilities	4		1
Forward bond purchase commitments	Other invested assets	11		6		Other liabilities	53		44
Total cash flow hedges		33		37			807		794
Total derivatives designated as hedges		33		37			807		794
Derivatives not designated as hedges
Equity index options	Other invested assets	19		19		Other liabilities	—		—
Financial futures (1)	Other invested assets	—		—		Other liabilities	—		—
Forward bond purchase commitments	Other invested assets	—		—		Other liabilities	32		27
Foreign currency forward contracts	Other invested assets	—		—		Other liabilities	16		—
Fixed indexed annuity embedded derivatives	Other assets	—		—		Policyholder account balances (2)	142		155
Indexed universal life embedded derivatives	Reinsurance recoverable	—		—		Policyholder account balances (3)	15		15
Total derivatives not designated as hedges		19		19			205		197
Total derivatives		$	52	$	56		$	1,012	$	991

______________

(1) The period end valuations of financial futures were zero as a result of settling the margins on these contracts on a daily basis.

(2) Represents the embedded derivatives associated with our fixed indexed annuity liabilities.

(3) Represents the embedded derivatives associated with our indexed universal life liabilities.

The fair value of derivative positions presented above was not offset by the respective collateral amounts received or provided under these agreements.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:


(Notional in millions)	Measurement	December 31, 2024		Additions		Maturities/ terminations		September 30, 2025
Derivatives designated as hedges
Cash flow hedges:
Interest rate swaps	Notional	$	8,757	$	—	$	( 542 )	$	8,215
Foreign currency swaps	Notional	144		12		—		156
Forward bond purchase commitments	Notional	2,639		425		—		3,064
Total cash flow hedges		11,540		437		( 542 )		11,435
Total derivatives designated as hedges		11,540		437		( 542 )		11,435
Derivatives not designated as hedges
Equity index options	Notional	604		355		( 426 )		533
Financial futures	Notional	1,102		3,192		( 3,316 )		978
Forward bond purchase commitments	Notional	500		—		—		500
Foreign currency forward contracts	Notional	—		521		—		521
Total derivatives not designated as hedges		2,206		4,068		( 3,742 )		2,532
Total derivatives		$	13,746	$	4,505	$	( 4,284 )	$	13,967


(Number of policies)	Measurement	December 31, 2024	Additions	Maturities/ terminations	September 30, 2025
Derivatives not designated as hedges
Fixed indexed annuity embedded derivatives	Policies	4,867	—	( 526 )	4,341
Indexed universal life embedded derivatives	Policies	717	—	( 23 )	694

Cash Flow Hedges

Certain derivative instruments are designated as cash flow hedges. The changes in fair value of these instruments are recorded as a component of other comprehensive income (loss) (“OCI”). We designate and account for the following as cash flow hedges when they have met the effectiveness requirements: (i) various types of interest rate swaps to convert floating rate liabilities into fixed rate liabilities; (ii) receive U.S. dollar fixed on foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated investments; (iii) forward starting interest rate swaps to hedge against changes in interest rates associated with future fixed rate bond purchases and/or interest income; (iv) forward bond purchase commitments to hedge against the variability in the anticipated cash flows required to purchase future fixed rate bonds; and (v) other instruments to hedge the cash flows of various forecasted transactions.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table provides information about the pre-tax income effects of cash flow hedges for the three months ended September 30, 2025 :


(Amounts in millions)	Gain (loss) recognized in OCI		Gain (loss) reclassified into net income from OCI		Classification of gain (loss) reclassified into net income	Gain (loss) recognized in net income		Classification of gain (loss) recognized in net income
Interest rate swaps hedging assets	$	( 8 )	$	50	Net investment income	$	—	Net investment gains (losses)
Interest rate swaps hedging assets	—		9		Net investment gains (losses)	—		Net investment gains (losses)
Interest rate swaps hedging liabilities	—		( 1 )		Interest expense	—		Net investment gains (losses)
Foreign currency swaps	3		—		Net investment income	—		Net investment gains (losses)
Forward bond purchase commitments	19		—		Net investment gains (losses)	—		Net investment gains (losses)
Total	$	14	$	58		$	—

The following table provides information about the pre-tax income effects of cash flow hedges for the three months ended September 30, 2024 :


(Amounts in millions)	Gain (loss) recognized in OCI		Gain (loss) reclassified into net income from OCI		Classification of gain (loss) reclassified into net income	Gain (loss) recognized in net income		Classification of gain (loss) recognized in net income
Interest rate swaps hedging assets	$	181	$	55	Net investment income	$	—	Net investment gains (losses)
Interest rate swaps hedging assets	—		6		Net investment gains (losses)	—		Net investment gains (losses)


Foreign currency swaps	( 4 )		—		Net investment income	—		Net investment gains (losses)

Forward bond purchase commitments	53		—		Net investment gains (losses)	—		Net investment gains (losses)
Total	$	230	$	61		$	—

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table provides information about the pre-tax income effects of cash flow hedges for the nine months ended September 30, 2025 :


(Amounts in millions)	Gain (loss) recognized in OCI		Gain (loss) reclassified into net income from OCI		Classification of gain (loss) reclassified into net income	Gain (loss) recognized in net income		Classification of gain (loss) recognized in net income
Interest rate swaps hedging assets	$	( 31 )	$	145	Net investment income	$	—	Net investment gains (losses)
Interest rate swaps hedging assets	—		11		Net investment gains (losses)	—		Net investment gains (losses)
Interest rate swaps hedging liabilities	( 3 )		( 2 )		Interest expense	—		Net investment gains (losses)
Foreign currency swaps	( 11 )		—		Net investment income	—		Net investment gains (losses)
Forward bond purchase commitments	( 4 )		—		Net investment gains (losses)	—		Net investment gains (losses)
Total	$	( 49 )	$	154		$	—

The following table provides information about the pre-tax income effects of cash flow hedges for the nine months ended September 30, 2024 :


(Amounts in millions)	Gain (loss) recognized in OCI		Gain (loss) reclassified into net income from OCI		Classification of gain (loss) reclassified into net income	Gain (loss) recognized in net income		Classification of gain (loss) recognized in net income
Interest rate swaps hedging assets	$	( 44 )	$	160	Net investment income	$	—	Net investment gains (losses)
Interest rate swaps hedging assets	—		11		Net investment gains (losses)	—		Net investment gains (losses)
Interest rate swaps hedging liabilities	—		( 2 )		Interest expense	—		Net investment gains (losses)

Foreign currency swaps	( 1 )		—		Net investment income	—		Net investment gains (losses)

Forward bond purchase commitments	9		—		Net investment gains (losses)	—		Net investment gains (losses)
Total	$	( 36 )	$	169		$	—

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The change for these designated derivatives reported in accumulated other comprehensive income (loss) was as follows as of and for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Beginning balance	$	380	$	730	$	492	$	1,010
Current period increases (decreases) in fair value (1)	11		181		( 39 )		( 29 )
Reclassification to net (income) (2)	( 38 )		( 40 )		( 100 )		( 110 )
Ending balance	$	353	$	871	$	353	$	871

______________

(1) Net of deferred taxes of $( 3 ) million and $( 49 ) million during the three months ended September 30, 2025 and 2024, respectively, and $ 10 million and $ 7 million during the nine months ended September 30, 2025 and 2024, respectively.

(2) Net of deferred taxes of $ 20 million and $ 21 million during the three months ended September 30, 2025 and 2024, respectively, and $ 54 million and $ 59 million during the nine months ended September 30, 2025 and 2024, respectively.

The total balance in accumulated other comprehensive income (loss) from derivatives designated as cash flow hedges of $ 353 million, net of taxes, recorded in stockholders’ equity as of September 30, 2025 is expected to be reclassified to net income (loss) in the future, concurrently with and primarily offsetting changes in interest expense and interest income on floating rate instruments and interest income on future fixed rate bond purchases. Of this amount, $ 125 million, net of taxes, is expected to be reclassified to net income (loss) in the next 12 months. Actual amounts may vary from this amount as a result of market conditions. All forecasted transactions associated with qualifying cash flow hedges are expected to occur by 2057. During the nine months ended September 30, 2025 and 2024, we reclassified $ 10 million and $ 9 million, respectively, to net income in connection with forecasted transactions that were no longer considered reasonably possible of occurring.

Derivatives Not Designated As Hedges

We enter into certain non-qualifying derivative instruments such as equity index options and financial futures to mitigate the risks associated with liabilities that have guaranteed minimum benefits, fixed indexed annuities and indexed universal life. Our fixed indexed annuity and indexed universal life insurance products with certain features are required to be bifurcated as embedded derivatives. Additionally, we have forward bond purchase commitments to hedge against the variability in the anticipated cash flows required to purchase future fixed rate bonds, as well as foreign currency forward contracts to mitigate currency risk associated with anticipated future foreign currency denominated cash flows.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table provides the pre-tax gain (loss) recognized in net income for the effects of derivatives not designated as hedges for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,				Classification of gain (loss) recognized in net income
(Amounts in millions)	2025		2024		2025		2024
Equity index options	$	4	$	2	$	5	$	8		Net investment gains (losses)
Financial futures	( 24 )		6		( 41 )		( 73 )			Changes in fair value of market risk benefits and associated hedges
Forward bond purchase commitments	3		6		( 5 )		( 5 )			Net investment gains (losses)
Foreign currency forward contracts	8		—		( 16 )		—			Net investment gains (losses)
Fixed indexed annuity embedded derivatives	( 5 )		( 2 )		( 7 )		( 15 )			Net investment gains (losses)
Indexed universal life embedded derivatives	( 2 )		( 2 )		( 1 )		4			Net investment gains (losses)
Total derivatives not designated as hedges	$	( 16 )	$	10	$	( 65 )	$	( 81 )

Derivative Counterparty Credit Risk

Most of our derivative arrangements with counterparties require the posting of collateral upon meeting certain net exposure thresholds. The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of the dates indicated:



	September 30, 2025						December 31, 2024
(Amounts in millions)	Derivative assets (1)		Derivative liabilities (1)		Net derivatives		Derivative assets (1)		Derivative liabilities (1)		Net derivatives
Amounts presented in the balance sheet:
Gross amounts recognized	$	52	$	855	$	( 803 )	$	56	$	821	$	( 765 )
Gross amounts offset in the balance sheet	—		—		—		—		—		—
Net amounts presented in the balance sheet	52		855		( 803 )		56		821		( 765 )
Gross amounts not offset in the balance sheet:
Financial instruments (2)	( 25 )		( 25 )		—		( 31 )		( 31 )		—
Collateral received	( 21 )		—		( 21 )		( 11 )		—		( 11 )
Collateral pledged	—		( 1,617 )		1,617		—		( 1,592 )		1,592
Over collateralization	1		803		( 802 )		1		802		( 801 )
Net amount	$	7	$	16	$	( 9 )	$	15	$	—	$	15

______________

(1) Does not include amounts related to embedded derivatives as of September 30, 2025 and December 31, 2024.

(2) Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty.

(6) Fair Value of Financial Instruments

Recurring Fair Value Measurements

We have fixed maturity securities, equity securities, limited partnerships, derivatives, short-term investments, embedded derivatives, separate account assets, market risk benefits (“MRBs”) and certain other financial instruments, which are carried at fair value. Below is a description of the valuation techniques and inputs used to determine fair value by class of instrument.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Fixed maturity securities, equity securities and short-term investments

The fair value of fixed maturity securities, equity securities and short-term investments is estimated primarily based on information derived from third-party pricing services (“pricing services”), broker quotes and/or internal models, which may use a market approach, income approach or a combination of the market and income approach depending on the type of instrument and availability of information. In general, a market approach is utilized if there is readily available and relevant market activity for an individual security. In certain cases where market information is not available for a specific security but is available for similar securities, that security is valued using market information for similar securities, which is also a market approach. When market information is not available for a specific security (or similar securities) or is available but such information is less relevant or reliable, an income approach or a combination of a market and income approach is utilized. For securities with optionality, such as call or prepayment features (including mortgage-backed or asset-backed securities), an income approach may be used. These valuation techniques may change from period to period, based on the relevance and availability of market data.

Further, while we consider the valuations provided by pricing services and broker quotes to be of high quality, management determines the fair value of our investment securities after considering all relevant and available information.

In general, we first obtain valuations from pricing services. If prices are unavailable for public securities, we obtain broker quotes. For all securities, excluding certain private fixed maturity securities, if neither a pricing service nor broker quotes valuation is available, we determine fair value using internal models. For certain private fixed maturity securities where we do not obtain valuations from pricing services, we utilize an internal model to determine fair value since transactions for similar securities are not readily observable and these securities are not typically valued by pricing services.

Given our understanding of the pricing methodologies and procedures of pricing services, the securities valued by pricing services are typically classified as Level 2 unless we determine the valuation process for a security or group of securities utilizes significant unobservable inputs, which would result in the valuation being classified as Level 3. Broker quotes may be utilized when pricing services data is not available and are typically classified as Level 3 due to the use of significant unobservable inputs.

For private fixed maturity securities, we utilize an income approach where we obtain public bond spreads and utilize those in an internal model to determine fair value. Other inputs to the model include rating and weighted-average life, as well as sector which is used to assign the spread. We then add an additional premium, which represents an unobservable input, to the public bond spread to adjust for the liquidity and other features of our private placements. We utilize the estimated market yield to discount the expected cash flows of the security to determine fair value. We utilize price caps for securities where the estimated market yield results in a valuation that may exceed the amount that would be received in a market transaction. When a security does not have an external rating, we assign the security an internal rating to determine the appropriate public bond spread that should be utilized in the valuation. While we generally consider the public bond spreads by sector and maturity to be observable inputs, we evaluate the similarities of our private placements with the public bonds, price caps, liquidity premiums applied, and whether external ratings are available for our private placements to determine whether the spreads utilized would be considered observable inputs, leading to a classification of Level 2. We classify private securities without an external rating or public bond spread as Level 3. In general, a significant increase (decrease) in credit spreads would have resulted in a significant decrease (increase) in the fair value for our fixed maturity securities as of September 30, 2025.

For remaining securities priced using internal models, we determine fair value using an income approach. We maximize the use of observable inputs but typically utilize significant unobservable inputs to determine fair value. Accordingly, the valuations are typically classified as Level 3.

Our assessment of whether or not there were significant unobservable inputs related to fixed maturity securities was based on our observations obtained through the course of managing our investment portfolio, including interaction with other market participants, observations related to the availability and consistency of pricing and/or rating, and understanding of general market activity such as new issuance and the level of secondary market trading for a class of securities. Additionally, we considered data obtained from pricing services to determine whether our estimated values incorporate significant unobservable inputs that would result in the valuation being classified as Level 3.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

A summary of the inputs used for our financial instruments carried at fair value based on the level in which instruments are classified is included below. We have combined certain classes of instruments together as the nature of the inputs is similar.

Level 1 measurements

Equity securities. The primary inputs to the valuation of exchange-traded equity securities include quoted prices for the identical instrument.

Separate account assets. The fair value of separate account assets is based on the quoted prices of the underlying fund investments and, therefore, represents Level 1 pricing.

Level 2 measurements

Fixed maturity securities

• Third-party pricing services: In estimating the fair value of fixed maturity securities, 88 % of our portfolio was priced using third-party pricing services as of September 30, 2025. These pricing services utilize industry-standard valuation techniques that include market-based approaches, income-based approaches, a combination of market-based and income-based approaches or other proprietary, internally generated models as part of the valuation processes. These third-party pricing vendors maximize the use of publicly available data inputs to generate valuations for each asset class. Priority and type of inputs used may change frequently as certain inputs may be more direct drivers of valuation at the time of pricing. Examples of significant inputs incorporated by pricing services may include sector and issuer spreads, seasoning, capital structure, security optionality, collateral data, prepayment assumptions, default assumptions, delinquencies, debt covenants, benchmark yields, trade data, dealer quotes, credit ratings, maturity and weighted-average life. We conduct regular meetings with our pricing services for the purpose of understanding the methodologies, techniques and inputs used by the third-party pricing providers.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents a summary of the significant inputs used by our pricing services for certain fair value measurements of fixed maturity securities that are classified as Level 2 as of September 30, 2025:

(Amounts in millions)

Fair value

Primary methodologies

Significant inputs

U.S. government, agencies and government-sponsored enterprises

3,593

Price quotes from trading desk, broker feeds

Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association OAS, Treasury Curve, Agency Bullet Curve, maturity to issuer spread

State and political subdivisions

2,145

Multi-dimensional attribute-based modeling systems, exchanges for the bond or comparable liquid bonds

Trade prices, material event notices, Municipal Market Data benchmark yields, broker quotes

Non-U.S. government

1,188

Price quotes from market makers, spread priced to benchmark curves, matrix pricing

Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources

U.S. corporate

23,806

Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, OAS-based models

Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports

Non-U.S. corporate

5,795

Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from market makers

Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources

Residential mortgage-backed

1,057

OAS-based models, single factor binomial models, internally priced, pay-up to the to be announced price

Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports

Commercial

mortgage-backed

1,332

Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp commercial mortgage-backed securities analytics model

Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swap curves, TRACE reports

Other asset-backed

1,790

Multi-dimensional attribute-based modeling systems, spread matrix priced to swap curves, price quotes from market makers

Spreads to daily updated swap curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of prepayment speeds, cash flows, collateral loss analytics, historical issue analysis, trade data from market makers, TRACE reports

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

• Internal models: A portion of our U.S. corporate and n on-U.S. corporate securities are valued using internal models. The fair value of these fixed maturity securities was $ 1,669 million and $ 820 million, re spectively, as of September 30, 2025. Internally modeled securities are primarily private fixed maturity securities where we use market observable inputs such as an interest rate yield curve, published credit spreads for similar securities based on the external ratings of the instrument and related industry sector of the issuer. Additionally, we may apply certain price caps and liquidity premiums in the valuation of private fixed maturity securities. Price caps and liquidity premiums are established using inputs from market participants.

Equity securities. The primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active.

Short-term investments. The fair value of short-term investments classified as Level 2 is determined after considering prices obtained by pricing services.

Level 3 measurements

Fixed maturity securities

• Broker quotes: A portion of our non-U.S. government, U.S. corporate, non-U.S. corporate, residential mortgage-backed, commercial mortgage-backed and other asset-backed securities are valued using broker quotes. Broker quotes are obtained from third-party providers that have current market knowledge to provide a reasonable price for securities not routinely priced by pricing services. Brokers utilized for valuation of assets are reviewed annually. The fair value of our Level 3 fixed maturity securities priced by broker quotes was $ 355 million as of September 30, 2025.

• Internal models: A portion of our U.S. corporate, non-U.S. corporate, residential mortgage-backed and other asset-backed securities are valued using internal models. The primary inputs to the valuation of the bond population include quoted prices for similar assets in markets that are not active, contractual cash flows, duration, call provisions, issuer rating, benchmark yields and credit spreads. Certain private fixed maturity securities are valued using an internal model using market observable inputs such as the interest rate yield curve, as well as published credit spreads for similar securities, which can include significant unobservable inputs. Additionally, we may apply certain price caps and liquidity premiums in the valuation of private fixed maturity securities. Price caps are established using inputs from market participants. For structured securities, the primary inputs to the valuation include quoted prices for similar assets in markets that are not active, contractual cash flows, weighted-average coupon, weighted-average maturity, issuer rating, structure of the security, expected prepayment speeds and volumes, collateral type, current and forecasted loss severity, average delinquency rates, vintage of the loans, geographic region, debt service coverage ratios, payment priority with the tranche, benchmark yields and credit spreads. The fair value of our Level 3 fixed maturity securities priced using internal models was $ 2,560 million as of September 30, 2025.

Equity securities. The primary inputs to the valuation include broker quotes where the underlying inputs are unobservable and for internal models, structure of the security and issuer rating.

Limited partnerships. The fair value of limited partnerships classified as Level 3 is determined based on third-party valuation sources that utilize unobservable inputs, such as a reference to public market or private transactions, valuations for comparable companies or assets, discounted cash flows and/or recent transactions.

Short-term investments. The primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, duration, call provisions, issuer rating, benchmark yields and credit spreads.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Net asset value

Limited partnerships. Limited partnerships are valued based on comparable market transactions, discounted future cash flows, quoted market prices and/or estimates using the most recent data available for the underlying instrument. We utilize the net asset value (“NAV”) from the underlying fund statements as a practical expedient for fair value.

Derivatives

We consider counterparty collateral arrangements and rights of set-off when evaluating our net credit risk exposure to our derivative counterparties. Accordingly, we are permitted to include consideration of these arrangements when determining whether any incremental adjustment should be made for both the counterparty’s and our non-performance risk in measuring fair value for our derivative instruments. As a result of these counterparty arrangements, we determined that any adjustment for credit risk would not be material and we have not recorded any incremental adjustment for our non-performance risk or the non-performance risk of the derivative counterparties for our derivative assets or liabilities.

Interest rate swaps. The valuation of interest rate swaps is determined using an income approach. The primary input into the valuation represents the forward interest rate swap curve, which is generally considered an observable input, and results in the derivative being classified as Level 2. For certain interest rate swaps, the inputs into the valuation also include the total returns of certain bonds that would primarily be considered an observable input and result in the derivative being classified as Level 2.

Foreign currency swaps. The valuation of foreign currency swaps is determined using an income approach. The primary inputs into the valuation represent the forward interest rate swap curve and foreign currency exchange rates, both of which are considered observable inputs, and results in the derivative being classified as Level 2.

Equity index options. We have equity index options associated with various equity indices. The valuation of equity index options is determined using an income approach. The primary inputs into the valuation represent forward interest rates, equity index volatility, equity index and time value component associated with the optionality in the derivative. The equity index volatility surface is determined based on market information that is not readily observable and is developed based upon inputs received from several third-party sources. Accordingly, these options are classified as Level 3. As of September 30, 2025, a significant increase (decrease) in the equity index volatility discussed above would have resulted in a significantly higher (lower) fair value measurement.

Financial futures. The fair value of financial futures is based on the closing exchange prices. Accordingly, these financial futures are classified as Level 1. The period end valuation is zero as a result of settling the margins on these contracts on a daily basis.

Forward bond purchase commitments. The valuation of forward bond purchase commitments is determined using an income approach. The primary inputs into the valuation represent current bond prices and interest rates, as well as an estimate of the cost of counterparty financing to acquire and carry the bond during the forward period. The estimated cost of counterparty financing is not readily observable and is developed based upon an assumed spread; accordingly, these derivatives are classified as Level 3.

Foreign currency forward contracts. The valuation of foreign currency forward contracts is determined using an income approach. The primary inputs into the valuation represent the forward foreign currency exchange rates, which are generally considered observable inputs and results in the derivative being classified as Level 2.

Fixed indexed annuity and indexed universal life embedded derivatives. We have fixed indexed annuity and indexed universal life insurance products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. As a result of our assumptions for expected future interest credited being considered significant unobservable inputs, we classify these

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

instruments as Level 3. As expected future interest credited decreases, the value of our embedded derivative liability will decrease. As of September 30, 2025, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement.

Market risk benefits

MRBs are contracts or contract features that provide protection to the contractholder from and expose us to other-than-nominal capital market risk. MRBs include certain contract features on fixed and variable annuity products that provide minimum guarantees, in addition to the policyholder account balance, such as guaranteed minimum death benefits (“GMDBs”), guaranteed minimum withdrawal benefits (“GMWBs”) and guaranteed payout annuity floor benefits (“GPAFs”). MRBs are measured at fair value using an income-based valuation model based on current net amounts at risk, market data, experience and other factors.

MRB assets and liabilities for minimum guarantees are valued and presented separately from the related separate account and policyholder account balances.

Fixed indexed annuities

The valuation of fixed indexed annuities MRBs, which includes GMWB features, is based on an income approach that incorporates inputs such as policyholder behavior (GMWB utilization, lapses and mortality), equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. Our discount rate used to determine fair value of our fixed indexed annuities MRBs includes market credit spreads above U.S. Treasury rates to reflect an adjustment for the non-performance risk of the fixed indexed annuities MRBs. We determine fair value using an internal model based on the various inputs noted above. As a result of our assumptions for GMWB utilization, expected future interest credited and non-performance risk being considered significant unobservable inputs, we classify these instruments as Level 3. As expected future interest credited decreases or GMWB utilization increases, the value of our fixed indexed annuities MRB liability will increase. Any increase in non-performance risk would increase the discount rate and would decrease the fair value of the liability. As of September 30, 2025, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. Refer to note 11 for additional details related to the changes in the fair value measurement of fixed indexed annuities MRBs as of September 30, 2025 and December 31, 2024.

Variable annuities

The valuation of our variable annuities MRBs, which includes GMWB, GMDB and GPAF features, is based on an income approach that incorporates inputs such as policyholder behavior (GMWB utilization, lapses and mortality), equity index volatility, interest rates, equity index and fund correlation and an adjustment to the discount rate to incorporate non-performance risk and risk margins. Our discount rate used to determine fair value of our variable annuities MRBs includes market credit spreads above U.S. Treasury rates to reflect an adjustment for the non-performance risk of the variable annuities MRBs. We determine fair value using an internal model based on the various inputs noted above. We classify the variable annuities MRBs valuation as Level 3 based on having significant unobservable inputs, with policyholder behavior (GMWB utilization and lapses), equity index volatility and non-performance risk being considered the more significant unobservable inputs. As equity index volatility increases, the fair value of the variable annuities MRBs will increase. An increase in our lapse assumption would decrease the fair value of the variable annuities MRBs, whereas an increase in our GMWB utilization rate would increase the fair value. Any increase in non-performance risk would increase the discount rate and would decrease the fair value of the liability. As of September 30, 2025, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. Refer to note 11 for additional details related to the changes in the fair value measurement of variable annuities MRBs as of September 30, 2025 and December 31, 2024.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables set forth our assets by class of instrument that are measured at fair value on a recurring basis as of the dates indicated:



	September 30, 2025
(Amounts in millions)	Total		Level 1		Level 2		Level 3		NAV (1)
Assets
Investments:
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises	$	3,593	$	—	$	3,593	$	—	$	—
State and political subdivisions	2,145		—		2,145		—		—
Non-U.S. government	1,203		—		1,188		15		—
U.S. corporate:
Utilities	4,543		—		3,612		931		—
Energy	2,415		—		2,394		21		—
Finance and insurance	7,095		—		6,495		600		—
Consumer—non-cyclical	4,482		—		4,433		49		—
Technology and communications	2,816		—		2,797		19		—
Industrial	1,035		—		1,019		16		—
Capital goods	2,314		—		2,278		36		—
Consumer—cyclical	1,358		—		1,277		81		—
Transportation	1,064		—		1,036		28		—
Other	269		—		134		135		—
Total U.S. corporate	27,391		—		25,475		1,916		—
Non-U.S. corporate:
Utilities	655		—		413		242		—
Energy	1,003		—		897		106		—
Finance and insurance	1,708		—		1,686		22		—
Consumer—non-cyclical	573		—		541		32		—
Technology and communications	733		—		724		9		—
Industrial	762		—		646		116		—
Capital goods	698		—		641		57		—
Consumer—cyclical	245		—		243		2		—
Transportation	444		—		408		36		—
Other	480		—		416		64		—
Total non-U.S. corporate	7,301		—		6,615		686		—
Residential mortgage-backed	1,059		—		1,057		2		—
Commercial mortgage-backed	1,360		—		1,332		28		—
Other asset-backed	2,058		—		1,790		268		—
Total fixed maturity securities	46,110		—		43,195		2,915		—
Equity securities	546		477		28		41		—
Limited partnerships	2,743		—		—		16		2,727
Other invested assets:
Derivative assets:
Interest rate swaps	17		—		17		—		—
Foreign currency swaps	5		—		5		—		—
Equity index options	19		—		—		19		—
Forward bond purchase commitments	11		—		—		11		—

Total derivative assets	52		—		22		30		—
Short-term investments	26		—		19		7		—
Total other invested assets	78		—		41		37		—
Separate account assets	4,449		4,449		—		—		—
Total assets	$	53,926	$	4,926	$	43,264	$	3,009	$	2,727

________________

(1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)



	December 31, 2024
(Amounts in millions)	Total		Level 1		Level 2		Level 3		NAV (1)
Assets
Investments:
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises	$	3,493	$	—	$	3,493	$	—	$	—
State and political subdivisions	2,149		—		2,149		—		—
Non-U.S. government	909		—		896		13		—
U.S. corporate:
Utilities	4,282		—		3,437		845		—
Energy	2,312		—		2,291		21		—
Finance and insurance	6,911		—		6,223		688		—
Consumer—non-cyclical	4,387		—		4,324		63		—
Technology and communications	2,723		—		2,711		12		—
Industrial	1,072		—		1,057		15		—
Capital goods	2,243		—		2,200		43		—
Consumer—cyclical	1,497		—		1,398		99		—
Transportation	1,074		—		1,043		31		—
Other	270		—		137		133		—
Total U.S. corporate	26,771		—		24,821		1,950		—
Non-U.S. corporate:
Utilities	693		—		411		282		—
Energy	1,006		—		890		116		—
Finance and insurance	1,774		—		1,753		21		—
Consumer—non-cyclical	556		—		517		39		—
Technology and communications	726		—		709		17		—
Industrial	766		—		699		67		—
Capital goods	591		—		544		47		—
Consumer—cyclical	230		—		230		—		—
Transportation	436		—		401		35		—
Other	549		—		498		51		—
Total non-U.S. corporate	7,327		—		6,652		675		—
Residential mortgage-backed	811		—		809		2		—
Commercial mortgage-backed	1,301		—		1,290		11		—
Other asset-backed	2,141		—		1,999		142		—
Total fixed maturity securities	44,902		—		42,109		2,793		—
Equity securities	515		401		70		44		—
Limited partnerships	2,460		—		—		19		2,441
Other invested assets:
Derivative assets:
Interest rate swaps	18		—		18		—		—
Foreign currency swaps	13		—		13		—		—
Equity index options	19		—		—		19		—
Forward bond purchase commitments	6		—		—		6		—
Total derivative assets	56		—		31		25		—
Short-term investments	4		—		4		—		—
Total other invested assets	60		—		35		25		—
Separate account assets	4,438		4,438		—		—		—
Total assets	$	52,375	$	4,839	$	42,214	$	2,881	$	2,441

_________________

(1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated:


	Beginning balance as of July 1, 2025		Total realized and unrealized gains (losses)																Ending balance as of September 30, 2025		Total gains (losses) attributable to assets still held
(Amounts in millions)			Included in net income		Included in OCI		Purchases		Sales		Issuances		Settlements		Transfer into Level 3 (1)		Transfer out of Level 3 (1)				Included in net income		Included in OCI
Fixed maturity securities:

Non-U.S. government	$	15	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	15	$	—	$	—
U.S. corporate:
Utilities	886		1		15		32		—		—		( 3 )		—		—		931		1		16
Energy	21		—		—		—		—		—		—		—		—		21		—		—
Finance and insurance	668		—		10		—		—		—		( 49 )		—		( 29 )		600		—		9
Consumer—non-cyclical	49		—		1		—		—		—		( 1 )		—		—		49		—		1
Technology and communications	17		—		1		1		—		—		—		—		—		19		—		1
Industrial	15		—		1		—		—		—		—		—		—		16		—		1
Capital goods	45		—		—		—		—		—		—		—		( 9 )		36		—		—
Consumer—cyclical	90		—		1		—		( 1 )		—		( 1 )		—		( 8 )		81		—		—
Transportation	29		—		—		—		—		—		( 1 )		—		—		28		—		—
Other	135		—		1		—		—		—		( 1 )		—		—		135		—		1
Total U.S. corporate	1,955		1		30		33		( 1 )		—		( 56 )		—		( 46 )		1,916		1		29
Non-U.S. corporate:
Utilities	262		( 1 )		—		1		( 20 )		—		—		—		—		242		—		—
Energy	106		—		—		—		—		—		—		—		—		106		—		—
Finance and insurance	22		—		1		—		—		—		( 1 )		—		—		22		—		1
Consumer—non-cyclical	31		—		1		—		—		—		—		—		—		32		—		1
Technology and communications	17		—		—		—		—		—		( 8 )		—		—		9		—		—
Industrial	111		—		1		4		—		—		—		—		—		116		—		1
Capital goods	56		—		1		—		—		—		—		—		—		57		—		—
Consumer—cyclical	—		—		—		2		—		—		—		—		—		2		—		—
Transportation	36		—		—		—		—		—		—		—		—		36		—		—
Other	64		—		—		—		—		—		—		—		—		64		—		—
Total non-U.S. corporate	705		( 1 )		4		7		( 20 )		—		( 9 )		—		—		686		—		3
Residential mortgage-backed	2		—		—		—		—		—		—		—		—		2		—		—
Commercial mortgage-backed	11		—		—		17		—		—		—		—		—		28		—		—
Other asset-backed	201		—		2		44		—		—		( 4 )		26		( 1 )		268		—		3
Total fixed maturity securities	2,889		—		36		101		( 21 )		—		( 69 )		26		( 47 )		2,915		1		35
Equity securities	41		—		—		—		—		—		—		—		—		41		—		—
Limited partnerships	17		( 1 )		—		—		—		—		—		—		—		16		( 1 )		—
Other invested assets:
Derivative assets:
Equity index options	17		4		—		3		—		—		( 5 )		—		—		19		4		—
Forward bond purchase commitments	6		—		5		—		—		—		—		—		—		11		—		5
Total derivative assets	23		4		5		3		—		—		( 5 )		—		—		30		4		5
Short-term investments	—		—		—		7		—		—		—		—		—		7		—		—
Total other invested assets	23		4		5		10		—		—		( 5 )		—		—		37		4		5
Total Level 3 assets	$	2,970	$	3	$	41	$	111	$	( 21 )	$	—	$	( 74 )	$	26	$	( 47 )	$	3,009	$	4	$	40

_______________

(1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Beginning balance as of July 1, 2024		Total realized and unrealized gains (losses)																Ending balance as of September 30, 2024		Total gains (losses) attributable to assets still held
(Amounts in millions)			Included in net income		Included in OCI		Purchases		Sales		Issuances		Settlements		Transfer into Level 3 (1)		Transfer out of Level 3 (1)				Included in net income		Included in OCI
Fixed maturity securities:
State and political subdivisions	$	65	$	1	$	3	$	—	$	—	$	—	$	—	$	—	$	( 65 )	$	4	$	—	$	—
Non-U.S. government	—		—		—		14		—		—		—		—		—		14		—		—
U.S. corporate:
Utilities	843		( 5 )		52		8		—		—		( 16 )		—		—		882		—		46
Energy	45		—		2		—		—		—		—		—		—		47		—		1
Finance and insurance	680		( 2 )		30		—		—		—		( 2 )		—		—		706		—		27
Consumer—non-cyclical	63		—		2		—		—		—		—		—		—		65		—		2
Technology and communications	12		—		—		—		—		—		—		—		—		12		—		—
Industrial	15		( 1 )		1		—		—		—		—		—		—		15		—		—
Capital goods	54		—		3		—		—		—		( 10 )		—		—		47		—		3
Consumer—cyclical	117		—		2		—		—		—		( 2 )		—		( 14 )		103		—		2
Transportation	20		—		1		13		—		—		( 1 )		—		—		33		—		1
Other	135		—		3		—		—		—		—		—		—		138		—		3
Total U.S. corporate	1,984		( 8 )		96		21		—		—		( 31 )		—		( 14 )		2,048		—		85
Non-U.S. corporate:
Utilities	280		—		7		—		—		—		( 1 )		36		( 7 )		315		—		8
Energy	119		—		4		—		—		—		( 2 )		—		—		121		—		4
Finance and insurance	133		2		5		—		—		—		—		—		( 99 )		41		—		1
Consumer—non-cyclical	77		( 1 )		2		—		( 14 )		—		( 25 )		—		—		39		—		1
Technology and communications	17		—		—		—		—		—		—		—		—		17		—		—
Industrial	60		—		2		—		—		—		—		—		—		62		—		3
Capital goods	45		—		2		—		( 4 )		—		—		—		—		43		—		1
Consumer—cyclical	7		—		1		—		—		—		—		—		( 8 )		—		—		—
Transportation	22		—		—		—		( 1 )		—		—		—		—		21		—		—
Other	51		—		2		—		—		—		—		—		—		53		—		2
Total non-U.S. corporate	811		1		25		—		( 19 )		—		( 28 )		36		( 114 )		712		—		20
Residential mortgage-backed	2		—		1		—		—		—		—		—		—		3		—		—
Commercial mortgage-backed	11		—		1		—		—		—		—		—		—		12		—		1
Other asset-backed	113		—		1		13		—		—		( 2 )		—		( 25 )		100		—		1
Total fixed maturity securities	2,986		( 6 )		127		48		( 19 )		—		( 61 )		36		( 218 )		2,893		—		107
Equity securities	42		—		—		1		—		—		—		—		—		43		—		—
Limited partnerships	16		( 1 )		—		—		—		—		( 1 )		—		—		14		( 1 )		—
Other invested assets:
Derivative assets:
Equity index options	21		2		—		3		—		—		( 5 )		—		—		21		2		—
Forward bond purchase commitments	21		—		39		—		—		—		—		—		—		60		—		39
Total derivative assets	42		2		39		3		—		—		( 5 )		—		—		81		2		39

Total other invested assets	42		2		39		3		—		—		( 5 )		—		—		81		2		39
Total Level 3 assets	$	3,086	$	( 5 )	$	166	$	52	$	( 19 )	$	—	$	( 67 )	$	36	$	( 218 )	$	3,031	$	1	$	146

___________________

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Beginning balance as of January 1, 2025		Total realized and unrealized gains (losses)																Ending balance as of September 30, 2025		Total gains (losses) attributable to assets still held
(Amounts in millions)			Included in net income		Included in OCI		Purchases		Sales		Issuances		Settlements		Transfer into Level 3 (1)		Transfer out of Level 3 (1)				Included in net income		Included in OCI
Fixed maturity securities:

Non-U.S. government	$	13	$	—	$	1	$	1	$	—	$	—	$	—	$	—	$	—	$	15	$	—	$	1
U.S. corporate:
Utilities	845		1		29		73		—		—		( 8 )		10		( 19 )		931		1		29
Energy	21		—		—		—		—		—		—		—		—		21		—		—
Finance and insurance	688		—		30		25		—		—		( 79 )		—		( 64 )		600		—		28
Consumer—non-cyclical	63		—		2		—		—		—		( 16 )		—		—		49		—		2
Technology and communications	12		—		1		1		—		—		—		5		—		19		—		1
Industrial	15		—		1		—		—		—		—		—		—		16		—		1
Capital goods	43		—		2		—		—		—		—		—		( 9 )		36		—		2
Consumer—cyclical	99		( 3 )		6		8		( 17 )		—		( 4 )		—		( 8 )		81		—		3
Transportation	31		—		1		—		—		—		( 4 )		—		—		28		—		1
Other	133		—		2		10		—		—		( 10 )		—		—		135		—		2
Total U.S. corporate	1,950		( 2 )		74		117		( 17 )		—		( 121 )		15		( 100 )		1,916		1		69
Non-U.S. corporate:
Utilities	282		( 5 )		9		1		( 20 )		—		( 4 )		—		( 21 )		242		( 4 )		9
Energy	116		—		( 1 )		3		( 4 )		—		( 8 )		—		—		106		—		( 1 )
Finance and insurance	21		—		2		—		—		—		( 1 )		—		—		22		—		2
Consumer—non-cyclical	39		—		1		—		—		—		( 8 )		—		—		32		—		1
Technology and communications	17		—		—		—		—		—		( 8 )		—		—		9		—		—
Industrial	67		—		5		4		—		—		—		40		—		116		—		5
Capital goods	47		—		2		8		—		—		—		—		—		57		—		2
Consumer—cyclical	—		—		—		2		—		—		—		—		—		2		—		—
Transportation	35		—		1		—		—		—		—		—		—		36		—		1
Other	51		—		1		12		—		—		—		—		—		64		—		1
Total non-U.S. corporate	675		( 5 )		20		30		( 24 )		—		( 29 )		40		( 21 )		686		( 4 )		20
Residential mortgage-backed	2		—		—		—		—		—		—		—		—		2		—		—
Commercial mortgage-backed	11		—		—		17		—		—		—		—		—		28		—		—
Other asset-backed	142		1		2		92		—		—		( 9 )		46		( 6 )		268		—		3
Total fixed maturity securities	2,793		( 6 )		97		257		( 41 )		—		( 159 )		101		( 127 )		2,915		( 3 )		93
Equity securities	44		—		—		—		( 3 )		—		—		—		—		41		—		—
Limited partnerships	19		( 3 )		—		—		—		—		—		—		—		16		( 3 )		—
Other invested assets:
Derivative assets:
Equity index options	19		5		—		9		—		—		( 14 )		—		—		19		5		—
Forward bond purchase commitments	6		—		5		—		—		—		—		—		—		11		—		5
Total derivative assets	25		5		5		9		—		—		( 14 )		—		—		30		5		5
Short-term investments	—		—		—		7		—		—		—		—		—		7		—		—
Total other invested assets	25		5		5		16		—		—		( 14 )		—		—		37		5		5
Total Level 3 assets	$	2,881	$	( 4 )	$	102	$	273	$	( 44 )	$	—	$	( 173 )	$	101	$	( 127 )	$	3,009	$	( 1 )	$	98

_______________

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Beginning balance as of January 1, 2024		Total realized and unrealized gains (losses)																Ending balance as of September 30, 2024		Total gains (losses) attributable to assets still held
(Amounts in millions)			Included in net income		Included in OCI		Purchases		Sales		Issuances		Settlements		Transfer into Level 3 (1)		Transfer out of Level 3 (1)				Included in net income		Included in OCI
Fixed maturity securities:
State and political subdivisions	$	60	$	3	$	6	$	—	$	—	$	—	$	—	$	—	$	( 65 )	$	4	$	2	$	3
Non-U.S. government	—		—		—		14		—		—		—		—		—		14		—		—
U.S. corporate:
Utilities	881		( 5 )		17		40		( 13 )		—		( 42 )		8		( 4 )		882		—		9
Energy	60		( 1 )		3		—		( 4 )		—		( 11 )		—		—		47		—		1
Finance and insurance	717		( 1 )		24		—		—		—		( 67 )		33		—		706		—		18
Consumer—non-cyclical	69		—		1		—		—		—		( 5 )		—		—		65		—		1
Technology and communications	12		—		—		—		—		—		—		—		—		12		—		—
Industrial	23		( 1 )		1		—		—		—		( 8 )		—		—		15		—		—
Capital goods	35		—		2		20		—		—		( 10 )		—		—		47		—		2
Consumer—cyclical	122		—		( 1 )		—		—		—		( 4 )		—		( 14 )		103		—		( 1 )
Transportation	22		—		1		13		—		—		( 3 )		—		—		33		—		1
Other	149		—		—		—		—		—		( 11 )		—		—		138		—		—
Total U.S. corporate	2,090		( 8 )		48		73		( 17 )		—		( 161 )		41		( 18 )		2,048		—		31
Non-U.S. corporate:
Utilities	269		—		( 2 )		35		—		—		( 16 )		36		( 7 )		315		—		( 2 )
Energy	131		—		3		—		—		—		( 13 )		—		—		121		—		3
Finance and insurance	134		5		1		—		—		—		—		—		( 99 )		41		3		( 3 )
Consumer—non-cyclical	81		( 1 )		1		—		( 14 )		—		( 28 )		—		—		39		—		—
Technology and communications	24		—		—		—		—		—		( 7 )		—		—		17		—		—
Industrial	63		—		—		—		—		—		( 1 )		—		—		62		—		1
Capital goods	53		—		—		14		( 4 )		—		( 20 )		—		—		43		—		—
Consumer—cyclical	1		—		—		7		—		—		—		—		( 8 )		—		—		—
Transportation	22		—		—		—		( 1 )		—		—		—		—		21		—		—
Other	52		—		1		—		—		—		—		—		—		53		—		1
Total non-U.S. corporate	830		4		4		56		( 19 )		—		( 85 )		36		( 114 )		712		3		—
Residential mortgage-backed	3		—		1		—		—		—		( 1 )		—		—		3		—		—
Commercial mortgage-backed	11		—		1		—		—		—		—		—		—		12		—		1
Other asset-backed	102		—		—		53		—		—		( 9 )		—		( 46 )		100		—		—
Total fixed maturity securities	3,096		( 1 )		60		196		( 36 )		—		( 256 )		77		( 243 )		2,893		5		35
Equity securities	32		—		—		19		( 8 )		—		—		—		—		43		—		—
Limited partnerships	20		( 5 )		—		—		—		—		( 1 )		—		—		14		( 5 )		—
Other invested assets:
Derivative assets:
Equity index options	15		8		—		11		—		—		( 13 )		—		—		21		8		—
Forward bond purchase commitments	51		—		9		—		—		—		—		—		—		60		—		9
Total derivative assets	66		8		9		11		—		—		( 13 )		—		—		81		8		9
Short-term investments	7		—		—		—		—		—		( 7 )		—		—		—		—		—
Total other invested assets	73		8		9		11		—		—		( 20 )		—		—		81		8		9
Total Level 3 assets	$	3,221	$	2	$	69	$	226	$	( 44 )	$	—	$	( 277 )	$	77	$	( 243 )	$	3,031	$	8	$	44

___________________

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents the gains and losses included in net income from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Total realized and unrealized gains (losses) included in net income:
Net investment income	$	1	$	2	$	2	$	8
Net investment gains (losses)	2		( 7 )		( 6 )		( 6 )
Total	$	3	$	( 5 )	$	( 4 )	$	2
Net gains (losses) included in net income attributable to assets still held:
Net investment income	$	1	$	—	$	1	$	5
Net investment gains (losses)	3		1		( 2 )		3
Total	$	4	$	1	$	( 1 )	$	8

The amount presented for net investment income relates to fixed maturity securities and primarily represents amortization and accretion of premiums and discounts on certain fixed maturity securities.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents a summary of the significant unobservable inputs used for certain asset fair value measurements that are based on internal models and classified as Level 3 as of September 30, 2025:

(Amounts in millions)

Fair value

Unobservable input

Range

Weighted-average (1)

Fixed maturity securities:

U.S. corporate:

Utilities

909

Credit spreads

59 bps - 207 bps

113 bps

Energy

Credit spreads

110 bps - 144 bps

129 bps

Finance and insurance

591

Credit spreads

14 bps - 183 bps

122 bps

Consumer—non-cyclical

Credit spreads

61 bps - 191 bps

127 bps

Technology and communications

Credit spreads

61 bps - 160 bps

97 bps

Industrial

Credit spreads

82 bps - 144 bps

103 bps

Capital goods

Credit spreads

110 bps - 126 bps

116 bps

Consumer—cyclical

Credit spreads

73 bps - 122 bps

108 bps

Transportation

Credit spreads

41 bps - 136 bps

115 bps

Other

Credit spreads

70 bps - 132 bps

86 bps

Total U.S. corporate

1,824

Credit spreads

14 bps - 207 bps

115 bps

Non-U.S. corporate:

Utilities

234

Credit spreads

79 bps - 195 bps

107 bps

Energy

Credit spreads

75 bps - 145 bps

102 bps

Finance and insurance

Credit spreads

95 bps - 115 bps

106 bps

Consumer—non-cyclical

Credit spreads

82 bps - 125 bps

89 bps

Technology and communications

Credit spreads

73 bps

Not applicable

Industrial

116

Credit spreads

88 bps - 151 bps

108 bps

Capital goods

Credit spreads

108 bps - 180 bps

128 bps

Transportation

Credit spreads

82 bps - 126 bps

104 bps

Other

Credit spreads

59 bps - 110 bps

92 bps

Total non-U.S. corporate

643

Credit spreads

59 bps - 195 bps

105 bps

Derivative assets:

Equity index options

Equity index volatility

6 % - 58 %

24 %

Forward bond purchase commitments

Counterparty financing spreads

15 bps - 49 bps

29 bps

Other assets (2)

101

Lapse rate

2 % - 9 %

5 %

Non-performance risk
(counterparty credit risk)

42 bps - 83 bps

69 bps

Equity index volatility

16 % - 29 %

23 %

______________

(1) Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities, notional for derivative assets and the policyholder account balances associated with the instrument for the net reinsured portion of our variable annuity MRBs.

(2) Represents the net reinsured portion of our variable annuity MRBs.

The assets included in the table above are valued using internal models for our fixed maturity securities and discounted cash flows for derivative and other assets. Certain classes of instruments classified as Level 3 are excluded above as a result of not being material or due to limitations in being able to obtain the underlying inputs used by certain third-party sources, such as broker quotes, used as an input in determining fair value.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables set forth our liabilities by class of instrument that are measured at fair value on a recurring basis as of the dates indicated:



	September 30, 2025
(Amounts in millions)	Total		Level 1		Level 2		Level 3
Liabilities
Policyholder account balances:
Fixed indexed annuity embedded derivatives	$	142	$	—	$	—	$	142
Indexed universal life embedded derivatives	15		—		—		15
Total policyholder account balances	157		—		—		157
Derivative liabilities:
Interest rate swaps	750		—		750		—
Foreign currency swaps	4		—		4		—
Forward bond purchase commitments	85		—		—		85
Foreign currency forward contracts	16		—		16		—
Total derivative liabilities	855		—		770		85
Total liabilities	$	1,012	$	—	$	770	$	242



	December 31, 2024
(Amounts in millions)	Total		Level 1		Level 2		Level 3
Liabilities
Policyholder account balances:
Fixed indexed annuity embedded derivatives	$	155	$	—	$	—	$	155
Indexed universal life embedded derivatives	15		—		—		15
Total policyholder account balances	170		—		—		170
Derivative liabilities:
Interest rate swaps	749		—		749		—
Foreign currency swaps	1		—		1		—
Forward bond purchase commitments	71		—		—		71
Total derivative liabilities	821		—		750		71
Total liabilities	$	991	$	—	$	750	$	241

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of and for the dates indicated:


	Beginning balance as of July 1, 2025		Total realized and unrealized (gains) losses																Ending balance as of September 30, 2025		Total (gains) losses attributable to liabilities still held
(Amounts in millions)			Included in net (income)		Included in OCI		Purchases		Sales		Issuances		Settlements		Transfer into Level 3		Transfer out of Level 3				Included in net (income)		Included in OCI
Policyholder account balances:
Fixed indexed annuity embedded derivatives	$	144	$	5	$	—	$	—	$	—	$	—	$	( 7 )	$	—	$	—	$	142	$	5	$	—
Indexed universal life embedded derivatives	13		2		—		—		—		—		—		—		—		15		2		—
Total policyholder account balances	157		7		—		—		—		—		( 7 )		—		—		157		7		—
Derivative liabilities:
Forward bond purchase commitments	102		( 3 )		( 14 )		—		—		—		—		—		—		85		( 3 )		( 13 )
Total derivative liabilities	102		( 3 )		( 14 )		—		—		—		—		—		—		85		( 3 )		( 13 )
Total Level 3 liabilities	$	259	$	4	$	( 14 )	$	—	$	—	$	—	$	( 7 )	$	—	$	—	$	242	$	4	$	( 13 )


	Beginning balance as of July 1, 2024		Total realized and unrealized (gains) losses																Ending balance as of September 30, 2024		Total (gains) losses attributable to liabilities still held
(Amounts in millions)			Included in net (income)		Included in OCI		Purchases		Sales		Issuances		Settlements		Transfer into Level 3		Transfer out of Level 3				Included in net (income)		Included in OCI
Policyholder account balances:
Fixed indexed annuity embedded derivatives	$	160	$	2	$	—	$	—	$	—	$	—	$	( 8 )	$	—	$	( 1 )	$	153	$	2	$	—
Indexed universal life embedded derivatives	16		2		—		—		—		—		( 1 )		—		—		17		2		—
Total policyholder account balances	176		4		—		—		—		—		( 9 )		—		( 1 )		170		4		—
Derivative liabilities:
Forward bond purchase commitments	33		( 6 )		( 13 )		—		—		—		—		—		—		14		( 6 )		1
Total derivative liabilities	33		( 6 )		( 13 )		—		—		—		—		—		—		14		( 6 )		1
Total Level 3 liabilities	$	209	$	( 2 )	$	( 13 )	$	—	$	—	$	—	$	( 9 )	$	—	$	( 1 )	$	184	$	( 2 )	$	1

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Beginning balance as of January 1, 2025		Total realized and unrealized (gains) losses																Ending balance as of September 30, 2025		Total (gains) losses attributable to liabilities still held
(Amounts in millions)			Included in net (income)		Included in OCI		Purchases		Sales		Issuances		Settlements		Transfer into Level 3		Transfer out of Level 3				Included in net (income)		Included in OCI
Policyholder account balances:
Fixed indexed annuity embedded derivatives	$	155	$	7	$	—	$	—	$	—	$	—	$	( 18 )	$	—	$	( 2 )	$	142	$	7	$	—
Indexed universal life embedded derivatives	15		1		—		—		—		—		( 1 )		—		—		15		1		—
Total policyholder account balances	170		8		—		—		—		—		( 19 )		—		( 2 )		157		8		—
Derivative liabilities:
Forward bond purchase commitments	71		5		9		—		—		—		—		—		—		85		5		10
Total derivative liabilities	71		5		9		—		—		—		—		—		—		85		5		10
Total Level 3 liabilities	$	241	$	13	$	9	$	—	$	—	$	—	$	( 19 )	$	—	$	( 2 )	$	242	$	13	$	10


	Beginning balance as of January 1, 2024		Total realized and unrealized (gains) losses																Ending balance as of September 30, 2024		Total (gains) losses attributable to liabilities still held
(Amounts in millions)			Included in net (income)		Included in OCI		Purchases		Sales		Issuances		Settlements		Transfer into Level 3		Transfer out of Level 3				Included in net (income)		Included in OCI
Policyholder account balances:
Fixed indexed annuity embedded derivatives	$	165	$	15	$	—	$	—	$	—	$	—	$	( 25 )	$	—	$	( 2 )	$	153	$	15	$	—
Indexed universal life embedded derivatives	15		( 4 )		—		—		—		7		( 1 )		—		—		17		( 4 )		—
Total policyholder account balances	180		11		—		—		—		7		( 26 )		—		( 2 )		170		11		—
Derivative liabilities:
Forward bond purchase commitments	9		5		—		—		—		—		—		—		—		14		5		—
Total derivative liabilities	9		5		—		—		—		—		—		—		—		14		5		—
Total Level 3 liabilities	$	189	$	16	$	—	$	—	$	—	$	7	$	( 26 )	$	—	$	( 2 )	$	184	$	16	$	—

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents the gains and losses included in net (income) from liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Total realized and unrealized (gains) losses included in net (income):
Net investment income	$	—	$	—	$	—	$	—
Net investment (gains) losses	4		( 2 )		13		16
Total	$	4	$	( 2 )	$	13	$	16
Total (gains) losses included in net (income) attributable to liabilities still held:
Net investment income	$	—	$	—	$	—	$	—
Net investment (gains) losses	4		( 2 )		13		16
Total	$	4	$	( 2 )	$	13	$	16

Purchases, sales, issuances and settlements represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases, sales and settlements of fixed maturity and equity securities and purchases, issuances and settlements of derivative instruments.

Issuances for fixed indexed annuity and indexed universal life embedded derivative liabilities represent the amount of the premium received that is attributed to the value of the embedded derivative. Settlements of embedded derivatives are characterized as the change in fair value upon exercising the embedded derivative instrument, effectively representing a settlement of the embedded derivative instrument. We have shown these changes in fair value separately based on the classification of this activity as effectively issuing and settling the embedded derivative instrument with all remaining changes in the fair value of these embedded derivative instruments being shown separately in the category labeled “included in net (income)” in the tables presented above.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents a summary of the significant unobservable inputs used for certain liability fair value measurements that are based on internal models and classified as Level 3 as of September 30, 2025:


(Amounts in millions)	Fair value		Unobservable input	Range	Weighted-average (1)
Policyholder account balances:
Fixed indexed annuity embedded derivatives	$	142	Expected future interest credited	1 % - 4 %	2 %
Indexed universal life embedded derivatives	$	15	Expected future interest credited	2 % - 10 %	5 %
Net market risk benefits: (2)
Fixed indexed annuities	$	55	GMWB utilization rate	20 % - 100 %	71 %
			Non-performance risk (credit spreads)	42 bps - 83 bps	69 bps
			Expected future interest credited	1 % - 4 %	2 %
Variable annuities	$	312	Lapse rate	2 % - 11 %	5 %
			GMWB utilization rate	59 % - 90 %	80 %
			Non-performance risk (credit spreads)	42 bps - 83 bps	69 bps
			Equity index volatility	16 % - 29 %	23 %
Derivative liabilities:
Forward bond purchase commitments	$	85	Counterparty financing spreads	29 bps - 49 bps	41 bps

______________

(1) Unobservable inputs weighted by the policyholder account balances associated with the instrument and notional for derivative liabilities.

(2) Refer to note 11 for additional details related to MRBs.

The liabilities included in the table above are valued using an option budget method for our fixed indexed annuity and indexed universal life embedded derivative liabilities and discounted cash flows for our MRBs and derivative liabilities.

Assets and Liabilities Not Required to Be Carried at Fair Value

Assets and liabilities that are reflected in the accompanying condensed consolidated financial statements at fair value are not included in the following disclosure of fair value. Such items include cash and cash equivalents, short-term investments, investment securities, MRBs, separate accounts and derivative instruments. Apart from certain of our borrowings and certain marketable securities, few of the instruments are actively traded and their fair values must often be determined using internal models. The fair value estimates are made at a specific point in time, based upon available market information and judgments about the financial instruments, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such estimates do not reflect any premium or discount that could result from offering for sale at one time our entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value estimates cannot be substantiated by comparison to independent markets.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following represents our estimated fair value of financial assets and liabilities that are not required to be carried at fair value as of the dates indicated:



	September 30, 2025
(Amounts in millions)	Notional amount			Carrying amount		Fair value
						Total		Level 1		Level 2		Level 3
Assets:
Commercial mortgage loans, net			(1)	$	6,315	$	6,062	$	—	$	—	$	6,062
Bank loan investments			(1)	521		527		—		—		527
Liabilities:
Long-term borrowings			(1)	1,520		1,487		—		1,487		—
Investment contracts			(1)	4,004		4,085		—		—		4,085
Commitments to fund investments:
Bank loan investments	$	134		—		—		—		—		—
Private placement investments	379			—		—		—		—		—
Commercial mortgage loans	19			—		—		—		—		—

______________

(1) These financial instruments do not have notional amounts.



	December 31, 2024
(Amounts in millions)	Notional amount			Carrying amount		Fair value
						Total		Level 1		Level 2		Level 3
Assets:
Commercial mortgage loans, net			(1)	$	6,411	$	5,950	$	—	$	7	$	5,943
Bank loan investments			(1)	535		542		—		—		542
Liabilities:
Long-term borrowings			(1)	1,518		1,436		—		1,436		—
Investment contracts			(1)	4,498		4,499		—		—		4,499
Commitments to fund investments:
Bank loan investments	$	140		—		—		—		—		—
Private placement investments	263			—		—		—		—		—
Commercial mortgage loans	2			—		—		—		—		—

______________

(1) These financial instruments do not have notional amounts.

As of September 30, 2025 and December 31, 2024, we had $ 34 million and $ 25 million, respectively, of real estate owned assets included in other invested assets in our condensed consolidated balance sheets acquired through foreclosure in full or partial settlement of commercial mortgage loan obligations. These properties are initially recorded at fair value less estimated selling costs (the carrying value) and are subsequently valued at the lower of the carrying value or current fair value less estimated selling costs. As of December 31, 2024, these properties were recorded at fair value less estimated selling costs, which was less than the carrying value. These amounts represented the fair value as of September 30, 2025 and December 31, 2024. The fair value of the real estate owned assets is classified as Level 2.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Assets Measured Using Net Asset Value

Limited partnerships include partnership interests accounted for using NAV per share (or its equivalent) or fair value for those interests considered minor and partnership interests accounted for under the equity method of accounting for those interests exceeding the minor threshold. Our limited partnership interests accounted for using NAV per share (or its equivalent) are generally not redeemable by the investees and generally cannot be sold without approval of the general partner. We receive distributions of income and proceeds from the liquidation of the underlying assets of the investees, which usually takes place in years five to ten of the typical contractual life of ten to 12 years.

The following table presents the carrying value of limited partnerships and commitments to fund as of the dates indicated:



	September 30, 2025				December 31, 2024
(Amounts in millions)	Carrying value		Commitments to fund		Carrying value		Commitments to fund
Limited partnerships accounted for at NAV:
Private equity and credit funds (1)	$	2,450	$	1,488	$	2,190	$	1,434
Real estate funds (2)	136		68		128		74
Infrastructure funds (3)	141		166		123		178
Total limited partnerships accounted for at NAV	2,727		1,722		2,441		1,686
Limited partnerships accounted for at fair value	16		1		19		1
Limited partnerships accounted for under equity method of accounting	730		94		682		74
Total	$	3,473	$	1,817	$	3,142	$	1,761

______________

(1) This class employs various investment strategies such as leveraged buyout, growth equity, venture capital and mezzanine financing, generally investing in debt or equity positions directly in companies or assets of various sizes across diverse industries globally, primarily concentrated in North America.

(2) This class invests in real estate in North America, Europe and Asia via direct property ownership, joint ventures, mortgages and investments in debt and equity instruments.

(3) This class invests in the debt or equity of cash flow generating assets diversified across a variety of industries, including transportation, energy infrastructure, renewable power, social infrastructure, power generation, water, telecommunications and other regulated entities globally.

(7) Deferred Acquisition Costs

The following tables present the balances of and changes in deferred acquisition costs as of and for the periods indicated:



	September 30, 2025
(Amounts in millions)	Long- term care insurance		Life insurance		Fixed annuities		Variable annuities		Total
Balance as of January 1	$	823	$	812	$	37	$	83	$	1,755
Costs deferred	—		—		—		—		—
Amortization	( 41 )		( 90 )		( 6 )		( 9 )		( 146 )
Balance as of September 30	$	782	$	722	$	31	$	74	1,609
Enact segment									23
Total deferred acquisition costs									$	1,632

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)



	December 31, 2024
(Amounts in millions)	Long- term care insurance		Life insurance		Fixed annuities		Variable annuities		Total
Balance as of January 1	$	879	$	941	$	45	$	98	$	1,963
Costs deferred	—		—		—		—		—
Amortization	( 56 )		( 129 )		( 8 )		( 15 )		( 208 )
Balance as of December 31	$	823	$	812	$	37	$	83	1,755
Enact segment									24
Total deferred acquisition costs									$	1,779

(8) Future Policy Benefits

The following table sets forth our liability for future policy benefits as of the dates indicated:



(Amounts in millions)	September 30, 2025		December 31, 2024
Long-term care insurance	$	43,017	$	41,172
Life insurance	1,478		1,564
Fixed annuities	10,708		10,695
Total long-duration insurance contracts	55,203		53,431
Deferred profit liability	125		129
Cost of reinsurance	36		50
Total future policy benefits	$	55,364	$	53,610

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables present the balances of and changes in the liability for future policy benefits as of and for the periods indicated:



	September 30, 2025
(Dollar amounts in millions)	Long-term care insurance		Life insurance		Fixed annuities
Present value of expected net premiums:
Beginning balance as of January 1	$	17,315	$	3,690	$	—
Beginning balance, at original discount rate	$	17,625	$	3,640	$	—
Effect of changes in cash flow assumptions	( 12 )		—		—
Effect of actual variances from expected experience	( 37 )		( 33 )		—
Adjusted beginning balance	17,576		3,607		—
Issuances	—		—		28
Interest accretion	662		150		—
Net premiums collected (1)	( 1,392 )		( 306 )		( 28 )
Derecognition (lapses and withdrawals)	—		—		—
Other	—		1		—
Ending balance, at original discount rate	16,846		3,452		—
Effect of changes in discount rate assumptions	144		131		—
Ending balance as of September 30	$	16,990	$	3,583	$	—
Present value of expected future policy benefits:
Beginning balance as of January 1	$	58,487	$	4,741	$	10,695
Beginning balance, at original discount rate	$	60,587	$	4,645	$	9,568
Effect of changes in cash flow assumptions	10		—		—
Effect of actual variances from expected experience	174		( 11 )		( 16 )
Adjusted beginning balance	60,771		4,634		9,552
Issuances	—		—		26
Interest accretion	2,461		182		465
Benefit payments	( 2,838 )		( 544 )		( 714 )
Derecognition (lapses and withdrawals)	—		—		—
Other	—		1		1
Ending balance, at original discount rate	60,394		4,273		9,330
Effect of changes in discount rate assumptions	( 387 )		178		1,378
Ending balance as of September 30	$	60,007	$	4,451	$	10,708
Net liability for future policy benefits, before flooring adjustments	$	43,017	$	868	$	10,708
Flooring adjustments (2)	—		610		—
Net liability for future policy benefits	43,017		1,478		10,708
Less: reinsurance recoverable	7,522		754		8,255
Net liability for future policy benefits, net of reinsurance recoverable	$	35,495	$	724	$	2,453
Weighted-average liability duration (years)	12.2		5.6		10.0

______________

(1) Represents the portion of gross premiums collected from policyholders that is used to fund expected benefit payments.

(2) Flooring adjustments are necessary when a cohort’s present value of future net premiums exceeds the present value of future benefits. The flooring adjustment ensures that the liability for future policy benefits for each cohort is not less than zero. This adjustment is most prevalent in our term life insurance products due to their product design of a level premium period followed by annual premium rate increases.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)



	December 31, 2024
(Dollar amounts in millions)	Long-term care insurance		Life insurance		Fixed annuities
Present value of expected net premiums:
Beginning balance as of January 1	$	18,650	$	4,180	$	—
Beginning balance, at original discount rate	$	18,346	$	3,918	$	—
Effect of changes in cash flow assumptions	399		1		—
Effect of actual variances from expected experience	( 174 )		( 55 )		—
Adjusted beginning balance	18,571		3,864		—
Issuances	1		—		42
Interest accretion	915		212		—
Net premiums collected (1)	( 1,862 )		( 437 )		( 42 )
Derecognition (lapses and withdrawals)	—		—		—
Other	—		1		—
Ending balance, at original discount rate	17,625		3,640		—
Effect of changes in discount rate assumptions	( 310 )		50		—
Ending balance as of December 31	$	17,315	$	3,690	$	—
Present value of expected future policy benefits:
Beginning balance as of January 1	$	62,579	$	5,412	$	11,829
Beginning balance, at original discount rate	$	60,513	$	5,146	$	9,920
Effect of changes in cash flow assumptions	545		1		( 1 )
Effect of actual variances from expected experience	106		( 36 )		( 39 )
Adjusted beginning balance	61,164		5,111		9,880
Issuances	1		—		35
Interest accretion	3,276		266		639
Benefit payments	( 3,852 )		( 731 )		( 989 )
Derecognition (lapses and withdrawals)	—		—		—
Other	( 2 )		( 1 )		3
Ending balance, at original discount rate	60,587		4,645		9,568
Effect of changes in discount rate assumptions	( 2,100 )		96		1,127
Ending balance as of December 31	$	58,487	$	4,741	$	10,695
Net liability for future policy benefits, before flooring adjustments	$	41,172	$	1,051	$	10,695
Flooring adjustments (2)	—		513		—
Net liability for future policy benefits	41,172		1,564		10,695
Less: reinsurance recoverable	7,233		783		8,177
Net liability for future policy benefits, net of reinsurance recoverable	$	33,939	$	781	$	2,518
Weighted-average liability duration (years)	12.5		5.6		10.1

______________

(1) Represents the portion of gross premiums collected from policyholders that is used to fund expected benefit payments.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Long-term care insurance

For the nine months ended September 30, 2025, the impact of updates to cash flow assumptions resulted in an increase of $ 22 million in the liability for future policy benefits due to unfavorable updates related to implementation timing of in-force rate actions. The impact of actual variances from expected experience resulted in an increase of $ 211 million in the liability for future policy benefits. This increase was primarily due to lower terminations and higher benefit utilization, partially offset by a $ 26 million gain related to a third-party recapture of a block of long-term care insurance policies. See note 16 for additional information on the third-party reinsurance recapture. The unfavorable impacts of cash flow assumption updates and actual variances from expected experience were partially offset in net income as a portion of the updates and lower termination experience was related to fully reinsured blocks of business.

In the fourth quarter of 2024, we completed our annual review of cash flow assumptions including benefit utilization, incidence, mortality and in-force rate actions, among others. The impact of changes in cash flow assumptions during the year ended December 31, 2024 resulted in an increase of $ 146 million in the liability for future policy benefits primarily related to unfavorable updates to healthy life and near-term benefit utilization assumptions to better align with recent experience, including cost of care inflation. Although we did not make significant changes to our multi-year in-force rate action plan, the increase to the liability for future policy benefits was partially offset by favorable assumption updates for future in-force rate action approvals given our current plans for rate increase filings and our recent experience regarding approvals and regulatory support. The increase to the liability for future policy benefits was also partially offset by favorable updates to our short-term incidence assumptions for incurred but not reported claims, reducing sufficiency held through a period of heightened uncertainty around incidence during and immediately following the coronavirus pandemic. The unfavorable impact of changes in cash flow assumptions was partially offset in net income as a portion of the unfavorable updates was related to fully reinsured blocks of business. The impact of actual variances from expected experience during the year ended December 31, 2024 resulted in an increase of $ 280 million in the liability for future policy benefits primarily due to lower terminations and higher claims.

Life insurance

For the nine months ended September 30, 2025, the impact of actual variances from expected experience resulted in an increase of $ 22 million in the liability for future policy benefits primarily due to unfavorable mortality experience.

There were no significant cash flow assumption changes in the fourth quarter of 2024. The impact of actual variances from expected experience during the year ended December 31, 2024 resulted in an increase of $ 19 million in the liability for future policy benefits primarily due to unfavorable mortality impacts.

Fixed annuities

For the nine months ended September 30, 2025, the impact of actual variances from expected experience resulted in a decrease of $ 16 million in the liability for future policy benefits primarily due to favorable mortality.

There were no significant cash flow assumption changes in the fourth quarter of 2024. The impact of actual variances from expected experience during the year ended December 31, 2024 resulted in a decrease of $ 39 million in the liability for future policy benefits primarily due to favorable mortality.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table provides the weighted-average interest rates for the liability for future policy benefits as of the dates indicated:


	September 30, 2025		December 31, 2024
Long-term care insurance
Interest accretion (locked-in) rate	5.7	%	5.7	%
Current discount rate	5.4	%	5.7	%
Life insurance
Interest accretion (locked-in) rate	5.8	%	5.8	%
Current discount rate	4.9	%	5.3	%
Fixed annuities
Interest accretion (locked-in) rate	6.8	%	6.8	%
Current discount rate	5.4	%	5.6	%

See Note 2—Summary of Significant Accounting Policies included in the Notes to Consolidated Financial Statements in our 2024 Annual Report on Form 10-K for additional information related to the discount rate used to measure the liability for future policy benefits.

The following table sets forth the amount of undiscounted and discounted expected future gross premiums and expected future benefit payments as of the dates indicated:



	September 30, 2025				December 31, 2024
(Amounts in millions)	Undiscounted		Discounted		Undiscounted		Discounted
Long-term care insurance
Expected future gross premiums	$	34,122	$	23,880	$	36,325	$	24,430
Expected future benefit payments	$	118,864	$	60,007	$	121,356	$	58,487
Life insurance
Expected future gross premiums	$	9,307	$	5,365	$	9,896	$	5,549
Expected future benefit payments	$	6,184	$	4,451	$	6,764	$	4,741
Fixed annuities
Expected future gross premiums	$	—	$	—	$	—	$	—
Expected future benefit payments	$	22,238	$	10,708	$	22,933	$	10,695

During the nine months ended September 30, 2025, we recorded a charge of $ 6 million to net income due to expected benefits exceeding expected gross premiums, resulting in net premium ratios capped at 100 % for certain cohorts in our life insurance products primarily due to higher claim severity.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table sets forth the amount of revenue and interest accretion (expense) recognized in net income related to our liability for future policy benefits for the periods indicated:


	Three months ended September 30,								Nine months ended September 30,								Year ended December 31, 2024
	2025				2024				2025				2024
(Amounts in millions)	Gross premiums		Interest accretion (1)		Gross premiums		Interest accretion (1)		Gross premiums		Interest accretion (1)		Gross premiums		Interest accretion (1)		Gross premiums		Interest accretion (1)
Long-term care insurance	$	648	$	602	$	633	$	590	$	1,893	$	1,799	$	1,876	$	1,768	$	2,520	$	2,361
Life insurance	147		10		158		12		455		32		492		41		647		54
Fixed annuities	—		154		—		159		—		465		—		481		—		639
Total	$	795	$	766	$	791	$	761	$	2,348	$	2,296	$	2,368	$	2,290	$	3,167	$	3,054

______________

(1) Amounts for interest accretion are included in benefits and other changes in policy reserves in the condensed consolidated statements of income.

(9) Policyholder Account Balances

The following table sets forth our liabilities for policyholder account balances as of the dates indicated:



(Amounts in millions)	September 30, 2025		December 31, 2024
Life insurance	$	7,054	$	7,235
Fixed annuities	3,397		3,789
Variable annuities	431		467
Fixed indexed annuity embedded derivatives (1)	142		155
Indexed universal life embedded derivatives (1)	15		15
Additional insurance liabilities (2)	2,987		2,920
Other	13		13
Total policyholder account balances	$	14,039	$	14,594

______________

(1) See note 5 for additional information.

(2) Represents additional liabilities related to death or other insurance benefits that are recorded within policyholder account balances and are considered long-duration insurance contracts. See note 10 for additional information.

The contracts underlying the minimum guarantees, such as GMWBs and guaranteed annuitization benefits, are considered “in the money” if the present value of the contractholder’s benefits is greater than the account value, or commonly referred to as the net amount at risk. For GMWBs and guaranteed annuitization benefits, the only way the contractholder can monetize the excess of the benefits over the account value of the contract is through lifetime withdrawals or lifetime income payments after annuitization. For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current GMDB in excess of the current account balance at the balance sheet date.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables present the balances of and changes in policyholder account balances as of and for the periods indicated:



	September 30, 2025
(Dollar amounts in millions)	Life insurance			Fixed annuities			Variable annuities
Beginning balance as of January 1	$	7,235		$	3,789		$	467
Issuances	—			—			—
Premiums received	340			13			9
Policy charges	( 440 )			( 4 )			( 4 )
Surrenders and withdrawals	( 127 )			( 282 )			( 35 )
Benefit payments	( 192 )			( 233 )			( 44 )
Net transfers from separate accounts	—			—			2
Interest credited	222			94			3
Other	16			20			33
Ending balance as of September 30	$	7,054		$	3,397		$	431
Weighted-average crediting rate	3.9		%	3.0		%	3.3		%
Net amount at risk (1)	$	40,202		$	29		$	363
Cash surrender value	$	4,051		$	2,586		$	431

______________

(1) The net amount at risk presented for fixed and variable annuity products contains both general and separate accounts, including amounts related to annuitization and other insurance benefits classified as MRBs.



	December 31, 2024
(Dollar amounts in millions)	Life insurance			Fixed annuities			Variable annuities
Beginning balance as of January 1	$	7,460		$	4,479		$	529
Issuances	—			—			—
Premiums received	470			22			14
Policy charges	( 599 )			( 6 )			( 6 )
Surrenders and withdrawals	( 195 )			( 543 )			( 57 )
Benefit payments	( 227 )			( 347 )			( 55 )
Net transfers from separate accounts	—			—			1
Interest credited	350			143			4
Other	( 24 )			41			37
Ending balance as of December 31	$	7,235		$	3,789		$	467
Weighted-average crediting rate	3.9		%	3.0		%	3.3		%
Net amount at risk (1)	$	41,378		$	26		$	386
Cash surrender value	$	4,192		$	2,911		$	467

______________

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables present policyholder account balances by range of guaranteed minimum crediting rate and the related range of the difference between rates being credited to policyholders and the respective guaranteed minimums as of the dates indicated:



	September 30, 2025
(Amounts in millions)	At guaranteed minimum		1 – 50 basis points above		51 – 150 basis points above		Greater than 150 basis points above		Total (1)
Less than 2.00 %	$	101	$	48	$	32	$	—	$	181
2.00 %– 2.99 %	622		1		—		—		623
3.00 %– 3.99 %	1,784		589		1,091		81		3,545
4.00 % and greater	2,221		21		22		—		2,264
Total	$	4,728	$	659	$	1,145	$	81	$	6,613

______________

(1) Excludes universal life insurance and investment contracts of $ 4,269 million that have an equity market component to their crediting strategy.



	December 31, 2024
(Amounts in millions)	At guaranteed minimum		1 – 50 basis points above		51 – 150 basis points above		Greater than 150 basis points above		Total (1)
Less than 2.00 %	$	102	$	57	$	45	$	—	$	204
2.00 %– 2.99 %	659		27		—		—		686
3.00 %– 3.99 %	1,940		629		1,121		61		3,751
4.00 % and greater	2,318		19		18		—		2,355
Total	$	5,019	$	732	$	1,184	$	61	$	6,996

______________

(1) Excludes universal life insurance and investment contracts of $ 4,495 million that have an equity market component to their crediting strategy.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(10) Additional Insurance Liabilities

The following table presents the balances of and changes in additional liabilities related to death or other insurance benefits that are included within policyholder account balances related to universal and term universal life insurance products as of and for the periods indicated:



(Dollar amounts in millions)	September 30, 2025		December 31, 2024
Beginning balance as of January 1	$	2,920	$	2,887
Beginning balance before shadow accounting adjustments	$	3,003	$	2,939
Effect of changes in cash flow assumptions	—		28
Effect of actual variances from expected experience	12		( 58 )
Adjusted beginning balance	3,015		2,909
Issuances	—		—
Interest accretion	76		102
Assessments collected	176		245
Benefit payments	( 217 )		( 253 )
Derecognition (lapses and withdrawals)	—		—
Other (flooring adjustment)	—		—
Ending balance before shadow accounting adjustments	3,050		3,003
Effect of shadow accounting adjustments	( 63 )		( 83 )
Ending balance	2,987		2,920
Less: reinsurance recoverable	—		—
Additional insurance liabilities, net of reinsurance recoverable	$	2,987	$	2,920
Weighted-average liability duration (years)	17.2		17.8

For the nine months ended September 30, 2025, the effect of actual variances from expected experience resulted in an increase to our additional insurance liabilities primarily driven by unfavorable mortality.

In the fourth quarter of 2024, as part of our annual review of assumptions, we increased our additional insurance liabilities primarily related to an unfavorable update to mortality assumptions for universal life insurance contracts originating from term life insurance conversions and an unfavorable update to interest rate assumptions given the recent rate environment. The decrease in our additional insurance liabilities from the effect of actual variances from expected experience during the year ended December 31, 2024 was primarily due to a model refinement related to certain universal life insurance products with secondary guarantees.

The following table provides the weighted-average interest rates for our additional insurance liabilities as of the dates indicated:



	September 30, 2025		December 31, 2024
Interest accretion rate (1)	3.3	%	3.4	%
Projected crediting rate (2)	3.8	%	3.8	%

______________

(1) The interest accretion rate is determined by using the weighted-average policyholder crediting rates for the underlying policies over the period in-force, and based on the adjusted beginning balance, is used to measure the amount of interest accretion.

(2) The projected crediting rate is determined by using a future crediting rate curve that utilizes a portfolio approach reflecting anticipated reinvestment activity and runoff of existing assets over the projection period. The projected crediting rate is used to discount future assessments and excess benefits.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table sets forth the amount of revenue and interest accretion (expense) recognized in net income related to additional insurance liabilities for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,				Year ended December 31, 2024
(Amounts in millions)	2025		2024		2025		2024
Gross assessments	$	126	$	130	$	389	$	395	$	526
Interest accretion (1)	$	26	$	26	$	76	$	76	$	102

______________

(1) Amounts for interest accretion are included in benefits and other changes in policy reserves in the condensed consolidated statements of income.

(11) Market Risk Benefits

The following table sets forth our market risk benefits by asset and liability position as of the dates indicated:



	September 30, 2025						December 31, 2024
(Amounts in millions)	Asset		Liability		Net liability		Asset		Liability		Net liability
Fixed indexed annuities	$	—	$	55	$	55	$	—	$	48	$	48
Variable annuities	62		374		312		57		417		360
Total market risk benefits	$	62	$	429	$	367	$	57	$	465	$	408

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following tables present the balances of and changes in market risk benefits as of and for the periods indicated:



	September 30, 2025
(Dollar amounts in millions)	Fixed indexed annuities		Variable annuities		Reinsurance recoverable (1)
Beginning balance as of January 1	$	48	$	360	$	107
Beginning balance before effect of changes in instrument-specific credit risk	$	45	$	356	$	107
Issuances	—		—		—
Interest accretion	2		13		4
Attributed fees collected	3		26		6
Benefit payments	—		( 18 )		( 9 )
Effect of changes in interest rates	6		38		5
Effect of changes in equity markets	—		( 101 )		( 11 )
Actual policyholder behavior different from expected behavior	( 3 )		( 5 )		( 1 )
Effect of changes in future expected policyholder behavior	—		—		—
Effect of changes in other future expected assumptions	—		—		—
Other	( 1 )		—		—
Ending balance before effect of changes in instrument-specific credit risk	52		309		101
Effect of changes in instrument-specific credit risk	3		3		—
Ending balance as of September 30	55		312		$	101
Less: reinsurance recoverable	—		101
Market risk benefits, net of reinsurance recoverable	$	55	$	211
Weighted-average attained age of contractholders	74		77
Net amount at risk (2)

______________

(1) Represents the net reinsured asset related to our variable annuity MRBs.

(2) See note 9 for additional information on the net amount at risk.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)



	December 31, 2024
(Dollar amounts in millions)	Fixed indexed annuities		Variable annuities		Reinsurance recoverable (1)
Beginning balance as of January 1	$	55	$	527	$	140
Beginning balance before effect of changes in instrument-specific credit risk	$	52	$	520	$	140
Issuances	—		—		—
Interest accretion	3		25		7
Attributed fees collected	5		37		8
Benefit payments	—		( 28 )		( 13 )
Effect of changes in interest rates	( 17 )		( 112 )		( 22 )
Effect of changes in equity markets	( 2 )		( 97 )		( 17 )
Actual policyholder behavior different from expected behavior	( 5 )		5		4
Effect of changes in future expected policyholder behavior	13		6		—
Effect of changes in other future expected assumptions	—		—		—
Other	( 4 )		—		—
Ending balance before effect of changes in instrument-specific credit risk	45		356		107
Effect of changes in instrument-specific credit risk	3		4		—
Ending balance as of December 31	48		360		$	107
Less: reinsurance recoverable	—		107
Market risk benefits, net of reinsurance recoverable	$	48	$	253
Weighted-average attained age of contractholders	73		76
Net amount at risk (2)

______________

(1) Represents the net reinsured asset related to our variable annuity MRBs.

(2) See note 9 for additional information on the net amount at risk.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(12) Separate Accounts

The following table presents the balances of and changes in separate account liabilities, which are primarily comprised of variable annuity products, as of and for the periods indicated:



(Amounts in millions)	September 30, 2025		December 31, 2024
Beginning balance as of January 1	$	4,438	$	4,509
Premiums and deposits	23		29
Policy charges	( 74 )		( 104 )
Surrenders and withdrawals	( 285 )		( 406 )
Benefit payments	( 165 )		( 217 )
Investment performance	516		631
Net transfers to general account	( 2 )		( 1 )
Other charges	( 2 )		( 3 )
Ending balance	$	4,449	$	4,438
Cash surrender value (1)	$	4,447	$	4,436

______________

(1) Cash surrender value represents the amount of the contractholders’ account balances that was distributable less certain surrender charges.

Separate Account Assets

The following table presents the aggregate fair value of assets, by major investment asset category, supporting separate accounts as of the dates indicated:



(Amounts in millions)	September 30, 2025		December 31, 2024
Equity funds	$	2,116	$	2,087
Balanced funds	1,838		1,834
Bond funds	299		313
Money market funds	196		204
Total	$	4,449	$	4,438

(13) Liability for Policy and Contract Claims

The following table sets forth our liability for policy and contract claims as of the dates indicated:



(Amounts in millions)	September 30, 2025		December 31, 2024
Enact segment	$	572	$	525
Life and Annuities segment (1)	132		139
Other mortgage insurance business	6		6
Total liability for policy and contract claims	$	710	$	670

______________

(1) Primarily includes balances related to our universal and term universal life insurance products.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents the balances of and changes in our liability for policy and contract claims as of and for the periods indicated:


	Nine months ended September 30,
(Amounts in millions)		2025		2024
Beginning balance as of January 1		$	670	$	652
Less reinsurance recoverable		( 24 )		( 16 )
Net beginning balance		646		636
Incurred related to insured events of:
Current year		728		712
Prior years		( 126 )		( 185 )
Total incurred		602		527
Paid related to insured events of:
Current year		( 400 )		( 426 )
Prior years		( 156 )		( 95 )
Total paid		( 556 )		( 521 )
Foreign currency translation		1		( 1 )
Net ending balance		693		641
Add reinsurance recoverable		17		14
Ending balance as of September 30		$	710	$	655

The liability for policy and contract claims represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could be significant and result in increases in reserves by an amount that could be material to our results of operations, financial condition and liquidity. Given the extended period of time that may exist between the reporting of a delinquency and the claim payment in our Enact segment, and changes in economic conditions and the real estate market, significant uncertainty and variability exist on amounts actually paid.

For the nine months ended September 30, 2025 , our Enact segment recorded reserve releases of $ 140 million primarily related to insured events of prior years, largely driven by favorable cure performance on delinquencies from 2024 and prior.

During the nine months ended September 30, 2024, our Enact segment recorded reserve releases of $ 196 million primarily related to insured events of prior years, largely driven by favorable cure performance. As part of these reserve releases, Enact decreased its assumptions for the rate at which delinquencies go to claim, primarily resulting from sustained favorable cure performance and lessening uncertainty in the economic environment, impacting both current and prior year delinquencies.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(14) Income Taxes

The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
	2025		2024		2025		2024
Statutory U.S. federal income tax rate	21.0	%	21.0	%	21.0	%	21.0	%
Increase (decrease) in rate resulting from:
Valuation allowance	( 20.7 )		—		( 8.1 )		—
Tax on income from terminated swaps	4.6		5.1		4.9		4.2
Non-deductible expenses	0.9		1.3		1.2		1.2
Stock-based compensation	0.2		( 1.1 )		—		( 0.3 )

Other, net	( 0.5 )		( 1.5 )		0.3		( 0.5 )
Effective rate	5.5	%	24.8	%	19.3	%	25.6	%

The effective tax rate for the three and nine months ended September 30, 2025 was below the statutory U.S. federal income tax rate of 21 % largely due to a tax benefit related to a valuation allowance release, partially offset by tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35 % as they are amortized into net investment income. The effective tax rate for the three and nine months ended September 30, 2024 was above the statutory U.S. federal income tax rate of 21 % primarily from tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35 % as they are amortized into net investment income.

The decrease in the effective tax rate for the three and nine ended September 30, 2025 compared to the three and nine months ended September 30, 2024 was primarily driven by a valuation allowance release in the current year.

Our valuation allowance as of September 30, 2025 and December 31, 2024 was $ 545 million and $ 639 million, respectively. In the third quarter of 2025, we released $ 100 million of our valuation allowance related to capital deferred tax assets. The release in valuation allowance was a result of the change in unrealized gains (losses) on our fixed maturity securities, due to decreasing interest rates and current market conditions, and a corresponding increase in unrealized capital gains expected to be available in the future to offset our capital loss carryforwards and other capital deferred tax assets, in addition to an increase in unrealized gains on our limited partnerships. Of the $ 100 million released, $ 66 million was recorded through accumulated other comprehensive income (loss), and $ 34 million was recognized in income from continuing operations, resulting in an ending valuation allowance of $ 200 million related to deferred tax assets that would produce capital losses as of September 30, 2025 . The remaining valuation allowance as of September 30, 2025 was related to foreign and state net operating loss carryforwards.

U.S. GAAP generally requires an annualized effective tax rate to be used for interim reporting periods, utilizing projections of full year results. However, in certain circumstances it is appropriate to record the actual effective tax rate for the period if a reliable estimate cannot be made for the full year. Accordingly, for the three and nine months ended September 30, 2025 and 2024, we utilized the actual effective tax rate for the interim period to record the provision for income taxes for our Long-Term Care Insurance and Life and Annuities segments and the annualized projected effective tax rate for our Enact segment and Corporate and Other.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”), which includes certain tax provisions, was signed into law. The OBBBA did not have a material impact on our consolidated financial statements.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(15) Segment Information

We have the following three reportable segments: Enact, comprised primarily of private mortgage insurance products; Long-Term Care Insurance; and Life and Annuities. The products in the Life and Annuities segment include life insurance and fixed and variable annuities, none of which are actively marketed or sold. In addition to our three reportable segments, we also have Corporate and Other, which includes debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses and eliminations of inter-segment transactions. Corporate and Other also includes the results of other businesses that are not individually reportable, such as CareScout and certain international businesses.

We allocate tax to our businesses at the U.S. corporate federal income tax rate of 21 % . Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other. The annually-determined tax rates and adjustments to each segment’s provision for income taxes are estimates which are subject to review and could change from year to year. See note 14 for a discussion of the effective tax rates used for our segments and Corporate and Other.

Our chief operating decision maker (“CODM”) evaluates performance and allocates resources for our reportable segments based on “adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders.” We define adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders as income (loss) from continuing operations excluding the after-tax effects of income (loss) attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders because, in our opinion, they are not indicative of overall operating performance.

Adjustments to reconcile reportable segment adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders to consolidated net income (loss) available to Genworth Financial, Inc.’s common stockholders assume a 21 % current tax rate, plus any associated deferred taxes, and are net of the portion attributable to noncontrolling interests.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for our reportable segments for the three months ended September 30:


	2025						2024
(Amounts in millions)	Enact		Long-Term Care Insurance		Life and Annuities		Enact		Long-Term Care Insurance		Life and Annuities
Revenues:
Premiums	$	245	$	597	$	42	$	249	$	581	$	42
Net investment income	68		505		221		62		483		228
Policy fees and other income	1		—		150		—		—		163
	314		1,102		413		311		1,064		433
Less:
Benefits and other changes in policy reserves (1)	36		972		222		12		949		253
Cash flow assumption updates (1)	—		6		—		—		( 63 )		—
Actual variances from expected experience (1)	—		107		( 7 )		—		91		6
Amortization of deferred acquisition costs and intangibles (1)	2		17		37		3		17		41
Interest expense (2)	13		—		—		13		—		—
Other segment expenses (2), (3)	50		118		158		53		118		169
Provision (benefit) for income taxes (2)	48		( 18 )		( 1 )		49		( 2 )		( 9 )
Adjusted operating income attributable to noncontrolling interests	31		—		—		33		—		—
Reportable segment adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders	$	134	$	( 100 )	$	4	$	148	$	( 46 )	$	( 27 )

______________

(1) Significant expense category and amounts, which align with segment-level information, as applicable, that is regularly provided to the CODM.

(2) Other segment items not considered a significant expense category.

(3) Other segment expenses include interest credited; acquisition and operating expenses, net of deferrals, as reported in the condensed consolidated statements of income, excluding gains (losses) on the early extinguishment of debt and expenses related to restructuring, as applicable; and changes in fair value of market risk benefits, excluding the impacts of interest rates, equity markets and associated hedges.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for our reportable segments for the nine months ended September 30:


	2025						2024
(Amounts in millions)	Enact		Long-Term Care Insurance		Life and Annuities		Enact		Long-Term Care Insurance		Life and Annuities
Revenues:
Premiums	$	735	$	1,746	$	125	$	734	$	1,723	$	139
Net investment income	197		1,472		657		178		1,441		732
Policy fees and other income	4		—		462		3		—		485
	936		3,218		1,244		915		3,164		1,356
Less:
Benefits and other changes in policy reserves (1)	92		2,867		686		15		2,819		740
Cash flow assumption updates (1)	—		13		—		—		( 89 )		—
Actual variances from expected experience (1)	—		132		25		—		144		10
Amortization of deferred acquisition costs and intangibles (1)	7		50		114		7		52		125
Interest expense (2)	37		—		—		39		—		—
Other segment expenses (2), (3)	150		342		468		155		301		538
Provision (benefit) for income taxes (2)	142		( 19 )		( 13 )		150		9		( 14 )
Adjusted operating income attributable to noncontrolling interests	96		—		—		101		—		—
Reportable segment adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders	$	412	$	( 167 )	$	( 36 )	$	448	$	( 72 )	$	( 43 )

______________

(1) Significant expense category and amounts, which align with segment-level information, as applicable, that is regularly provided to the CODM.

(2) Other segment items not considered a significant expense category.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table presents the reconciliation of total reportable segment adjusted operating income available to Genworth Financial, Inc.’s common stockholders to net income available to Genworth Financial, Inc.’s common stockholders for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Total reportable segment adjusted operating income available to Genworth Financial, Inc.’s common stockholders	$	38	$	75	$	209	$	333
Corporate and Other adjusted operating loss available to Genworth Financial, Inc.’s common stockholders	( 21 )		( 27 )		( 73 )		( 75 )

Net investment gains (losses) available to Genworth Financial, Inc.’s common stockholders	99		66		100		56
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges	3		( 17 )		( 1 )		19
Gains (losses) on early extinguishment of debt	—		2		—		( 4 )
Expenses related to restructuring	( 1 )		—		—		( 11 )
Taxes on adjustments (1)	6		( 11 )		6		( 13 )
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders	124		88		241		305
Loss from discontinued operations, net of taxes	( 8 )		( 3 )		( 20 )		( 5 )
Net income available to Genworth Financial, Inc.’s common stockholders	$	116	$	85	$	221	$	300

______________

(1) The three and nine months ended September 30, 2025 included a $ 27 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets.

The following table presents total assets for our reportable segments as of the dates indicated:


(Amounts in millions)	September 30, 2025		December 31, 2024
Enact	$	6,875	$	6,525
Long-Term Care Insurance	$	46,654	$	44,877
Life and Annuities	$	33,347	$	33,797

(16) Commitments and Contingencies

(a) Litigation and Regulatory Matters

We face the risk of litigation and regulatory investigations or other actions in the ordinary course of operating our businesses, including the risk of class action lawsuits. Our pending legal and regulatory actions include proceedings specific to us and others generally applicable to business practices in the industries in which we operate. In our insurance operations, we are, have been, or may become subject to class actions and individual suits alleging, among other things, issues relating to sales or underwriting practices, increases to in-force long-term care insurance premiums, payment of contingent or other sales commissions, claims payments and procedures, product design, product disclosure, product administration, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, recommending unsuitable products to customers, our pricing structures and business practices in our mortgage insurance subsidiaries, such as captive reinsurance arrangements with lenders and contract underwriting services, violations of the Real Estate Settlement and Procedures Act of 1974 or related state anti-inducement laws, and mortgage insurance policy rescissions and curtailments, and breaching fiduciary or other duties to customers, including but not limited to cybersecurity breaches of customer information. We also from time to time have had, and may in the future have, disputes with reinsurance partners relating to the parties’ rights and obligations under

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

reinsurance treaties and/or related administration agreements. In our investment-related operations, we are subject to litigation involving commercial disputes with counterparties. We are also subject to litigation arising out of our general business activities such as our contractual and employment relationships, including claims under the Employee Retirement Income Security Act of 1974 (“ERISA”), post-closing obligations associated with previous dispositions and securities lawsuits. In addition, we are also subject to various regulatory inquiries, such as information requests, subpoenas, books and record examinations and market conduct and financial examinations from state, federal and international regulators and other authorities.

Plaintiffs in class action and other lawsuits against us have sought and/or may seek very large or indeterminate amounts which may remain unknown for substantial periods of time. A substantial legal liability or a significant regulatory action against us could have an adverse effect on our business, financial condition and results of operations. Moreover, even if we ultimately prevail in the litigation, regulatory action or investigation, we could suffer significant reputational harm, which could have an adverse effect on our business, financial condition or results of operations.

We record an accrual in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At this time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed below, management has concluded that it is not probable that a loss has been incurred in any of the pending cases, and management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases. Therefore, we have not recorded any amounts in our condensed consolidated financial statements for unfavorable outcomes, if any.

TVPX ARS, INC. v. GLAIC

In September 2018, Genworth Life and Annuity Insurance Company (“GLAIC”), our indirect wholly-owned subsidiary, was named as a defendant in a putative class action lawsuit pending in the United States District Court for the Eastern District of Virginia captioned TVPX ARS, INC., as Securities Intermediary for Consolidated Wealth Management, LTD. on behalf of itself and all others similarly situated v. Genworth Life and Annuity Insurance Company . The plaintiff alleges unlawful and excessive cost of insurance charges were imposed on policyholders. The complaint asserts claims for breach of contract, alleging that Genworth improperly considered non-mortality factors when calculating cost of insurance rates and failed to decrease cost of insurance charges in light of improved expectations of future mortality, and seeks unspecified compensatory damages, costs and equitable relief. On October 29, 2018, we filed a motion to enjoin the case in the Middle District of Georgia, and a motion to dismiss and motion to stay in the Eastern District of Virginia. We moved to enjoin the prosecution of the Eastern District of Virginia action on the basis that it involves claims released in a prior nationwide class action settlement (the “McBride settlement”) that was approved by the Middle District of Georgia. The plaintiff filed an amended complaint on November 13, 2018. On December 6, 2018, we moved the Middle District of Georgia for leave to file our counterclaim, which alleges that the plaintiff breached the covenant not to sue contained in the prior settlement agreement by filing its current action. On March 15, 2019, the Middle District of Georgia granted our motion to enjoin and denied our motion for leave to file our counterclaim. As such, the plaintiff is enjoined from pursuing its class action in the Eastern District of Virginia. On March 29, 2019, the plaintiff filed a notice of appeal in the Middle District of Georgia, notifying the Court of its appeal to the United States Court of Appeals for the Eleventh Circuit from the order granting our motion to enjoin. On March 29, 2019, we filed our notice of cross-appeal in the Middle District of Georgia, notifying the Court of our cross-appeal to the Eleventh Circuit from the portion of the order denying our motion for leave to file our counterclaim. On April 8, 2019, the Eastern District of Virginia dismissed the case without prejudice, with leave for the plaintiff to refile an amended complaint only if a final appellate Court decision vacates the injunction and reverses the Middle District of Georgia’s opinion. On May 21, 2019, the plaintiff filed its appeal and memorandum in support in the Eleventh Circuit. We filed our response to the plaintiff’s appeal memorandum on July 3, 2019. The Eleventh Circuit Court of Appeals heard oral argument on the plaintiff’s appeal and our cross-appeal on April 21, 2020. On May 26, 2020, the Eleventh Circuit Court of Appeals vacated the Middle District of Georgia’s order enjoining the plaintiff’s class action and remanded the case back to the Middle District of Georgia for further factual development as to whether Genworth has altered how it calculates or charges cost of insurance since the McBride settlement. The Eleventh Circuit Court of Appeals did not reach a decision on Genworth’s counterclaim. On June 30, 2021, we filed in the Middle District of Georgia our renewed motion to enforce the class action settlement and release and renewed our motion for leave to file a counterclaim. The briefing on both motions concluded in October 2021. On March 24, 2022, the Court denied our motions. On April 11, 2022, we filed an appeal of the Court’s denial to the United States Court of Appeals for the Eleventh Circuit. On June 22, 2022, we filed our opening brief in support of the appeal. The plaintiff filed its respondent’s brief on

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

September 20, 2022, and we filed our reply brief on November 10, 2022. The appeal was orally argued on August 17, 2023, and on January 8, 2025, the Eleventh Circuit entered an order affirming the district court’s order. On January 29, 2025, we moved for rehearing by the panel and by the full court. On March 4, 2025, the Eleventh Circuit denied our motion for rehearing. On March 7, 2025, the plaintiff refiled its complaint in the United States District Court for the Eastern District of Virginia. On May 9, 2025, we moved to dismiss the refiled complaint for failure to state a cause of action. The plaintiff filed an amended complaint on June 24, 2025 and a second amended complaint on July 14, 2025. On July 28, 2025, we moved to dismiss the second amended complaint for failure to state a cause of action. The plaintiff opposed our motion to dismiss the second amended complaint on August 25, 2025, and the court has scheduled a trial date for late April 2026. We intend to continue to vigorously defend this action.

Burkhart et al. v. Genworth Financial et al.

In September 2018, Genworth Financial, Genworth Holdings, Genworth North America Corporation, Genworth Financial International Holdings, LLC (“GFIH”) and Genworth Life Insurance Company (“GLIC”) were named as defendants in a putative class action lawsuit pending in the Court of Chancery of the State of Delaware captioned Richard F. Burkhart, William E. Kelly, Richard S. Lavery, Thomas R. Pratt, Gerald Green, individually and on behalf of all other persons similarly situated v. Genworth et al . The plaintiffs allege that GLIC paid dividends to its parent and engaged in certain reinsurance transactions causing it to maintain inadequate capital capable of meeting its obligations to GLIC policyholders and agents. The complaint alleges causes of action for intentional fraudulent transfer and constructive fraudulent transfer and seeks injunctive relief. We moved to dismiss this action in December 2018. On January 29, 2019, the plaintiffs exercised their right to amend their complaint. On March 12, 2019, we moved to dismiss the plaintiffs’ amended complaint. On April 26, 2019, the plaintiffs filed a memorandum in opposition to our motion to dismiss, which we replied to on June 14, 2019. On August 7, 2019, the plaintiffs filed a motion seeking to prevent proceeds that GFIH expected to receive from the then planned sale of its shares in Genworth MI Canada Inc. (“Genworth Canada”) from being transferred out of GFIH. On September 11, 2019 , the plaintiffs filed a renewed motion seeking the same relief as their August 7, 2019 motion with an exception that allowed GFIH to transfer $ 450 million of expected proceeds from the sale of Genworth Canada through a dividend to Genworth Holdings to allow the pay-off of a senior secured term loan facility dated March 7, 2018 among Genworth Holdings as the borrower, GFIH as the limited guarantor and the lending parties thereto. Oral arguments on our motion to dismiss and the plaintiffs’ motion occurred on October 21, 2019, and the plaintiffs’ motion was denied. On January 31, 2020 , the Court granted in part our motion to dismiss, dismissing claims relating to $ 395 million in dividends GLIC paid to its parent from 2012 to 2014 (out of the $ 410 million in total dividends subject to the plaintiffs’ claims). The Court denied the balance of the motion to dismiss leaving a claim relating to $ 15 million in dividends and unquantified claims relating to the 2016 termination of a reinsurance transaction. On March 27, 2020, we filed our answer to the plaintiffs’ amended complaint. On May 26, 2021, the plaintiffs filed a second amended and supplemental class action complaint adding additional factual allegations and three new causes of action. On July 26, 2021, we moved to dismiss the three new causes of action and answered the balance of the second amended and supplemental class action complaint. The plaintiffs filed an opposition to our motion to dismiss on September 30, 2021. The Court heard oral arguments on the motion on December 7, 2021 and ordered each party to file supplemental submissions, which were filed on January 28, 2022. On May 10, 2022, the Court granted our motion to dismiss the three new causes of action. On January 27, 2022, the plaintiffs filed a motion for a preliminary injunction seeking to enjoin GFIH from transferring any assets to any affiliate, including paying any dividends to Genworth Holdings and to enjoin Genworth Holdings and Genworth Financial from transferring or distributing any value to Genworth Financial’s shareholders. On June 2, 2022, the plaintiffs withdrew their motion for a preliminary injunction. On January 12, 2024, the plaintiffs moved for class certification. We filed our opposition papers on February 23, 2024. On March 25, 2025, we filed a motion for summary judgment dismissing the second amended complaint, and the plaintiffs filed opposition papers as well as a motion for rule 56(d) relief on May 14, 2025. On June 18, 2025, we filed reply papers in further support of our motion for summary judgment and moved separately to strike the plaintiffs’ motion. The plaintiffs opposed our motion to strike on July 11, 2025. We intend to continue to vigorously defend this action.

Trauernicht et al v. Genworth Financial

On August 1, 2022, a putative class action was filed in the United States District Court for the Eastern District of Virginia by two former Genworth employees against Genworth Financial, its Board of Directors and the Fiduciary and Investments Committee of Genworth Financial’s Retirement and Savings Plan (“Savings Plan”). The plaintiffs purport to act on behalf of the Savings Plan and all similarly situated participants and beneficiaries of the Savings Plan. The complaint

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

asserts that the defendants breached their fiduciary duties under ERISA by imprudently offering and inadequately monitoring a suite of BlackRock Target Date Funds as a retirement investment option for Genworth employees. The plaintiffs seek declaratory and injunctive relief, monetary damages and attorney’s fees. By stipulation entered September 6, 2022, the complaint was dismissed, without prejudice, against the Board of Directors and the Fiduciary and Investments Committee of Genworth Financial’s Savings Plan. On October 17, 2022, we moved to dismiss the complaint against the sole remaining defendant, Genworth Financial. The plaintiffs filed opposition papers on November 10, 2022, and we filed our reply papers on November 16, 2022. By order dated January 20, 2023, the Court granted the plaintiffs’ motion to serve an amended complaint, rendering our initial motion to dismiss moot. On January 20, 2023, the plaintiffs filed an amended complaint, and on February 2, 2023, we filed a motion to dismiss the amended complaint. On March 16, 2023, the Court directed the plaintiffs to file a second amended complaint and denied our motion to dismiss the amended complaint. The plaintiffs filed the second amended complaint on April 17, 2023. On May 15, 2023, we answered and moved to dismiss the second amended complaint. On September 13, 2023, the Court granted in part and denied in part our motion to dismiss the second amended complaint. The plaintiffs moved for class certification on October 16, 2023, and we filed opposition papers on December 4, 2023. Oral argument on the plaintiffs’ class certification motion was heard on February 12, 2024. On February 20, 2024, we moved for summary judgment dismissing the claims, and the plaintiffs filed opposition papers on March 5, 2024. Oral argument was conducted on our summary judgment motion on March 25, 2024. On August 15, 2024, the Court granted the plaintiffs’ motion and certified the case as a class action. On August 29, 2024, the Court denied our motion for summary judgment. We filed a motion for leave to appeal from the trial court’s class certification order, and the United States Court of Appeals for the Fourth Circuit granted leave to appeal on September 13, 2024. On March 7, 2025, we filed our opening appellate brief in the Fourth Circuit, and the plaintiffs filed their responding brief on April 7, 2025. The case is now stayed in trial court pending the determination of our appeal to the Fourth Circuit, oral argument of which occurred on October 21, 2025. We intend to continue to vigorously defend this action.

M/O Arbitration Between Blue Cross Blue Shield Nebraska and GLIC

On December 16, 2022, Blue Cross Blue Shield of Nebraska (“BCBSNE”) served an arbitration demand on GLIC in relation to BCBSNE’s stated intent to recapture a block of long-term care insurance policies for which the risk was partly ceded to GLIC. In its arbitration demand, BCBSNE alleged that GLIC breached the governing reinsurance agreement by refusing to agree to transfer assets equal to the fair value of the liabilities being recaptured. BCBSNE asserted it had satisfied all of its obligations under the reinsurance agreement and sought to recapture the ceded block of reinsurance. BCBSNE sought damages equal to the fair value of the recaptured liabilities, plus interest and other damages, including attorneys’ fees and costs. The arbitration panel was appointed, and an organizational meeting was held on August 30, 2023. The arbitration proceeding occurred in September 2024, and the arbitration panel issued its final decision on May 19, 2025. Following the arbitration panel’s final decision, we made a $ 24 million payment to BCBSNE and released $ 50 million in insurance reserves, at the locked-in discount rate, related to the policies recaptured, resulting in a pre-tax gain of $ 26 million in the second quarter of 2025.

In Re MOVEit Customer Data Security Breach Litigation

Starting in June 2023, various Genworth entities (including Genworth Financial, GLIC and GLAIC) have been named as defendants in certain putative class action lawsuits in the United States District Courts for the Eastern District of Virginia and the District of Massachusetts. These cases are captioned as follows: Anastasio v. Genworth Financial, Inc. et al; Hauser v. Genworth Life Insurance Company; Smith v. Genworth Financial, Inc.; Behrens v. Genworth Life Insurance Company; Hale et al v. Genworth Financial, Inc.; Burkett, Jr. v. Genworth Life and Annuity Insurance Company; Manar v. Genworth Financial, Inc.; Romine et al. v. Progress Software Corporation et al.; Schwarz et al. v. Progress Software Corporation et al.; Casey et al. v. Genworth Life & Annuity Insurance Company; and Bailey v. Genworth Financial, Inc . The actions relate to the data security events involving the MOVEit file transfer system, which PBI Research Services (“PBI”), a third-party vendor, uses in the performance of its services (“MOVEit Cybersecurity Incident”). Our life insurance subsidiaries use PBI to, among other things, satisfy applicable regulatory obligations to search various databases to identify the deaths of insured persons under life insurance policies, and to identify deaths under long-term care insurance and annuity policies which can impact premium payment obligations and benefit eligibility. The plaintiffs seek to represent various classes and subclasses of Genworth long-term care insurance policyholders and agents whose data was accessed or potentially accessed by the MOVEit Cybersecurity Incident, alleging that Genworth breached its purported duty to safeguard their sensitive data from cybercriminals. The complaints assert claims for, inter alia, negligence, negligence per se, breach of contract, unjust enrichment, and violations of various consumer protection and privacy statutes, and they seek,

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

inter alia, declaratory and injunctive relief, compensatory and punitive damages, restitution, attorneys’ fees and costs. On October 4, 2023, the Joint Panel on Multidistrict Litigation issued an order consolidating all actions relating to the MOVEit Cybersecurity Incident before a single federal judge in the United States District Court for the District of Massachusetts. All defendants, including the Genworth entities, filed a joint motion to dismiss the complaints on July 23, 2024. Oral argument on this motion occurred on October 9, 2024. On December 12, 2024, as relevant to Genworth, the court denied the motion. On February 4, 2025, several defendants, including the Genworth entities, filed a second motion to dismiss the complaints, and the plaintiffs filed opposition papers on April 7, 2025. Oral argument was conducted on the second motion to dismiss on May 12, 2025. On July 31, 2025, the court granted the second motion to dismiss in part and dismissed most of the causes of action against Genworth, retaining only the claims for common law negligence, breach of implied contract, and a Massachusetts statutory violation. On September 9, 2025, we moved for partial reconsideration of certain aspects of the July 31, 2025 decision, and the plaintiffs opposed that motion on September 23, 2025. We intend to continue to vigorously defend these actions.

Fox v. GLAIC

In March 2024, GLAIC was served with a putative class action lawsuit venued in the Superior Court of the State of California, Sacramento County, captioned James Fox, individually and on behalf of the class v. Genworth Life and Annuity Insurance Co . The plaintiff, the holder of a lapsed California GLAIC life insurance policy, seeks to represent a class of current and former California GLAIC policyholders and beneficiaries whose policies were allegedly wrongfully terminated. The complaint alleges that GLAIC wrongfully terminated hundreds of California life insurance policies by failing to provide the policyholders with the notices and grace periods mandated by the contract and by the California Insurance Code as interpreted by the California Supreme Court in McHugh v. Protective Life Ins. Co . The complaint asserts causes of action for breach of contract, violation of the California Insurance Code, unfair competition and bad faith, and it seeks, inter alia, declaratory and injunctive relief, compensatory damages, restitution, attorneys’ fees and costs. The action was removed to the United States District Court for the Eastern District of California on April 3, 2024. On May 8, 2024, we answered the complaint. On October 15, 2024, the court granted our motion to stay the action pending final determination of an appeal in a related case. On March 4, 2025, the court lifted the stay, and the plaintiff filed an amended complaint on April 21, 2025. On June 2, 2025, we answered the complaint and moved to strike its class action allegations. The plaintiff filed opposition papers to our motion to strike on June 16, 2025. The plaintiff moved to remand the matter to state court on June 30, 2025, and we opposed that motion on July 22, 2025. On August 19, 2025, the court denied both our motion to strike the class allegations and the plaintiff’s motion to remand the case to state court. The plaintiff filed a notice of appeal from that order on September 18, 2025, but the appeal was dismissed by the United States Court of Appeals for the Ninth Circuit on October 1, 2025. We intend to continue to vigorously defend this action.

Kaplan v. GLIC

On January 17, 2025, GLIC, Genworth Life Insurance Company of New York and various AARP entities were named as defendants in a putative class action lawsuit in the Superior Court of the District of Columbia captioned Sharon R. Kaplan and Richard A. Kaplan on behalf of themselves and all others similarly situated v. Genworth Life Insurance Co. et al . The complaint alleges that the Genworth and AARP defendants violated the District of Columbia Consumer Protection Procedures Act by affirmatively misrepresenting and failing to adequately disclose information regarding the pricing structure and likelihood of rate increases for the My Future My Plan 2 series of long-term care insurance policies. The complaint further alleges that the Genworth defendants breached the terms of the relevant insurance contracts by increasing premiums because of the policies’ inflation protection component and by acting unreasonably in violation of the covenant of good faith and fair dealing. The complaint seeks, among other things, monetary damages and civil penalties. We removed the action to the United States District Court for the District of Columbia on April 17, 2025. We moved to dismiss the complaint for failure to state a cause of action on May 15, 2025, and the plaintiff opposed that motion on July 7, 2025. We intend to continue to vigorously defend this action.

At this time, except to the extent discussed above, we cannot determine or predict the ultimate outcome of any of the pending legal and regulatory matters specifically identified above or the likelihood of potential future legal and regulatory matters against us. It is possible that related investigations and proceedings may be commenced in the future, and we could become subject to additional unrelated investigations and lawsuits. Increased regulatory scrutiny and any resulting investigations or proceedings could result in new legal precedents and industry-wide regulations or practices that could adversely affect our business, financial condition and results of operations.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(b) Commitments and Guarantees

See note 6 for amounts we were committed to fund related to our investments as of September 30, 2025.

As previously disclosed, in connection with pending litigation between AXA S.A. (“AXA”) and Santander Cards UK Limited (“Santander”) related to the payment protection insurance (“PPI”) mis-selling losses, Genworth has certain rights to share in any recoveries by AXA to recoup payments it previously made to AXA for the underlying PPI mis-selling losses. Genworth is not a named party in the litigation with Santander, and, therefore, does not ultimately control the litigation. In order to better align the interests of AXA and Genworth in the litigation, in March 2025, Genworth agreed to provide AXA a guarantee for the recovery of certain of AXA’s PPI mis-selling losses not previously reimbursed by Genworth, regardless of the ultimate outcome of the litigation. The guarantee was provided through a stand-by letter of credit (“LC”) issued by a third-party financial institution for the benefit of AXA and a reimbursement agreement between Genworth and the third-party financial institution. Genworth could be required to pay an amount under the guarantee, through the reimbursement agreement, up to £ 80 million. Whether AXA may draw upon the LC is subject to the amount of any settlement between AXA and Santander, or certain milestones in the court proceedings. On July 25, 2025, the U.K. High Court issued a liability judgment in favor of AXA in the legal proceedings against Santander. The judgment finds Santander liable for AXA’s losses resulting from Santander’s mis-selling. The judge awarded AXA damages, interest and costs of approximately £ 680 million ( $ 911 million based on then current exchange rates). Santander subsequently applied for permission to appeal, and the U.K. Court of Appeal granted that request on October 21, 2025. The case will now proceed to a determination by the U.K. Court of Appeal. Under prior agreements between Genworth and AXA, Genworth is entitled to share in funds that AXA recovers from third parties related to the mis-selling losses. If the appeal is resolved in favor of AXA, Genworth could be entitled to recover approximately $ 750 million , depending upon the applicable exchange rate at that time. As of September 30, 2025, we have not recorded any amounts related to the guarantee or loss recoveries in connection with the liability judgment. In November 2025, AXA initiated the process to cancel the LC .

(17) Changes in Accumulated Other Comprehensive Income (Loss)

The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated:


(Amounts in millions)	Net unrealized investment gains (losses)		Derivatives qualifying as hedges (1)		Change in the discount rate used to measure future policy benefits		Change in instrument- specific credit risk of market risk benefits		Foreign currency translation and other adjustments		Total
Balances as of July 1, 2025	$	( 2,536 )	$	380	$	770	$	( 5 )	$	19	$	( 1,372 )
OCI before reclassifications	635		11		( 627 )		1		( 1 )		19
Amounts reclassified from OCI	8		( 38 )		—		—		—		( 30 )
Current period OCI	643		( 27 )		( 627 )		1		( 1 )		( 11 )
Balances as of September 30, 2025 before noncontrolling interests	( 1,893 )		353		143		( 4 )		18		( 1,383 )
Less: change in OCI attributable to noncontrolling interests	12		—		—		—		—		12
Balances as of September 30, 2025	$	( 1,905 )	$	353	$	143	$	( 4 )	$	18	$	( 1,395 )

______________

(1) See note 5 for additional information.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


(Amounts in millions)	Net unrealized investment gains (losses)		Derivatives qualifying as hedges (1)		Change in the discount rate used to measure future policy benefits		Change in instrument- specific credit risk of market risk benefits		Foreign currency translation and other adjustments		Total
Balances as of July 1, 2024	$	( 3,042 )	$	730	$	624	$	( 6 )	$	7	$	( 1,687 )
OCI before reclassifications	1,656		181		( 1,965 )		—		3		( 125 )
Amounts reclassified from OCI	6		( 40 )		—		—		—		( 34 )
Current period OCI	1,662		141		( 1,965 )		—		3		( 159 )
Balances as of September 30, 2024 before noncontrolling interests	( 1,380 )		871		( 1,341 )		( 6 )		10		( 1,846 )
Less: change in OCI attributable to noncontrolling interests	25		—		—		—		—		25
Balances as of September 30, 2024	$	( 1,405 )	$	871	$	( 1,341 )	$	( 6 )	$	10	$	( 1,871 )

______________

(1) See note 5 for additional information.


(Amounts in millions)	Net unrealized investment gains (losses)		Derivatives qualifying as hedges (1)		Change in the discount rate used to measure future policy benefits		Change in instrument- specific credit risk of market risk benefits		Foreign currency translation and other adjustments		Total
Balances as of January 1, 2025	$	( 3,156 )	$	492	$	1,023	$	( 5 )	$	4	$	( 1,642 )
OCI before reclassifications	1,258		( 39 )		( 880 )		1		13		353
Amounts reclassified from OCI	25		( 100 )		—		—		—		( 75 )
Current period OCI	1,283		( 139 )		( 880 )		1		13		278
Balances as of September 30, 2025 before noncontrolling interests	( 1,873 )		353		143		( 4 )		17		( 1,364 )
Less: change in OCI attributable to noncontrolling interests	32		—		—		—		( 1 )		31
Balances as of September 30, 2025	$	( 1,905 )	$	353	$	143	$	( 4 )	$	18	$	( 1,395 )

______________

(1) See note 5 for additional information.

Table of Contents

GENWORTH FINANCIAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


(Amounts in millions)	Net unrealized investment gains (losses)		Derivatives qualifying as hedges (1)		Change in the discount rate used to measure future policy benefits		Change in instrument- specific credit risk of market risk benefits		Foreign currency translation and other adjustments		Total
Balances as of January 1, 2024	$	( 2,130 )	$	1,010	$	( 1,439 )	$	( 8 )	$	12	$	( 2,555 )
OCI before reclassifications	711		( 29 )		98		2		( 2 )		780
Amounts reclassified from OCI	38		( 110 )		—		—		—		( 72 )
Current period OCI	749		( 139 )		98		2		( 2 )		708
Balances as of September 30, 2024 before noncontrolling interests	( 1,381 )		871		( 1,341 )		( 6 )		10		( 1,847 )
Less: change in OCI attributable to noncontrolling interests	24		—		—		—		—		24
Balances as of September 30, 2024	$	( 1,405 )	$	871	$	( 1,341 )	$	( 6 )	$	10	$	( 1,871 )

______________

(1) See note 5 for additional information.

As of September 30, 2025 and 2024, the balances of the change in the discount rate used to measure future policy benefits were net of taxes of $( 39 ) million and $ 364 million, respectively, and the balances of the change in instrument-specific credit risk of MRBs were net of taxes of $ 2 million for both periods. The foreign currency translation and other adjustments balance in the charts above included $ 34 million and $ 30 million, respectively, net of taxes of $( 9 ) million and $( 8 ) million, respectively, related to a net unrecognized postretirement benefit obligation as of September 30, 2025 and 2024. The balance also included taxes of $( 2 ) million and $ — related to foreign currency translation adjustments as of September 30, 2025 and 2024, respectively .

The following table shows reclassifications from accumulated other comprehensive income (loss), net of taxes, for the periods indicated:



	Three months ended September 30,				Nine months ended September 30,				Affected line item in the condensed consolidated statements of income
(Amounts in millions)	2025		2024		2025		2024
Net unrealized investment (gains) losses:
Unrealized (gains) losses on investments	$	10	$	7	$	32	$	48		Net investment (gains) losses
Income taxes	( 2 )		( 1 )		( 7 )		( 10 )			Provision for income taxes
Total	$	8	$	6	$	25	$	38
Derivatives qualifying as hedges:
Interest rate swaps hedging assets	$	( 50 )	$	( 55 )	$	( 145 )	$	( 160 )		Net investment income
Interest rate swaps hedging assets	( 9 )		( 6 )		( 11 )		( 11 )			Net investment (gains) losses
Interest rate swaps hedging liabilities	1		—		2		2			Interest expense



Income taxes	20		21		54		59			Provision for income taxes
Total	$	( 38 )	$	( 40 )	$	( 100 )	$	( 110 )

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included herein and with our 2024 Annual Report on Form 10-K. Unless the context otherwise requires, references to “Genworth,” the “Company,” “we” or “our” herein are to Genworth Financial, Inc. on a consolidated basis. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries.

Cautionary note regarding forward-looking statements

This report contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expects,” “intends,” “anticipates,” “plans,” “believes,” “seeks,” “estimates,” “will,” “may” or words of similar meaning and include, but are not limited to, statements regarding the outlook for our future business and financial performance. Examples of forward-looking statements include statements we make relating to potential dividends or share repurchases; future return of capital by Enact Holdings, Inc. (“Enact Holdings”), including share repurchases, and quarterly and special dividends; the cumulative economic benefit of approved and future rate actions included in our long-term care insurance multi-year in-force rate action plan; planned investments in and our outlook for new lines of business or new insurance and other products and services, such as those we are pursuing with our CareScout business (“CareScout”), including through our CareScout services business (“CareScout Services”) and our CareScout insurance business (“CareScout Insurance”); the expected benefits and/or synergies of the Seniorly, Inc. (“Seniorly”) acquisition; future insurance offerings through CareScout Insurance ; future financial performance, including the expectation that quarterly adverse variances between actual and expected experience could persist resulting in future remeasurement losses in our long-term care insurance business; the resolution of the appeal or any potential litigation recovery amounts in connection with the AXA S.A. (“AXA”) and Santander Cards UK Limited (“Santander”) litigation, and Genworth’s planned use of proceeds from any recovery in connection with the litigation, including share repurchases, debt repurchases and investments in new businesses; future financial condition and liquidity of our businesses; and statements we make regarding the outlook of the U.S. economy.

Forward-looking statements are based on management’s current expectations and assumptions, which are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from those in the forward-looking statements due to global political, economic, inflation, business, competitive, market, regulatory and other factors and risks, including but not limited to, the following:

• the inability to successfully launch new lines of business, including long-term care insurance and other products and services we are pursuing with CareScout;

• our failure to maintain the self-sustainability of our legacy U.S. life insurance subsidiaries, including as a result of the inability to achieve desired levels of in-force rate actions and/or the timing of future premium rate increases and associated benefit reductions taking longer to achieve than originally assumed; other regulatory actions negatively impacting our life insurance businesses;

• inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections and/or models, which result in inadequate reserves or other adverse results (including as a result of any changes in connection with quarterly, annual or other reviews, including reviews we expect to complete in the fourth quarter of 2025);

• the impact on holding company liquidity caused by an inability to receive dividends or any other returns of capital from Enact Holdings, and limited sources of capital and financing and the need to seek additional capital on unfavorable terms;

• the impact on any potential recovery in the AXA and Santander litigation resulting from a successful appeal, significant delays or any other adverse development in the litigation;

• adverse changes to the structure or requirements of Federal National Mortgage Association (“Fannie Mae”), Federal Home Loan Mortgage Corporation (“Freddie Mac”) or the U.S. mortgage insurance market; an increase in the number of loans insured through federal government mortgage insurance programs, including those offered by the Federal Housing Administration (“FHA”); the inability of Enact Holdings and/or its U.S. mortgage insurance subsidiaries to continue to meet the requirements mandated by the private mortgage insurer eligibility requirements (“PMIERs”) (or any adverse changes thereto), the inability to meet minimum statutory capital requirements of applicable regulators or the mortgage insurer eligibility requirements of Fannie Mae or Freddie Mac;

Table of Contents

• changes in economic, market and political conditions, labor shortages and fluctuating interest rates; unanticipated financial events, which could lead to market-wide liquidity problems and other significant market disruption resulting in losses, defaults or credit rating downgrades of other financial institutions; deterioration in economic conditions, a recession or a decline in home prices, all of which could be driven by many potential factors, including the U.S. government shutdown; an increase in the cost of care impacting our long-term care insurance business; changes in international trade policy, including the potential impact of new or increased tariffs, retaliatory policies or actions from other countries, and trade wars or other events that lead to political and economic instability; changes in government or monetary policies, including U.S. federal tax laws, such as the One Big Beautiful Bill Act that was signed into law on July 4, 2025, tax rates or interest rates; changes within regulatory agencies as a result of the change in the U.S. Administration in January 2025; changes in immigration policy; and fluctuations in international securities markets;

• downgrades in financial strength and credit ratings and potential adverse impacts to liquidity; counterparty credit risks; defaults by counterparties to reinsurance arrangements or derivative instruments; defaults or other events impacting the value of invested assets;

• changes in tax rates or tax laws, or changes in accounting and reporting standards;

• litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties;

• the inability to retain, attract and motivate qualified employees or senior management;

• changes in the composition of Enact Holdings’ business or undue concentration by customer or geographic region;

• the impact from deficiencies in our disclosure controls and procedures or internal control over financial reporting;

• the occurrence of natural or man-made disasters, including geopolitical tensions and war (including the Russian invasion of Ukraine, the Israel-Hamas conflict and economic competition between the United States and China), a public health emergency, including pandemics, or climate change;

• the inability to effectively manage information technology systems (including artificial intelligence), cyber incidents or other failures, disruptions or security breaches of us or our third-party vendors, as well as unknown risks and uncertainties associated with artificial intelligence;

• the inability of third-party vendors to meet their obligations to us;

• the lack of availability, affordability or adequacy of reinsurance to protect us against losses;

• a decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations;

• unanticipated claims against Enact Holdings’ delegated underwriting and loss mitigation programs;

• the impact of medical advances such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation; and

• other factors described in the risk factors contained in Item 1A of our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on February 28, 2025 .

We provide additional information regarding these risks and uncertainties in our Annual Report on Form 10-K. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Accordingly, for the foregoing reasons, we caution the reader against relying on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required under applicable securities laws.

Overview

Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s legacy U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products. Genworth Financial

Table of Contents

also has start-up businesses whereby it offers fee-based services, advice, consulting and other aging care services, as well as long-term care insurance products, through CareScout.

We report our business results through three segments: Enact; Long-Term Care Insurance; and Life and Annuities. The products in the Life and Annuities segment include traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), and fixed and variable annuities, none of which are actively marketed or sold.

In addition to our three reportable segments, we also have Corporate and Other, which includes debt financing expenses that are incurred at the Genworth Holdings, Inc. (“Genworth Holdings”) level, unallocated corporate income and expenses, and eliminations of inter-segment transactions. Corporate and Other also includes the results of other businesses that are not individually reportable, such as CareScout Services and CareScout Insurance, and certain international businesses.

Enact Holdings is a public company traded on the Nasdaq Global Select Market exchange under the ticker symbol “ACT.” Genworth Financial maintains control of Enact Holdings through an indirect majority voting interest and accordingly, Enact Holdings remains a consolidated subsidiary of Genworth Financial. Enact Holdings and its mortgage insurance subsidiaries comprise, and can therefore generally be viewed as, our Enact segment, or commonly referred to as “Enact.”

Strategic Update

Creating shareholder value

We continue to create shareholder value through Enact’s growing market value and capital returns. Enact Holdings provided $110 million of capital returns to Genworth Holdings in the third quarter of 2025. We believe capital returns from Enact will continue to benefit our shareholders by funding our strategic initiatives, including new CareScout products and services, as well as share repurchases and opportunistic debt reduction. On September 18, 2025, Genworth Financial announced that its Board of Directors had authorized a new share repurchase program under which Genworth Financial may purchase up to $350 million of its outstanding common stock. Since the initial authorization of Genworth Financial’s share repurchase program in May 2022 and through October 31, 2025, we have repurchased $725 million worth of shares of Genworth Financial’s common stock. For additional information on our share repurchase program, see “—Liquidity and Capital Resources.”

Legacy businesses

We continue to make progress on our strategic priority to maintain self-sustaining, customer-centric legacy U.S. life insurance subsidiaries, including our long-term care insurance, life insurance and annuity businesses. Our long-term care insurance multi-year in-force rate action plan continues to be our most effective tool in supporting this strategic priority. We achieved an estimated cumulative economic benefit of approximately $31.8 billion, on a net present value basis, of approved rate actions since 2012 through the third quarter of 2025. As we manage our legacy U.S. life insurance subsidiaries on a standalone basis, these entities will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and long-term care insurance in-force rate actions to satisfy policyholder obligations. For additional information regarding our in-force rate actions, see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment—Long-Term Care Insurance segment.”

CareScout growth initiatives

We continue to drive future growth through CareScout with innovative, consumer-focused aging care services and funding solutions.

CareScout Services

CareScout Services made strong progress during the third quarter of 2025, increasing its network of long-term care providers (“CareScout Quality Network”) to over 700 home care providers with more than 950 locations nationwide, and continued to see growth in the number of CareScout members who received first-time services from the network. Substantially all of the home care providers in the CareScout Quality Network have agreed to hourly rates below the median cost of care in their respective zip codes (as determined by Genworth and CareScout’s Cost of Care Survey). In

Table of Contents

addition to the benefits to consumers, the discounts available through the network are expected to further mitigate risk in our legacy long-term care insurance block by reducing claims costs, aligning the interests of long-term care providers, CareScout Services and CareScout members. We also continue to work towards expanding network access to other long-term care insurance carriers with closed blocks of business. Two pilot programs are in progress, and we are in various stages of engagement with three other long-term care insurers.

On October 31, 2025, we acquired Seniorly, a leading platform with a large network of senior living communities that helps families with care planning and placement through its growing advisor network. The acquisition of Seniorly will expand the CareScout Quality Network to include assisted living communities and is expected to accelerate our expansion into the direct-to-consumer market. This expansion of the network will allow us to connect consumers to the full range of CareScout Services offerings, from personalized care plans to our national network of home care providers and assisted living communities, based on the their individual needs. We believe this strong strategic and cultural alignment positions CareScout Services for continued growth and leadership as we build a trusted aging-care platform.

In addition to expanding the network, we are scaling other fee-based service offerings that we anticipate will generate a growing stream of recurring revenue, including our new Care Plans product, which launched in the second quarter of 2025. Our Care Plans product provides virtual care evaluations conducted by a licensed nurse and tailored aging care strategies and local resources for consumers. We plan to launch an in-person evaluation option in the fourth quarter of 2025.

Over time, we expect to expand both the range of services offered by CareScout Services and the number of customers we serve. We continue to expect to invest approximately $45 million to $50 million in CareScout Services for the full year 2025, excluding our payment to acquire Seniorly. Our expected investment will go towards scaling our technology-enabled platform along with marketing and brand awareness as we continue to build out the offering.

CareScout Insurance

We have advanced our strategy to roll out innovative solutions to meet the growing demand for aging care funding through CareScout Insurance. In October 2025, we launched our individual long-term care insurance product, CareScout Care Assurance, with the product approved in 37 states as of October 31, 2025 and additional approvals pending. CareScout Care Assurance features customizable levels of coverage, inflation protection and individualized policyholder experiences. It also includes access to the CareScout Quality Network, which provides discounts on care costs to help policyholders optimize their claim dollars. This product has been developed with meaningful but limited coverage, and assumptions designed to reduce the need for future premium rate increases. We anticipate that future product offerings would include an asset-based hybrid long-term care insurance design that includes low-cost equity-based crediting strategies for accumulation, as well as worksite and association group long-term care insurance offerings to broaden distribution through employers and other partners. We have contributed $85 million to our CareScout Insurance subsidiary in 2025 to meet its regulatory capital requirements. Though actual funding may vary based on business performance and other developments, we anticipate this initial capital investment will be the majority of the funding we allocate to this business over the next few years.

While it will take time to scale these businesses, we believe our investments in CareScout Services and CareScout Insurance will drive sustainable future growth for Genworth and are aligned with our overarching priority to maximize long-term value for our shareholders. We will continue to strive to maintain a disciplined approach in our capital allocation strategy, balancing investments in CareScout growth initiatives with returning value to shareholders and opportunistically retiring debt.

Financial Strength and Credit Ratings

On August 6, 2025, Moody’s Investors Service, Inc. upgraded the credit rating of Genworth Holdings’ senior unsecured debt to “Baa3” from “Ba1” and upgraded the financial strength rating of Enact Mortgage Insurance Corporation (“EMICO”) to “A2” from “A3,” both with an outlook of stable.

On September 17, 2025, A.M. Best Company, Inc. (“A.M. Best”) revised the outlook to positive from stable and affirmed the financial strength rating of “C++” of Genworth Life Insurance Company and Genworth Life Insurance Company of New York. A.M. Best also affirmed the financial strength rating of “B-” of Genworth Life and Annuity Insurance Company and the credit rating of “bb-” of Genworth Financial and Genworth Holdings with an outlook of stable.

Table of Contents

On September 18, 2025, A.M. Best revised the outlook to positive from stable and affirmed the financial strength rating of “A-” of EMICO.

There were no other changes in the financial strength ratings of our principal insurance subsidiaries or the credit ratings of Genworth Financial and Genworth Holdings subsequent to February 28, 2025 , the date we filed our 2024 Annual Report on Form 10-K. For additional information regarding the financial strength ratings of Genworth Financial’s insurance subsidiaries and the credit ratings of Genworth Financial and Genworth Holdings, including their importance to our business, see “Item 1—Business—Ratings” in our 2024 Annual Report on Form 10-K.

Our Financial Information

The financial information in this Quarterly Report on Form 10-Q has been derived from our unaudited condensed consolidated financial statements.

Revenues and expenses

Our revenues consist primarily of the following:

• Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance.

• Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.”

• Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, and unrealized gains and losses on equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

• Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker/dealer commission revenues, fee revenue from contract underwriting services and other fees.

Our expenses consist primarily of the following:

• Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid, interest accretion expense and other reserve activity related to future policy benefits for long-term care insurance, life insurance, and fixed and variable annuities, and claim costs incurred related to mortgage insurance products.

• Liability remeasurement (gains) losses. Liability remeasurement (gains) losses represent changes to the net premium ratio for actual variances from expected experience and updates to cash flow assumptions used to measure long-duration traditional and limited-payment insurance contracts.

• Changes in fair value of market risk benefits and associated hedges. Changes in fair value of market risk benefits and associated hedges consist of fair value changes of market risk benefits (other than changes attributable to instrument-specific credit risk), net of changes in the fair value of non-qualified derivative instruments that support our market risk benefits.

• Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances.

• Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses. We allocate certain corporate expenses to each of our segments using various methodologies.

Table of Contents

• Amortization of deferred acquisition costs and intangibles. Amortization of deferred acquisition costs (“DAC”) and intangibles consists primarily of the amortization of capitalized acquisition costs, present value of future profits and capitalized software.

• Interest expense. Interest expense primarily represents interest incurred on borrowings of Genworth Holdings and Enact Holdings.

• Provision (benefit) for income taxes. We allocate tax to our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. generally accepted accounting principles (“U.S. GAAP”) and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other.

The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers. The annually-determined tax rates and adjustments to each segment’s provision for income taxes are estimates which are subject to review and could change from year to year. For a discussion of the effective tax rates used to record the provision for income taxes for our three reportable segments and Corporate and Other, see note 14 in our unaudited condensed consolidated financial statements under “Item 1—Financial Statements.”

• Net income attributable to noncontrolling interests. Net income attributable to noncontrolling interests represents third party ownership interests in income of Enact Holdings, a consolidated subsidiary of Genworth Financial.

Table of Contents

Consolidated Results of Operations

Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024

The following table sets forth the consolidated results of operations for the periods indicated:


	Three months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	886	$	874	$	12	1	%
Net investment income	799		777		22		3	%
Net investment gains (losses)	99		66		33		50	%
Policy fees and other income	151		163		(12)		(7)	%
Total revenues	1,935		1,880		55		3	%
Benefits and expenses:
Benefits and other changes in policy reserves	1,227		1,213		14		1	%
Liability remeasurement (gains) losses	106		34		72		NM⁽¹⁾
Changes in fair value of market risk benefits and associated hedges	(1)		21		(22)		(105)	%
Interest credited	96		102		(6)		(6)	%
Acquisition and operating expenses, net of deferrals	259		259		—		—	%
Amortization of deferred acquisition costs and intangibles	57		62		(5)		(8)	%
Interest expense	27		28		(1)		(4)	%
Total benefits and expenses	1,771		1,719		52		3	%
Income from continuing operations before income taxes	164		161		3		2	%
Provision for income taxes	9		40		(31)		(78)	%
Income from continuing operations	155		121		34		28	%
Loss from discontinued operations, net of taxes	(8)		(3)		(5)		(167)	%
Net income	147		118		29		25	%
Less: net income attributable to noncontrolling interests	31		33		(2)		(6)	%
Net income available to Genworth Financial, Inc.’s common stockholders	$	116	$	85	$	31	36	%

______________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

Table of Contents

Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024

The following table sets forth the consolidated results of operations for the periods indicated:


	Nine months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	2,613	$	2,604	$	9	—	%
Net investment income	2,340		2,367		(27)		(1)	%
Net investment gains (losses)	98		54		44		81	%
Policy fees and other income	466		488		(22)		(5)	%
Total revenues	5,517		5,513		4		—	%
Benefits and expenses:
Benefits and other changes in policy reserves	3,639		3,567		72		2	%
Liability remeasurement (gains) losses	170		65		105		162	%
Changes in fair value of market risk benefits and associated hedges	7		(10)		17		170	%
Interest credited	289		352		(63)		(18)	%
Acquisition and operating expenses, net of deferrals	744		724		20		3	%
Amortization of deferred acquisition costs and intangibles	174		187		(13)		(7)	%
Interest expense	79		88		(9)		(10)	%
Total benefits and expenses	5,102		4,973		129		3	%
Income from continuing operations before income taxes	415		540		(125)		(23)	%
Provision for income taxes	80		138		(58)		(42)	%
Income from continuing operations	335		402		(67)		(17)	%
Loss from discontinued operations, net of taxes	(20)		(5)		(15)		NM⁽¹⁾
Net income	315		397		(82)		(21)	%
Less: net income attributable to noncontrolling interests	94		97		(3)		(3)	%
Net income available to Genworth Financial, Inc.’s common stockholders	$	221	$	300	$	(79)	(26)	%

______________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.

Use of non-GAAP measures

Reconciliation of net income (loss) to adjusted operating income (loss)

Our chief operating decision maker (“CODM”) evaluates performance and allocates resources based on a non-GAAP financial measure entitled “adjusted operating income (loss).” Our CODM evaluates adjusted operating income (loss) as a key measure to assess performance and support new business initiatives because the measure more accurately reflects overall operating performance, as it minimizes the impact of macroeconomic volatility. Our legacy U.S. life insurance subsidiaries, which comprise our Long-Term Care Insurance and Life and Annuities segments, are managed on a standalone basis; therefore, we do not allocate capital to our Long-Term Care Insurance and Life and Annuities segments.

Table of Contents

We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating performance.

While some of these items may be significant components of net income (loss) determined in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Adjusted operating income (loss) is not a substitute for net income (loss) determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% current tax rate, plus any associated deferred taxes, and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.

Table of Contents

The following table presents a reconciliation of net income to adjusted operating income for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Net income available to Genworth Financial, Inc.’s common stockholders	$	116	$	85	$	221	$	300
Add: net income attributable to noncontrolling interests	31		33		94		97
Net income	147		118		315		397
Less: loss from discontinued operations, net of taxes	(8)		(3)		(20)		(5)
Income from continuing operations	155		121		335		402
Less: net income from continuing operations attributable to noncontrolling interests	31		33		94		97
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders	124		88		241		305
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (1)	(99)		(66)		(100)		(56)
Changes in fair value of market risk benefits attributable to changes in interest rates, equity markets and associated hedges (2)	(3)		17		1		(19)
(Gains) losses on early extinguishment of debt (3)	—		(2)		—		4
Expenses related to restructuring	1		—		—		11
Taxes on adjustments (4)	(6)		11		(6)		13
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders	$	17	$	48	$	136	$	258

______________

(1) Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million for both the nine months ended September 30, 2025 and 2024.

(2) Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(2) million and $(4) million for the three months ended September 30, 2025 and 2024, respectively, and $(6) million and $(9) million for the nine months ended September 30, 2025 and 2024, respectively.

(3) (Gains) losses on early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million for the nine months ended September 30, 2024.

(4) The three and nine months ended September 30, 2025 included a $27 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets.

Table of Contents

Earnings per share

The following table provides basic and diluted earnings per common share for the periods indicated:


	Three months ended September 30,				Increase (decrease) and percentage change				Nine months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions, except per share amounts)	2025		2024		2025 vs. 2024				2025		2024		2025 vs. 2024
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share:
Basic	$	0.30	$	0.20	$	0.10	50	%	$	0.58	$	0.70	$	(0.12)	(17)	%
Diluted	$	0.30	$	0.20	$	0.10	50	%	$	0.58	$	0.69	$	(0.11)	(16)	%
Net income available to Genworth Financial, Inc.’s common stockholders per share:
Basic	$	0.29	$	0.20	$	0.09	45	%	$	0.54	$	0.69	$	(0.15)	(22)	%
Diluted	$	0.28	$	0.19	$	0.09	47	%	$	0.53	$	0.68	$	(0.15)	(22)	%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share:
Basic	$	0.04	$	0.11	$	(0.07)	(64)	%	$	0.33	$	0.59	$	(0.26)	(44)	%
Diluted	$	0.04	$	0.11	$	(0.07)	(64)	%	$	0.33	$	0.58	$	(0.25)	(43)	%
Weighted-average common shares outstanding:
Basic	408.0		430.8						413.2		436.7
Diluted	413.3		435.8						417.9		442.3

Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including performance stock units, restricted stock units and other equity-based awards.

The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other for the periods indicated:


	Three months ended September 30,				Increase (decrease) and percentage change			Nine months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024			2025		2024		2025 vs. 2024
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Enact segment	$	134	$	148	$	(14)	(9)%	$	412	$	448	$	(36)	(8)%
Long-Term Care Insurance segment	(100)		(46)		(54)		(117)%	(167)		(72)		(95)		(132)%
Life and Annuities segment:
Life insurance	(15)		(40)		25		63%	(79)		(96)		17		18%
Fixed annuities	10		6		4		67%	22		29		(7)		(24)%
Variable annuities	9		7		2		29%	21		24		(3)		(13)%
Life and Annuities segment	4		(27)		31		115%	(36)		(43)		7		16%
Corporate and Other	(21)		(27)		6		22%	(73)		(75)		2		3%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders	$	17	$	48	$	(31)	(65)%	$	136	$	258	$	(122)	(47)%

Table of Contents

Executive Summary of Consolidated Financial Results

Below is an executive summary of our condensed consolidated financial results for the periods indicated. Amounts within this “Executive Summary of Consolidated Financial Results” and in our discussion of adjusted operating income (loss) within “—Results of Operations and Selected Financial and Operating Performance Measures by Segment” are net of taxes, unless otherwise indicated. After-tax amounts assume a tax rate of 21%.

For a discussion of selected financial information and detailed descriptions of operating performance measures, see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”

Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024

• Net income for the three months ended September 30, 2025 and 2024 was $116 million and $85 million , respectively, and adjusted operating income was $17 million and $48 million , respectively.

• Enact segment

• Adjusted operating income decreased primarily due to a lower reserve release and higher new delinquencies, partially offset by higher net investment income in the current year.

• Long-Term Care Insurance segment

• The adjusted operating loss increased primarily due to unfavorable cash flow assumption updates in the current year compared to favorable updates in the prior year, partially offset by higher limited partnership income in the current year.

• Life and Annuities segment

• The adjusted operating loss in our life insurance products decreased primarily due to favorable mortality in the current year.

• Adjusted operating income in our fixed annuities increased primarily from favorable mortality, partially offset by lower spread income in the current year largely related to block runoff.

• Corporate and Other

• The adjusted operating loss decreased primarily from a $7 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets in the current year.

Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024

• Net income for the nine months ended September 30, 2025 and 2024 was $221 million and $300 million , respectively, and adjusted operating income was $136 million and $258 million , respectively.

• Enact segment

• Adjusted operating income decreased primarily due to lower reserve releases and higher new delinquencies, partially offset by higher net investment income and lower operating expenses in the current year.

• Long-Term Care Insurance segment

• The adjusted operating loss increased primarily driven by unfavorable cash flow assumption updates in the current year compared to favorable updates in the prior year, net insurance recoveries of $22 million in the prior year that did not recur and aging of the in-force block, including higher interest accretion.

• These adverse developments were partially offset by higher limited partnership income and a $21 million gain related to a third-party reinsurance recapture in the current year . For additional information on the third-party reinsurance recapture, see note 16 in our unaudited condensed consolidated financial statements under “Item 1—Financial Statements.”

Table of Contents

• Life and Annuities segment

• The adjusted operating loss in our life insurance products decreased largely due to less unfavorable mortality experience in the current year.

• Adjusted operating income in our fixed annuities decreased primarily from lower spread income driven mostly by block runoff, partially offset by a favorable change in mortality experience in the current year.

• Corporate and Other

• The adjusted operating loss decreased primarily from a $7 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets and lower interest expense, partially offset by higher expenses related to CareScout growth initiatives in the current year.

Significant Developments and Key Highlights

Enact segment

• Mortgage insurance portfolio . Enact’s primary persistency rate remained elevated at 83% in the third quarter of 2025 . New insurance written increased 3% in the third quarter of 2025 compared to the third quarter of 2024 .

• Loss performance . Enact recorded a pre-tax reserve release of $45 million during the third quarter of 2025 primarily driven by favorable cure performance compared to a pre-tax reserve release of $65 million in the third quarter of 2024 .

• PMIERs compliance . Enact’s PMIERs sufficiency ratio was 162% or $1,904 million above the PMIERs requirements as of September 30, 2025 .

• Liquidity and financial flexibility . On September 30, 2025, Enact Holdings entered into a $435 million five-year unsecured revolving credit facility (“2025 Credit Facility”), which replaces the previous $200 million revolving credit facility dated June 30, 2022 (“2022 Credit Facility”). The 2025 Credit Facility remained undrawn as of September 30, 2025.

Long-Term Care Insurance segment

• In-force rate actions . We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan since 2012 through the third quarter of 2025 was approximately $31.8 billion, on a net present value basis.

Capital of U.S. life insurance subsidiaries

• Risk-based capital ratio . As of September 30, 2025 , the consolidated risk-based capital ratio on a company action level basis of our U.S. domiciled life insurance subsidiaries was approximately 303 %, down slightly from 306% as of December 31, 2024 . The decrease was primarily attributable to higher required capital as our limited partnership portfolio grows, partially offset by statutory earnings in the current year.

Capital and liquidity

• Holding company liquidity . Genworth Holdings had $254 million of unrestricted cash and cash equivalents as of September 30, 2025 , which included approximately $145 million of cash held for future obligations, including advance cash payments from our subsidiaries. Genworth Holdings received $110 million of capital returns from Enact Holdings during the third quarter of 2025 .

• Share repurchases . Genworth Financial executed $76 million of share repurchases, before excise taxes and other associated costs, during the third quarter of 2025 . On September 18, 2025, Genworth Financial announced that its Board of Directors had authorized a new share repurchase program under which Genworth Financial may purchase up to $350 million of its outstanding common stock.

Table of Contents

Results of Operations and Selected Financial and Operating Performance Measures by Segment

Enact segment

Trends and conditions

Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the size of the overall private mortgage insurance market and the effect of regulatory actions thereon; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included in “Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.

Macroeconomic environment

During the first three quarters of 2025, the U.S. economy was subject to significant volatility and uncertainty, largely related to changing economic policies, including new and increasing tariffs, continued inflationary pressure and the then impending federal government shutdown, as well as certain domestic and geopolitical tensions. The ancillary effects of these factors on the domestic and global economies could materially impact the U.S. housing market and Enact’s business.

The U.S. Bureau of Labor Statistics reported that the Consumer Price Index increased 3.0% year-over-year in September 2025 compared to 2.7% year-over-year in June 2025. The unemployment rate rose to 4.3% in August 2025 from 4.1% in June 2025.

The mortgage origination market remained relatively slow in response to elevated mortgage rates. Over the past few years, housing affordability has deteriorated as elevated mortgage rates and home price appreciation outpaced median family income, according to the National Association of Realtors Housing Affordability Index. Affordability pressures eased slightly during the third quarter of 2025 as mortgage rates began to decline and national home price growth has slowed, according to the Federal Housing Finance Agency (“FHFA”) Monthly Purchase-Only House Price Index (seasonally adjusted).

Regulatory developments

Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the government-sponsored enterprises (“GSEs”) and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products.

In July 2025, the FHFA announced that it will implement the acceptance of VantageScore 4.0 for mortgages delivered to Fannie Mae and Freddie Mac. The GSEs have not yet released implementation details and timelines, and the full impact of this initiative on Enact’s business, processes and financial results remains uncertain.

Competitive environment

The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite, enabling it to write new business at returns it views as attractive.

Mortgage insurance portfolio

New insurance written of $14.0 billion in the third quarter of 2025 increased 3% compared to the third quarter of 2024. Changes in new insurance written are primarily impacted by the size of the mortgage insurance market and Enact’s market share. Enact’s primary persistency rate was 83% for both the three months ended September 30, 2025 and 2024. The persistency rate continues to remain higher than historical averages driven by a large percentage of Enact’s in-force policies with interest rates below current mortgage rates.

Table of Contents

Net earned premiums decreased modestly in the third quarter of 2025 compared to the third quarter of 2024 primarily as a result of higher ceded premiums, partially offset by insurance in force growth in the current year.

Loss experience

Enact’s loss ratio for the three months ended September 30, 2025 and 2024 was 15% and 5% , respectively. Both periods were impacted by favorable reserve development. Enact released reser ves of $45 mi llion during the third quarter of 2025 primarily driven by favorable cure performance on delinquencies from 2024 and prior. This compares to a reserve release of $65 million in the third quarter of 2024 primarily related to cure performance on 2023 and prior delinquencies.

New primary delinquencies in the third quarter of 2025 increased slightly compared to the third quarter of 2024 primarily due to the normal loss development pattern on newer books of business. New primary delinquencies of 12,998 contributed $79 million of loss expense in the third quarter of 2025, while Enact incurred $75 million of loss expense from 12,964 new primary delinquencies in the third quarter of 2024. In determining the loss expense estimate, considerations were given to recent cure and claim experience and the prevailing and prospective economic conditions.

The severity of loss on loans that go to claim may be negatively impacted by extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. The majority of Enact’s mortgage insurance pol icies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.

Reinsurance transactions

On September 23, 2025, Enact entered into a quota share reinsurance agreement with a panel of reinsurers under which it will cede approximately 34% of a portion of its expected new insurance written for the 2027 book year. On October 27, 2025, Enact entered into an excess of loss reinsurance transaction that provides approximately $170 million of reinsurance coverage on a portion of expected new insurance written for the 2027 book year.

Capital requirements

As of September 30, 2025 , EMICO’s estimated risk-to-capital ratio under North Carolina law and enforced by the North Carolina Department of Insurance (“NCDOI”), EMICO’s domestic insurance regulator, was 10.2:1, compared with risk-to-capital ratios of 10.5:1 and 10.4:1 as of December 31, 2024 and September 30, 2024 , respectively. EMICO’s risk-to-capital ratio remains below the NCDOI’s maximum risk-to-capital ratio of 25:1. North Carolina’s calculation of risk-to-capital excludes the risk in-force for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the impact of quota share reinsurance, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business.

Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. As of September 30, 2025 , Enact had estimated available assets of $4,974 million against $3,070 million net required assets under PMIERs compared to available assets of $4,992 million against $3,031 million net required assets as of June 30, 2025 . The sufficiency ratio as of September 30, 2025 was 162% or $1,904 m illion above the PMIERs requirements, compared to 165% or $1,961 million above the PMIERs requirements as of June 30, 2025. Enact’s PMIERs required assets benefited from a reinsurance credit of $1,889 million and $1,870 million as of September 30, 2025 and June 30, 2025, respectively, related to third-party reinsurance transactions.

On August 21, 2024, the GSEs and the FHFA released updated PMIERs requirements phasing in a revision to the available assets standards between March 31, 2025 and September 30, 2026. The updated standards differentiate between bonds held as available assets under PMIERs based on credit quality and liquidity. The updates also establish limits for assets backed by residential mortgages or commercial real estate to mitigate the impact if such assets lose value during periods of housing stress. Enact expects to hold capital sufficiency well in excess of these requirements and does not expect the impact of these updates to be material to its sufficiency.

Table of Contents

Capital returns

During each of the first three quarters of 2025, EMICO paid dividends to Enact Holdings that support Enact Holdings’ ability to return capital to shareholders. On May 1, 2024, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $250 million of its common stock. Enact Holdings completed the repurchase of shares under this authorization in the second quarter of 2025. On April 30, 2025, Enact Holdings announced the authorization of a new share repurchase program that allows for the repurchase of up to an additional $350 million of its common stock. Genworth Holdings entered into an agreement with Enact Holdings to participate in the share repurchase program in order to maintain its current ownership interest in Enact Holdings. In addition to its share repurchase program, Enact Holdings pays a quarterly dividend. As the majority shareholder, Genworth Holdings received $110 million of capital returns from Enact Holdings during the third quarter of 2025, comprised of $85 million of share repurchases and $25 million of quarterly dividends.

Returning capital to shareholders, balanced with growth and risk management priorities, remains a priority for Enact Holdings as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, which sets the following priorities: supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.

Table of Contents

Segment results of operations

Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024

The following table sets forth the results of operations relating to our Enact segment for the periods indicated:


	Three months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	245	$	249	$	(4)	(2)	%
Net investment income	68		62		6		10	%
Net investment gains (losses)	(2)		(1)		(1)		(100)	%
Policy fees and other income	1		—		1		NM⁽¹⁾
Total revenues	312		310		2		1	%
Benefits and expenses:
Benefits and other changes in policy reserves	36		12		24		200	%
Acquisition and operating expenses, net of deferrals	51		53		(2)		(4)	%
Amortization of deferred acquisition costs and intangibles	2		3		(1)		(33)	%
Interest expense	13		13		—		—	%
Total benefits and expenses	102		81		21		26	%
Income from continuing operations before income taxes	210		229		(19)		(8)	%
Provision for income taxes	47		49		(2)		(4)	%
Income from continuing operations	163		180		(17)		(9)	%
Less: net income attributable to noncontrolling interests	31		33		(2)		(6)	%
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders	132		147		(15)		(10)	%
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses	2		1		1		100	%

Expenses related to restructuring	1		—		1		NM⁽¹⁾
Taxes on adjustments	(1)		—		(1)		NM⁽¹⁾
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders	$	134	$	148	$	(14)	(9)	%

______________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income decreased primarily due to a lower reserve release and higher new delinquencies, partially offset by higher net investment income in the current year.

Revenues

Premiums decreased mainly driven by higher ceded premiums, partially offset by insurance in-force growth in the current year.

Net investment income increased primarily from higher investment yields and higher average invested assets in the current year.

Table of Contents

Benefits and expenses

Benefits and other changes in policy reserves increased primarily driven by a lower reserve release and higher new delinquencies in the current year. Enact released reserves o f $45 m illion during the third quarter of 2025 primarily related to favorable cure performance on delinquencies from 2024 and prior. During the third quarter of 2024, Enact recorded a reserve release of $65 million primarily related to cure performance on 2023 and prior delinquencies.

Provision for income taxes. The effective tax rate was 22.1% and 21.3% for the three months ended September 30, 2025 and 2024 , respectively, consistent with the U.S. corporate federal income tax rate.

Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024

The following table sets forth the results of operations relating to our Enact segment for the periods indicated:


	Nine months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	735	$	734	$	1	—	%
Net investment income	197		178		19		11	%
Net investment gains (losses)	(13)		(15)		2		13	%
Policy fees and other income	4		3		1		33	%
Total revenues	923		900		23		3	%
Benefits and expenses:
Benefits and other changes in policy reserves	92		15		77		NM⁽¹⁾
Acquisition and operating expenses, net of deferrals	151		169		(18)		(11)	%
Amortization of deferred acquisition costs and intangibles	7		7		—		—	%
Interest expense	37		39		(2)		(5)	%
Total benefits and expenses	287		230		57		25	%
Income from continuing operations before income taxes	636		670		(34)		(5)	%
Provision for income taxes	139		145		(6)		(4)	%
Income from continuing operations	497		525		(28)		(5)	%
Less: net income attributable to noncontrolling interests	94		97		(3)		(3)	%
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders	403		428		(25)		(6)	%
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (2)	11		13		(2)		(15)	%
(Gains) losses on early extinguishment of debt, net (3)	—		9		(9)		(100)	%
Expenses related to restructuring	1		3		(2)		(67)	%
Taxes on adjustments	(3)		(5)		2		40	%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders	$	412	$	448	$	(36)	(8)	%

______________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

(2) Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $2 million for both the nine months ended September 30, 2025 and 2024.

(3) For the nine months ended September 30, 2024, (gains) losses on early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million.

Table of Contents

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income decreased primarily due to lower reserve releases and higher new delinquencies, partially offset by higher net investment income and lower operating expenses in the current year.

Revenues

Premiums increased slightly mainly driven by insurance-in force growth and higher assumed premiums, partially offset by higher ceded premiums and slightly lower average premium rates in the current year.

Net investment income increased primarily from higher investment yields and higher average invested assets in the current year.

Benefits and expenses

Benefits and other changes in policy reserves increased largely from lower reserve releases and higher new delinquencies in the current year. Enact released reserves of $140 million in the current year primarily related to favorable cure performance on delinquencies from 2024 and prior. In the prior year, Enact recorded reserve releases of $196 million primarily related to cure performance on 2023 and prior delinquencies. As part of the reserve releases in 2024, Enact decreased its assumptions for the rate at which delinquencies go to claim (“claim rate”) largely as a result of sustained favorable cure performance and lessening uncertainty in the economic environment, impacting both current and prior year delinquencies.

Acquisition and operating expenses, net of deferrals, decreased primarily due to expenses in the prior year that did not recur, including an $11 million loss on the early redemption of Enact Holdings’ 6.50% senior notes due in August 2025 (“2025 Notes”) and restructuring expenses. The decrease was also driven by lower operating costs in the current year.

Provision for income taxes. The effective tax rate was 21.8% and 21.6% for the nine months ended September 30, 2025 and 2024 , respectively, consistent with the U.S. corporate federal income tax rate.

Enact selected operating performance measures

Management regularly monitors and reports insurance in-force and risk in-force for our Enact segment. Insurance in-force is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. These metrics are presented on a direct basis and exclude reinsurance. We consider insurance in-force and risk in-force to be measures of Enact’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period.

Management also regularly monitors and reports new insurance written for our Enact segment as a measure of volume of new business generated in a period. We consider new insurance written to be a measure of Enact’s operating performance because it represents a measure of new sales of mortgage insurance policies during a specified period, rather than a measure of revenues or profitability during that period.

Substantially all of Enact’s policies are primary mortgage insurance, which provides protection on individual loans at specified coverage percentages. Primary mortgage insurance is placed on individual loans at the time of origination and is typically delivered to Enact on a loan-by-loan basis. Primary mortgage insurance can also be delivered to Enact on an aggregated basis, whereby each mortgage in a given loan portfolio is insured in a single transaction after the point of origination. Enact also selectively enters into insurance transactions with lenders and investors, under which it insures a portfolio of loans at or after origination (“pool mortgage insurance”).

100

Table of Contents

The following tables set forth selected operating performance measures regarding Enact as of and for the dates indicated:


	As of September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Primary insurance in-force	$	272,349	$	268,003	$	4,346	2	%
Risk in-force:
Primary	$	71,144	$	69,611	$	1,533	2	%
Pool	52		60		(8)		(13)	%
Total risk in-force	$	71,196	$	69,671	$	1,525	2	%


	Three months ended September 30,				Increase (decrease) and percentage change				Nine months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024				2025		2024		2025 vs. 2024
New insurance written	$	14,048	$	13,591	$	457	3	%	$	37,120	$	37,736	$	(616)	(2)	%

Primary insurance in-force and risk in-force

Primary insurance in-force increased mainly from new insurance written and elevated persistency, partially offset by lapses and cancellations. The primary persistency rate was 83% for both the nine months ended September 30, 2025 and 2024. Total risk in-force increased primarily as a result of higher primary insurance in-force.

New insurance written

Changes in new insurance written are primarily impacted by the size of the mortgage insurance market and Enact’s market share.

Loss and expense ratios

Management regularly monitors and reports a loss ratio and an expense ratio for our Enact segment. We consider the loss ratio, which is the ratio of benefits and other changes in policy reserves to net earned premiums, to be a measure of underwriting performance. The expense ratio is the ratio of general expenses to net earned premiums. Enact’s general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles. We believe these ratios help to enhance the understanding of Enact’s operating performance.

The following table sets forth the loss and expense ratios for Enact for the dates indicated:


	Three months ended September 30,				Increase (decrease)		Nine months ended September 30,			Increase (decrease)
	2025		2024		2025 vs. 2024		2025	2024		2025 vs. 2024
Loss ratio	15	%	5	%	10	%		12	%	2	%	10	%
Expense ratio	22	%	22	%	—	%		22	%	24	%	(2)	%

The loss ratio increased for the three and nine months ended September 30, 2025 largely from lower reserve releases and higher new delinquencies in the current year as discussed above.

The expense ratio decreased for the nine months ended September 30, 2025 due to an $11 million loss on the early redemption of Enact Holdings’ 2025 Notes, which increased the expense ratio by two percentage points for the nine months ended September 30, 2024.

101

Table of Contents

Mortgage insurance loan portfolio

The following table sets forth selected financial information regarding Enact’s loan portfolio as of September 30 :



(Amounts in millions)	2025		2024
Primary insurance in-force by loan-to-value ratio at origination:
95.01% and above	$	53,522	$	49,363
90.01% to 95.00%	113,852		111,992
85.01% to 90.00%	79,390		79,628
85.00% and below	25,585		27,020
Total	$	272,349	$	268,003
Primary risk in-force by loan-to-value ratio at origination:
95.01% and above	$	15,374	$	14,141
90.01% to 95.00%	33,121		32,579
85.01% to 90.00%	19,589		19,649
85.00% and below	3,060		3,242
Total	$	71,144	$	69,611
Primary insurance in-force by FICO (1) score at origination:
Over 760	$	119,234	$	114,424
740-759	44,675		43,793
720-739	37,955		37,671
700-719	29,567		29,910
680-699	20,886		21,557
660-679 (2)	11,079		11,391
640-659	6,001		6,179
620-639	2,414		2,495
<620	538		583
Total	$	272,349	$	268,003
Primary risk in-force by FICO score at origination:
Over 760	$	30,991	$	29,644
740-759	11,709		11,423
720-739	10,058		9,912
700-719	7,728		7,751
680-699	5,432		5,553
660-679 (2)	2,906		2,951
640-659	1,564		1,592
620-639	619		636
<620	137		149
Total	$	71,144	$	69,611

______________

(1) Fair Isaac Company.

(2) Loans with unknown FICO scores are included in the 660-679 category.

102

Table of Contents

Delinquent loans

The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of the dates indicated:



	September 30, 2025		December 31, 2024		September 30, 2024
Primary insurance:
Insured loans in-force	953,657		962,849		967,501
Delinquent loans	23,382		23,566		21,027
Percentage of delinquent loans (delinquency rate)	2.45	%	2.45	%	2.17	%

The delinquency rate increased compared to September 30, 2024 largely due to new delinquencies exceeding cures and paid claims.

The following tables set forth primary delinquencies, direct primary case reserves and risk in-force by aged missed payment status in Enact’s loan portfolio as of the dates indicated:



	September 30, 2025
(Dollar amounts in millions)	Delinquencies	Direct primary case reserves (1)		Risk in-force		Reserves as % of risk in-force
Payments in default:
3 payments or less	11,969	$	109	$	806	14	%
4 - 11 payments	7,951	216		594		36	%
12 payments or more	3,462	195		250		78	%
Total	23,382	$	520	$	1,650	32	%

______________

(1) Direct primary case reserves exclude loss adjustment expenses, pool, incurred but not reported (“IBNR”) and reinsurance reserves.



	December 31, 2024
(Dollar amounts in millions)	Delinquencies	Direct primary case reserves (1)		Risk in-force		Reserves as % of risk in-force
Payments in default:
3 payments or less	12,712	$	108	$	849	13	%
4 - 11 payments	7,701	191		545		35	%
12 payments or more	3,153	173		213		81	%
Total	23,566	$	472	$	1,607	29	%

______________

(1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Reserves as a percentage of risk in-force as of September 30, 2025 increased slightly compared to December 31, 2024 as a result of fewer new delinquencies that have a lower expected claim rate.

103

Table of Contents

Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk in-force as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property rather than the location of the lender.




	% of primary risk in-force as of September 30, 2025		% of direct primary case reserves as of September 30, 2025 ⁽¹⁾		Delinquency rate as of
					September 30, 2025		December 31, 2024		September 30, 2024
By State:
California	12	%	13	%	2.63	%	2.53	%	2.27	%
Texas	9	%	9	%	2.64	%	2.64	%	2.64	%
Florida (2)	8	%	13	%	3.11	%	3.67	%	2.49	%
New York (2)	5	%	9	%	3.28	%	3.30	%	3.19	%
Illinois (2)	4	%	5	%	3.01	%	2.96	%	2.67	%
Arizona	4	%	4	%	2.57	%	2.35	%	2.05	%
Michigan	4	%	3	%	2.20	%	2.14	%	1.90	%
Georgia	3	%	4	%	3.07	%	3.02	%	2.48	%
North Carolina	3	%	2	%	2.00	%	2.14	%	1.69	%
Pennsylvania	3	%	3	%	2.23	%	2.17	%	2.11	%

______________

(1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

(2) Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed.




	% of primary risk in-force as of September 30, 2025		% of direct primary case reserves as of September 30, 2025 ⁽¹⁾		Delinquency rate as of
					September 30, 2025		December 31, 2024		September 30, 2024
By MSA or MD:
Phoenix, AZ MSA	3	%	3	%	2.66	%	2.41	%	2.10	%
Chicago-Naperville, IL MD	3	%	4	%	3.20	%	3.29	%	2.95	%
Atlanta, GA MSA	3	%	3	%	3.28	%	3.02	%	2.68	%
New York, NY MD	2	%	5	%	3.68	%	3.53	%	3.37	%
Dallas, TX MD	2	%	2	%	2.34	%	2.38	%	2.29	%
Houston, TX MSA	2	%	3	%	3.27	%	3.58	%	3.92	%
Washington-Arlington, DC MD	2	%	2	%	2.27	%	2.03	%	1.95	%
Riverside-San Bernardino, CA MSA	2	%	3	%	3.32	%	3.25	%	2.92	%
Los Angeles-Long Beach, CA MD	2	%	3	%	3.05	%	2.65	%	2.36	%
Denver-Aurora-Lakewood, CO MSA	2	%	1	%	1.52	%	1.38	%	1.13	%

______________

(1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

104

Table of Contents

The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance in-force and risk in-force by year of policy origination, and delinquency rate as of September 30, 2025 :


(Amounts in millions)	% of direct primary case reserves (1)		Primary insurance in-force		% of total		Primary risk in-force		% of total		Delinquency rate
Policy Year
2008 and prior	8	%	$	4,372	2	%	$	1,131	2	%	7.85	%
2009 to 2017	7		6,942		2		1,796		3		4.85	%
2018	4		4,147		1		1,069		1		4.91	%
2019	6		9,993		4		2,615		4		3.17	%
2020	12		29,735		11		8,178		11		2.20	%
2021	21		48,447		18		13,072		18		2.45	%
2022	22		47,952		18		12,289		17		2.69	%
2023	14		40,694		15		10,590		15		2.33	%
2024	6		44,401		16		11,401		16		1.36	%
2025	—		35,666		13		9,003		13		0.18	%
Total portfolio	100	%	$	272,349	100	%	$	71,144	100	%	2.45	%

_____________

(1) Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk in-force. The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. The concentration of loss reserves has shifted to newer book years in line with changes in risk in-force. As of September 30, 2025 , Enact’s 2018 and newer policy years represented approximately 95 % of its primary risk in-force and 85 % of its total direct primary case reserves.

Long-Term Care Insurance segment

Trends and conditions

The results of our long-term care insurance business depend upon how our actual experience compares with our valuation assumptions, including but not limited to in-force rate actions, morbidity, mortality and persistency. Estimates for in-force rate actions reflect certain simplifying assumptions that may vary materially from actual results, including but not limited to consistent policyholder behavior over time in addition to a uniform rate of coinsurance and premium taxes. Actual policyholder behavior may differ significantly from these assumptions. Results of our long-term care insurance business are also influenced by our ability to improve investment yields and manage expenses and reinsurance, among other factors. Changes in laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, also impact our long-term care insurance business either positively or negatively.

Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments as our actual claims experience will emerge over many years, or decades. For example, average claim reserves for new claims have trended higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on certain of our oldest long-term care insurance blocks of business have reached their peak claim years and will decrease as the blocks run off, we expect overall claims costs to continue to increase as the ap proximately 596,000 insured individuals in our two largest blocks, Choice I and Choice II, with average attained ages of 78 and 75, respective ly, reach their peak claim years, which are over age 85 .

Additionally, we have observed an increase in the cost of care in our long-term care insurance business, due in part to elevated inflation. Increases in cost of care have resulted in higher claim payments, which could have a material adverse impact on our liquidity, results of operations and financial condition if the increases persist. We will continue to monitor our experience and make changes to our assumptions and methodologies, as appropriate, for our long-term care insurance

105

Table of Contents

products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.

The impacts of assumption updates and actual variances from expected experience will continue to drive volatility in our long-term care insurance results, particularly for our unprofitable capped cohorts. Our profitable uncapped cohorts have to date had a more modest earnings impact related to assumption updates and actual variances from expected experience, as a portion of the impact is reflected in current period results with the remaining majority of the impact recognized over the life of the cohort. However, we may see increased volatility as the uncapped cohorts continue to age, with more of the impact related to assumption updates and actual variances from expected experience recognized immediately in net income. It is important to note that quarterly variations resulting from assumption updates and actual variances from expected experience are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $43.5 billion , at the locked-in discount rate, for our long-term care insurance business as of September 30, 2025 .

The financial condition of our long-term care insurance business is also impacted by interest rates. We remeasure our liability for future policy benefits and the related reinsurance recoverables at the single-A bond rate each quarter. As a result, our reported insurance liabilities are sensitive to movements in interest rates, which will likely result in continued vo latility to our reserve balances and equity.

Annual review of cash flow assumptions

We will complete the required annual review of our cash flow assumptions, including benefit utilization, expected claim incidence, terminations and benefit reductions related to in-force rate actions, among other assumptions, for our long-term care insurance products in the fourth quarter of 2025.

In connection with our 2025 cash flow assumption reviews, we are focused on short-term trends in key assumptions, including benefit utilization, incidence, terminations and in-force rate actions, which include benefit reduction initiatives. Our 2025 assumption review will consider trends during, and following, the coronavirus pandemic (“COVID-19”) years, but any proposed updates to long-term assumptions will generally exclude or adjust experience data for 2020 through 2022, as we do not have sufficient information around the long-term effects of COVID-19. We face pressure from higher benefit utilization and cost of care inflation. We will evaluate this pressure relative to the tailwinds of additional premium rate increases and benefit reductions in our multi-year in-force rate action plan, as well as other initiatives, which we would expect to reduce the overall impact in aggregate. While our reviews are still underway and not yet complete, any impact is expected to be a relatively small percentage change compared to the overall size of our liability for future policy benefits mentioned above. For capped cohorts, these updates would be reported immediately in earnings.

We will also complete statutory cash flow testing for our life insurance companies in the fourth quarter of 2025. Under cash flow testing, changes impacting active life reserves are included in our margin review and only impact statutory income if the margin falls below zero. However, changes to our claim reserve assumptions are immediately reflected in statutory income. While our statutory process is not yet complete and work remains, our early assessment is that the margin for Genworth Life Insurance Company, one of our principal life insurance subsidiaries, should remain positive.

In-force rate actions and legal settlements

Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including premium rate increases and associated benefit reductions on our in-force policies. Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. Although we anticipate approvals in 2025 to be lower than previous years due to past successes in achieving approvals, this does not impact our overall strategy for rate actions. In some cases, we received large approvals that either materially completed the current multi-year rate action plan or resulted in multi-year implementations. For an update on in-force rate actions, refer to the selected operating performance measures below.

In addition, we previously reached three legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. These legal settlements covered approximately 70% of our long-term care insurance block and accelerated benefit reductions. The legal settlements resulted in an overall net favorable economic impact to our long-term care insurance business as they reduced tail risk on these long-duration liabilities.

106

Table of Contents

While we expect renewal premiums to decline over time as the block runs off, benefit reductions elected by policyholders in connection with our in-force rate actions and legal settlements have accelerated that decline. However, we expect this decline to be partially offset by future approved rate actions.

Segment results of operations

Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024

The following table sets forth the results of operations relating to our Long-Term Care Insurance segment for the periods indicated:


	Three months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	597	$	581	$	16	3	%
Net investment income	505		483		22		5	%
Net investment gains (losses)	104		71		33		46	%
Total revenues	1,206		1,135		71		6	%
Benefits and expenses:
Benefits and other changes in policy reserves	972		949		23		2	%
Liability remeasurement (gains) losses	113		28		85		NM⁽¹⁾
Acquisition and operating expenses, net of deferrals	118		118		—		—	%
Amortization of deferred acquisition costs and intangibles	17		17		—		—	%
Total benefits and expenses	1,220		1,112		108		10	%
Income (loss) from continuing operations before income taxes	(14)		23		(37)		(161)	%
Provision for income taxes	4		13		(9)		(69)	%
Income (loss) from continuing operations	(18)		10		(28)		NM⁽¹⁾
Adjustments to income (loss) from continuing operations:
Net investment (gains) losses	(104)		(71)		(33)		(46)	%

Taxes on adjustments	22		15		7		47	%
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders	$	(100)	$	(46)	$	(54)	(117)	%

______________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss increased primarily due to unfavorable cash flow assumption updates in the current year compared to favorable updates in the prior year, partially offset by higher limited partnership income in the current year.

Revenues

Premiums increased primarily drive n by $26 million of higher premiums in the current year from newly implemented in-force rate actions, partially offset by lower re newal premiums from prior benefit reduction elections made by policyholders in connection with our in-force rate actions and prior legal settlements. Policy terminations also drove lower renewal premiums in the current year.

Net investment income increased la rgely due to $25 million of higher income from limited partnerships, partially offset by lower investment yields in the current year.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

107

Table of Contents

Benefits and expenses

Benefits and other changes in policy reserves increased primarily due to a higher unfavorable change in reserves from an increase in net premiums collected and aging of the in-force block, including higher interest accretion, in the current year.

The liability remeasurement loss in the current year was largely due to unfavorable actual variances from expected experience primarily driven by lower terminations and higher benefit utilization. The liability remeasurement loss in the prior year was mainly attributable to adverse actual variances from expected experience principally from higher benefit utilization, including new claims, and lower terminations, partially offset by favorable cash flow assumption updates largely related to higher approval amounts on our in-force rate action plan.

Provision for income taxes . The tax provision in the current year was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income, partially offset by the tax benefit on the pre-tax loss. The tax provision in the prior year was largely attributable to tax expense on certain forward starting swap gains and tax expense on pre-tax income.

Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024

The following table sets forth the results of operations relating to our Long-Term Care Insurance segment for the periods indicated:


	Nine months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	1,746	$	1,723	$	23	1	%
Net investment income	1,472		1,441		31		2	%
Net investment gains (losses)	158		87		71		82	%
Total revenues	3,376		3,251		125		4	%
Benefits and expenses:
Benefits and other changes in policy reserves	2,867		2,819		48		2	%
Liability remeasurement (gains) losses	145		55		90		164	%
Acquisition and operating expenses, net of deferrals	342		302		40		13	%
Amortization of deferred acquisition costs and intangibles	50		52		(2)		(4)	%
Total benefits and expenses	3,404		3,228		176		5	%
Income (loss) from continuing operations before income taxes	(28)		23		(51)		NM⁽¹⁾
Provision for income taxes	14		27		(13)		(48)	%
Loss from continuing operations	(42)		(4)		(38)		NM⁽¹⁾
Adjustments to loss from continuing operations:
Net investment (gains) losses	(158)		(87)		(71)		(82)	%
Expenses related to restructuring	—		1		(1)		(100)	%
Taxes on adjustments	33		18		15		83	%
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders	$	(167)	$	(72)	$	(95)	(132)	%

______________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss increased primarily driven by unfavorable cash flow assumption updates in the current year compared to favorable updates in the prior year, net insurance recoveries of $22 million in the prior year that did not

108

Table of Contents

recur and aging of the in-force block, including higher interest accretion. These adverse developments were partially offset by higher limited partnership income and a $21 million gain related to a third-party reinsurance recapture in the current year .

Revenues

Premiums increased primarily driven by $80 million of higher premiums in the current year from newly implemented in-force rate actions, partially offset by lower renew al premiums from prior benefit reduction elections made by policyholders in connection with our in-force rate actions and prior legal settlements. Policy terminations also drove lower renewal premiums in the current year.

Net investment income increased largely due to $ 46 million of higher income from limited partnerships, partially offset by lower investment yields in the current year.

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Benefits and other changes in policy reserves increased primarily due to aging of the in-force block, including higher interest accretion, and a higher unfavorable change in reserves from an increase in net premiums collected in the current year.

The liability remeasurement loss in the current year was largely due to unfavorable actual variances from expected experience primarily driven by higher benefit utilization and lower terminations, partially offset by a $26 million gain related to a third-party recapture of a block of long-term care insurance policies. For additional information on the third-party reinsurance recapture, see note 16 in our unaudited condensed consolidated financial statements under “Item 1—Financial Statements.” The liability remeasurement loss in the prior year was mainly attributable to adverse actual variances from expected experience principally driven by higher claims and lower terminations, partially offset by favorable cash flow assumption updates largely related to approval amounts and implementation timing of our in-force rate action plan.

Acquisition and operating expenses, net of deferrals, increased principally from $28 million of net insurance recoveries in the prior year that did not recur related to previously incurred legal settlement expenses. The increase was also driven by higher operating costs, including higher employee-related expenses, in the current year.

Provision for income taxes. The tax provision in the current year was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income, partially offset by the tax benefit on the pre-tax loss. The tax provision in the prior year was largely attributable to tax expense on certain forward starting swap gains and tax expense on pre-tax income.

Long-Term Care Insurance selected operating performance measures

Liability remeasurement (gains) losses

We include expectations for benefit reductions related to in-force rate actions in our assumptions for the liability for future policy benefits, which have impacted and will continue to impact our reported U.S. GAAP financial results. We previously included expectations for benefit reductions related to legal settlements in our assumptions; however, the settlements were materially complete in the fourth quarter of 2024. We update the net premium ratio quarterly for actual variances from expected experience; therefore, forecasted cash flow assumptions will be replaced with actual cash flows each quarter with any difference recorded in net income (loss). As a result, variances between actual experience and our expectations for benefit reductions will be reflected in liability remeasurement (gains) losses in our operating results on a quarterly basis.

109

Table of Contents

The following table sets forth the pre-tax components of the liability remeasurement (gains) losses, net of reinsurance, for the periods indicated:


	Three months ended September 30,				(Favorable) unfavorable change and percentage change				Nine months ended September 30,				(Favorable) unfavorable change and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024				2025		2024		2025 vs. 2024
Cash flow assumption updates	$	6	$	(63)	$	69	110	%	$	13	$	(89)	$	102	115	%
Actual variances from expected experience	107		91		16		18	%	132		144		(12)		(8)	%
Total liability remeasurement (gains) losses	$	113	$	28	$	85	NM⁽¹⁾		$	145	$	55	$	90	164	%

______________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

For additional discussion of liability remeasurement (gains) losses, see the comparison for this line item above.

In-force rate actions

As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions in order to maintain the self-sustainability of our legacy U.S. life insurance subsidiaries and reduce the strain on earnings and capital.

Management regularly monitors and reports in-force rate actions, including state filing approvals; impacted in-force premiums; weighted-average percentage rate increases approved; and gross incremental premiums approved in our Long-Term Care Insurance segment. We also estimate the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan on a net present value basis, discounted at our investment portfolio yield. This is based on current assumptions and is defined as the net present value of historical and future expected premium increases and benefit reductions as a result of rate increases approved on individual and group long-term care insurance policies. It also includes the net present value of reserve reductions related to prior legal settlements less cash payments made to policyholders who elected certain reduced benefit options in connection with the legal settlements, referred to as settlement payments. We monitor these selected operating performance measures for in-force rate actions to track our progress on maintaining the self-sustainability of our legacy U.S. life insurance subsidiaries. We consider these in-force rate action metrics to be measures of financial performance and help to enhance the understanding of the operating performance of our Long-Term Care Insurance segment.

The following table sets forth filing approvals as part of our multi-year in-force rate action plan for the periods indicated:


	Three months ended September 30,						Nine months ended September 30,
(Dollar amounts in millions)	2025			2024			2025			2024
State filings approved	18			24			48			72
Impacted in-force premiums	$	71		$	235		$	270		$	695
Weighted-average percentage rate increase approved	63		%	53		%	40		%	44		%
Gross incremental premiums approved	$	44		$	124		$	109		$	303

During the nine months ended September 30, 2025 , we also submitted 58 new filings on approximately $639 million in annualized in-force premiums. We estimate that the cumulative economic benefit of approved rate actions since 2012 through the third quarter of 2025 was approximately $31.8 billion , on a net present value basis.

The approval process for in-force rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state and product. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase, and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.

110

Table of Contents

We continue to work closely with the National Association of Insurance Commissioners and state regulators to demonstrate the broad-based need for actuarially justified rate increases in order to pay future claims. Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims and reduces cross-state premium inequities, we will consider litigation against states that decline to approve those actuarially justified rate increases. As of September 30, 2025, we were in litigation with two states that have refused to approve actuarially justified rate increases for certain products.

Life and Annuities segment

Trends and conditions

Many factors can affect the results of our life insurance and annuity products, as further discussed below. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our life insurance and annuity products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Results of our life insurance and annuity products depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves.

Results of our life insurance and annuity products are also impacted by interest rates. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates could materially adversely affect our business and profitability” in our 2024 Annual Report on Form 10-K.

We no longer solicit sales of traditional life insurance and annuity products; however, we continue to service our existing retained and reinsured blocks of business.

Annual review of cash flow assumptions

We will complete the required annual review of our cash flow assumptions for our life insurance and annuity products in the fourth quarter of 2025. In connection with our 2025 cash flow assumption reviews, we are reviewing mortality, lapse rates and the potential impacts of the recent changes in interest rates. Consistent with our long-term care insurance business, our 2025 assumption review will consider trends during the pandemic years, but any proposed updates to long-term assumptions will generally exclude or adjust experience data for 2020 through 2022, as we do not have sufficient information around the long-term effects of COVID-19.

Our statutory reviews are also still underway and not yet complete, and we plan to report the outcome of these reviews in connection with the release of our fourth quarter of 2025 financial results.

Life insurance

Results of our life insurance products are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors.

Mortality levels may deviate each period from historical trends. Overall mortality experience improved during the third quarter of 2025 compared to the second quarter of 2025 and the third quarter of 2024. We have experienced unfavorable mortality compared to our then-current and priced-for assumptions in recent years for our universal life insurance block. Reinsurance costs typically increase due to natural aging of the yearly renewable term reinsured blocks. In prior periods, we have received some yearly renewable term reinsurance premium increases from some of our reinsurance partners that reflect unfavorable mortality.

Fixed annuities

Results of our fixed annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels.

111

Table of Contents

We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we have seen and could continue to see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change.

For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts.

Variable annuities

Results of our variable annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our variable annuity products can significantly impact our regulatory capital requirements and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate these impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results.

Equity market volatility and interest rate movements have caused, and may continue to cause, fluctuations in the results of our variable annuity products and regulatory capital requirements. Equity market performance was less favorable in the third quarter of 2025 compared to the second quarter of 2025 and the third quarter of 2024. Interest rate performance had an unfavorable impact in the third quarter of 2025 compared to a favorable impact in the second quarter of 2025, although less unfavorable than in the third quarter of 2024. In the future, equity market and interest rate performance and volatility could result in additional gains or losses in these products, although associated hedging activities are expected to partially mitigate these impacts.

112

Table of Contents

Segment results of operations

Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024

The following table sets forth the results of operations relating to our Life and Annuities segment for the periods indicated:


	Three months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	42	$	42	$	—	—	%
Net investment income	221		228		(7)		(3)	%
Net investment gains (losses)	(11)		(4)		(7)		(175)	%
Policy fees and other income	150		163		(13)		(8)	%
Total revenues	402		429		(27)		(6)	%
Benefits and expenses:
Benefits and other changes in policy reserves	222		253		(31)		(12)	%
Liability remeasurement (gains) losses	(7)		6		(13)		NM⁽¹⁾
Changes in fair value of market risk benefits and associated hedges	(1)		21		(22)		(105)	%
Interest credited	96		102		(6)		(6)	%
Acquisition and operating expenses, net of deferrals	60		63		(3)		(5)	%
Amortization of deferred acquisition costs and intangibles	37		41		(4)		(10)	%
Total benefits and expenses	407		486		(79)		(16)	%
Loss from continuing operations before income taxes	(5)		(57)		52		91	%
Benefit for income taxes	(2)		(13)		11		85	%
Loss from continuing operations	(3)		(44)		41		93	%
Adjustments to loss from continuing operations:
Net investment (gains) losses	11		4		7		175	%
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (2)	(3)		17		(20)		(118)	%
Taxes on adjustments	(1)		(4)		3		75	%
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders	$	4	$	(27)	$	31	115	%

______________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

(2) For the three months ended September 30, 2025 and 2024, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(2) million and $(4) million, respectively.

113

Table of Contents

The following table sets forth adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for the products included in our Life and Annuities segment for the periods indicated:


	Three months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Life insurance	$	(15)	$	(40)	$	25	63	%
Fixed annuities	10		6		4		67	%
Variable annuities	9		7		2		29	%
Total adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders	$	4	$	(27)	$	31	115	%

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

• The adjusted operating loss in our life insurance products decreased primarily due to favorable mortality in the current year.

• Adjusted operating income in our fixed annuities increased primarily from favorable mortality, partially offset by lower spread income in the current year largely related to block runoff.

Revenues

Net investment income . The decrease was primarily driven by lower average invested assets in our fixed annuity products in the current year driven mostly by block runoff.

Net investment gains (losses) . For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Policy fees and other income. The decrease was primarily driven by our life insurance products principally due to block runoff.

Benefits and expenses

Benefits and other changes in policy reserves

• Our life insurance products decreased $27 million primarily due to a favorable change in reserves related to mortality and persistency experience in the current year.

• Our fixed annuity products decreased $4 million primarily attributable to block runoff.

Liability remeasurement (gains) losses . The liability remeasurement gain in the current year was principally due to favorable mortality experience in our fixed annuity products. The liability remeasurement loss in the prior year was largely driven by unfavorable mortality in our life insurance products.

Changes in fair value of market risk benefits and associated hedges. The prior year loss was driven by our annuity products primarily due to unfavorable interest rate impacts, partially offset by favorable equity market performance and derivative gains.

Interest credited . The decrease was primarily due to block runoff in our life insurance and fixed annuity products.

Benefit for income taxes. The effective tax rate w a s 38.9% and 22.7% for the three months ended September 30, 2025 and 2024, respectively. The increase in the effective tax rate was primarily attributable to tax benefits from tax favored items in relation to the pre-tax loss in the current year.

114

Table of Contents

Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024

The following table sets forth the results of operations relating to our Life and Annuities segment for the periods indicated:


	Nine months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	125	$	139	$	(14)	(10)	%
Net investment income	657		732		(75)		(10)	%
Net investment gains (losses)	(27)		(12)		(15)		(125)	%
Policy fees and other income	462		485		(23)		(5)	%
Total revenues	1,217		1,344		(127)		(9)	%
Benefits and expenses:
Benefits and other changes in policy reserves	686		740		(54)		(7)	%
Liability remeasurement (gains) losses	25		10		15		150	%
Changes in fair value of market risk benefits and associated hedges	7		(10)		17		170	%
Interest credited	289		352		(63)		(18)	%
Acquisition and operating expenses, net of deferrals	173		177		(4)		(2)	%
Amortization of deferred acquisition costs and intangibles	114		125		(11)		(9)	%
Total benefits and expenses	1,294		1,394		(100)		(7)	%
Loss from continuing operations before income taxes	(77)		(50)		(27)		(54)	%
Benefit for income taxes	(18)		(12)		(6)		(50)	%
Loss from continuing operations	(59)		(38)		(21)		(55)	%
Adjustments to loss from continuing operations:
Net investment (gains) losses	27		12		15		125	%
Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (1)	1		(19)		20		105	%
Taxes on adjustments	(5)		2		(7)		NM⁽²⁾
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders	$	(36)	$	(43)	$	7	16	%

______________

(1) For the nine months ended September 30, 2025 and 2024, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(6) million and $(9) million, respectively.

(2) We define “NM” as not meaningful for increases or decreases greater than 200%.

115

Table of Contents


	Nine months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Life insurance	$	(79)	$	(96)	$	17	18	%
Fixed annuities	22		29		(7)		(24)	%
Variable annuities	21		24		(3)		(13)	%
Total adjusted operating loss available to Genworth Financial, Inc.’s common stockholders	$	(36)	$	(43)	$	7	16	%

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

• The adjusted operating loss in our life insurance products decreased largely due to less unfavorable mortality experience in the current year.

Revenues

Premiums . The decrease was driven by our life insurance products largely due to the continued runoff of our in-force blocks.

Net investment income

• Our life insurance products decreased $49 million primarily from lower policy loan rates in our corporate-owned life insurance products in the current year.

• Our fixed annuity products decreased $26 million primarily attributable to lower average invested assets in the current year driven mostly by block runoff.

Net investment gains (losses) . For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Policy fees and other income. The decrease was primarily driven by our life insurance products principally due to block runoff.

Benefits and expenses

Benefits and other changes in policy reserves. The decrease was primarily driven by our life insurance products largely due to a higher favorable change in reserves related to mortality and persistency experience in the current year.

Liability remeasurement (gains) losses

• The liability remeasurement loss in our life insurance products increased $18 million primarily driven by more unfavorable mortality in the current year.

• The liability remeasurement gain in our fixed annuity products increased $3 million largely from a favorable change in mortality experience in the current year.

Changes in fair value of market risk benefits and associated hedges. The change to a loss in the current year from a gain in the prior year was primarily attributable to unfavorable interest rate impacts in our annuity products in the current year compared to favorable impacts in the prior year, partially offset by lower derivative losses in the current year in our variable annuity products.

116

Table of Contents

Interest credited

• Our life insurance products decreased $53 million primarily driven by lower policy loan rates in our corporate-owned life insurance products in the current year.

• Our fixed annuity products decreased $10 million largely due to block runoff.

Amortization of deferred acquisition costs and intangibles. The decrease was primarily driven by lower DAC amortization in our life insurance products in the current year due to block runoff.

Benefit for income taxes. The effective tax rate was 23.5% and 23.9% for the nine months ended September 30, 2025 and 2024, respectively. The decrease in the effective tax rate was primarily attributable to tax benefits from tax favored items in relation to the pre-tax loss in the current year.

Corporate and Other

Results of operations

Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024

The following table sets forth the results of operations relating to Corporate and Other for the periods indicated:


	Three months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	2	$	2	$	—	—	%
Net investment income	5		4		1		25	%
Net investment gains (losses)	8		—		8		NM⁽¹⁾
Total revenues	15		6		9		150	%
Benefits and expenses:
Benefits and other changes in policy reserves	(3)		(1)		(2)		(200)	%
Acquisition and operating expenses, net of deferrals	30		25		5		20	%
Amortization of deferred acquisition costs and intangibles	1		1		—		—	%
Interest expense	14		15		(1)		(7)	%
Total benefits and expenses	42		40		2		5	%
Loss from continuing operations before income taxes	(27)		(34)		7		21	%
Benefit for income taxes	(40)		(9)		(31)		NM⁽¹⁾
Income (loss) from continuing operations	13		(25)		38		152	%
Adjustments to income (loss) loss from continuing operations:
Net investment (gains) losses	(8)		—		(8)		NM⁽¹⁾
(Gains) losses on early extinguishment of debt	—		(2)		2		100	%

Taxes on adjustments (2)	(26)		—		(26)		NM⁽¹⁾
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders	$	(21)	$	(27)	$	6	22	%

_____________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

(2) The three months ended September 30, 2025 included a $27 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets.

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss decreased primarily from a $7 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets in the current year.

117

Table of Contents

Revenues

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Acquisition and operating expenses, net of deferrals, increased primarily from higher expenses related to CareScout growth initiatives in the current year. The prior year also included gains related to the repurchase of Genworth Holdings’ debt that did not recur.

The increase in the benefit for income taxes was primarily related to a $34 million release of a portion of the valuation allowance on certain deferred tax assets in the current year.

Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024

The following table sets forth the results of operations relating to Corporate and Other for the periods indicated:


	Nine months ended September 30,				Increase (decrease) and percentage change
(Amounts in millions)	2025		2024		2025 vs. 2024
Revenues:
Premiums	$	7	$	8	$	(1)	(13)	%
Net investment income	14		16		(2)		(13)	%
Net investment gains (losses)	(20)		(6)		(14)		NM⁽¹⁾
Total revenues	1		18		(17)		(94)	%
Benefits and expenses:
Benefits and other changes in policy reserves	(6)		(7)		1		14	%
Acquisition and operating expenses, net of deferrals	78		76		2		3	%
Amortization of deferred acquisition costs and intangibles	3		3		—		—	%
Interest expense	42		49		(7)		(14)	%
Total benefits and expenses	117		121		(4)		(3)	%
Loss from continuing operations before income taxes	(116)		(103)		(13)		(13)	%
Benefit for income taxes	(55)		(22)		(33)		(150)	%
Loss from continuing operations	(61)		(81)		20		25	%
Adjustments to loss from continuing operations:
Net investment (gains) losses	20		6		14		NM⁽¹⁾
(Gains) losses on early extinguishment of debt	—		(5)		5		100	%
Expenses related to restructuring	(1)		7		(8)		(114)	%
Taxes on adjustments (2)	(31)		(2)		(29)		NM⁽¹⁾
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders	$	(73)	$	(75)	$	2	3	%

_____________

(1) We define “NM” as not meaningful for increases or decreases greater than 200%.

(2) The nine months ended September 30, 2025 included a $27 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets.

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss decreased primarily from a $7 million tax benefit related to a release of a portion of the valuation allowance on certain deferred tax assets and lower interest expense, partially offset by higher expenses related to CareScout growth initiatives in the current year.

118

Table of Contents

Revenues

For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”

Benefits and expenses

Acquisition and operating expenses, net of deferrals, increased mainly from higher expenses related to CareScout growth initiatives in the current year, partially offset by restructuring expenses in the prior year that did not recur. The prior year also included gains related to the repurchase of Genworth Holdings’ debt that did not recur.

Interest expense decreased from a lower floating interest rate on Genworth Holdings’ junior subordinated notes in the current year and from the repurchase of Genworth Holdings’ debt in the prior year.

The increase in the benefit for income taxes was primarily related to a $34 million release of a portion of the valuation allowance on certain deferred tax assets in the current year.

Investments and Derivative Instruments

Trends and conditions

Investments

During the three months ended September 30, 2025 , our investment portfolio was impacted, and we believe will continue to be impacted, by the following macroeconomic trends:

• The U.S. Federal Reserve decreased interest rates by 25 basis points at its September 2025 meeting while continuing to monitor labor market conditions and inflation, including any impacts from rising tariffs. In its October 2025 meeting, the U.S. Federal Reserve decreased interest rates by an additional 25 basis points.

• During the third quarter of 2025 , the U.S. Treasury yield curve steepened as short-term yields decreased more than long-term yields driven by mixed economic data and increased concerns with the federal government’s fiscal deficit.

• During the third quarter of 2025, credit spreads tightened to record levels despite mixed economic indicators, reflecting strong demand from yield-focused investors and a broader shift toward a willingness to take on higher risk. Equity markets mirrored this momentum, achieving all-time highs during the three months ended September 30, 2025.

• As of September 30, 2025 , our fixed maturity securities portfolio, which was 97% investment grade, comprised 75% of our total invested assets and cash.

Derivatives

• As of September 30, 2025 , $1.0 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”).

• The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of September 30, 2025 , we posted initial margin of $84 million to our clearing agents, which represented $42 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings.

• As of September 30, 2025 , $13.0 billion notional of our derivatives portfolio was in bilateral over-the-counter derivative transactions pursuant to which we have posted aggregate independent amounts of $594 million and are holding collateral from counterparties in the amount of $21 million.

119

Table of Contents

Investment results

The following tables set forth information about investment income, excluding net investment gains (losses), for each component of our investment portfolio for the periods indicated:


	Three months ended September 30,								Increase (decrease)
	2025				2024				2025 vs. 2024
(Amounts in millions)	Yield		Amount		Yield		Amount		Yield		Amount
Fixed maturity securities—taxable	4.7	%	$	565	4.6	%	$	557	0.1	%	$	8
Fixed maturity securities—non-taxable	19.0	%	1		—	%	—		19.0	%	1
Equity securities	2.3	%	3		2.7	%	3		(0.4)	%	—
Commercial mortgage loans	4.7	%	74		4.5	%	74		0.2	%	—
Policy loans	6.7	%	39		6.5	%	38		0.2	%	1
Limited partnerships (1)	7.3	%	62		4.7	%	36		2.6	%	26
Other invested assets (2)	45.1	%	64		45.5	%	70		(0.4)	%	(6)
Cash, cash equivalents, restricted cash and short-term investments	3.7	%	18		4.8	%	24		(1.1)	%	(6)
Gross investment income before expenses and fees	5.2	%	826		5.0	%	802		0.2	%	24
Expenses and fees	(0.2)	%	(27)		(0.1)	%	(25)		(0.1)	%	(2)
Net investment income	5.0	%	$	799	4.9	%	$	777	0.1	%	$	22
Average invested assets and cash			$	63,607			$	64,010			$	(403)

______________

(1) Limited partnership investments are primarily equity-based and do not have fixed returns by period.

(2) Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation.


	Nine months ended September 30,								Increase (decrease)
	2025				2024				2025 vs. 2024
(Amounts in millions)	Yield		Amount		Yield		Amount		Yield		Amount
Fixed maturity securities—taxable	4.6	%	$	1,694	4.6	%	$	1,682	—	%	$	12
Fixed maturity securities—non-taxable	5.6	%	1		3.8	%	1		1.8	%	—
Equity securities	2.3	%	9		2.5	%	8		(0.2)	%	1
Commercial mortgage loans	4.6	%	219		4.5	%	224		0.1	%	(5)
Policy loans	6.1	%	107		8.9	%	152		(2.8)	%	(45)
Limited partnerships (1)	5.6	%	139		4.1	%	92		1.5	%	47
Other invested assets (2)	43.3	%	187		46.2	%	205		(2.9)	%	(18)
Cash, cash equivalents, restricted cash and short-term investments	4.0	%	59		4.9	%	76		(0.9)	%	(17)
Gross investment income before expenses and fees	5.1	%	2,415		5.1	%	2,440		—	%	(25)
Expenses and fees	(0.2)	%	(75)		(0.2)	%	(73)		—	%	(2)
Net investment income	4.9	%	$	2,340	4.9	%	$	2,367	—	%	$	(27)
Average invested assets and cash			$	63,653			$	64,138			$	(485)

______________

(1) Limited partnership investments are primarily equity-based and do not have fixed returns by period.

(2) Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation.

Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments.

120

Table of Contents

For the three months ended September 30, 2025, gross annualized weighted-average investment yields increased primarily driven by higher net investment income on lower average invested assets. Net investment income increased for the three months ended September 30, 2025 largely from higher income from limited partnerships. Net investment income for the nine months ended September 30, 2025 decreased as higher income from limited partnerships was more than offset by lower policy loan rates in our corporate-owned life insurance products, lower amortization of cash flow hedges and lower returns on our short-term investments due to a decrease in interest rates in the current year.

The following table sets forth net investment gains (losses) for the periods indicated:


	Three months ended September 30,				Nine months ended September 30,
(Amounts in millions)	2025		2024		2025		2024
Realized investment gains (losses):
Available-for-sale fixed maturity securities:
Realized gains	$	3	$	7	$	14	$	35
Realized losses	(13)		(14)		(46)		(83)
Net realized gains (losses) on available-for-sale fixed maturity securities	(10)		(7)		(32)		(48)
Net realized gains (losses) on equity securities sold	—		—		5		—
Total net realized investment gains (losses)	(10)		(7)		(27)		(48)
Net change in allowance for credit losses on available-for-sale fixed maturity securities	(3)		—		(18)		7
Write-down of available-for-sale fixed maturity securities	—		—		(4)		—
Net unrealized gains (losses) on equity securities still held	30		22		48		66
Net unrealized gains (losses) on limited partnerships	66		55		129		46
Commercial mortgage loans	(3)		(8)		(20)		(11)
Derivative instruments	17		10		(13)		3
Other	2		(6)		3		(9)
Net investment gains (losses)	$	99	$	66	$	98	$	54

Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024

• We recorded $11 million and $8 million of higher net unrealized gains on limited partnerships and equity securities, respectively, driven by more favorable private and public equity market performance, respectively, in the current year.

• We had $7 million of higher net investment gains related to derivatives primarily attributable to gains in the current year on foreign currency forward contracts used to mitigate foreign currency exchange risk.

Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024

• We recorded $16 million of lower net realized losses related to the sale of available-for-sale fixed maturity securities in the current year.

• We recorded $83 million of higher net unrealized gains on limited partnerships driven by more favorable private equity market performance in the current year. We also recorded $18 million of lower net unrealized gains on equity securities from less favorable equity market performance in the current year.

• During the current year, we increased the provision for credit losses for commercial mortgage loans by $20 million primarily as a result of updates to the analytical model used to determine the adequacy of the allowance for credit losses. We also increased the allowance for credit losses on available-for-sale fixed maturity securities by $18 million in the current year compared to a decrease of $7 million in the prior year related to sales of securities.

121

Table of Contents

• We had $13 million of net investment losses related to derivatives in the current year compared to $3 million of net investment gains in the prior year primarily attributable to losses in the current year on foreign currency forward contracts used to mitigate foreign currency exchange risk.

Investment portfolio

The following table sets forth our cash, cash equivalents and invested assets as of the dates indicated:



	September 30, 2025				December 31, 2024
(Amounts in millions)	Carrying value		% of total		Carrying value		% of total
Available-for-sale fixed maturity securities:
Public	$	31,605	51	%	$	30,650	51	%
Private	14,505		24		14,252		24
Equity securities	546		1		515		1
Commercial mortgage loans, net	6,315		10		6,411		11
Policy loans	2,311		4		2,310		4
Limited partnerships	3,473		6		3,142		5
Other invested assets	658		1		648		1
Cash, cash equivalents and restricted cash	2,036		3		2,048		3
Total cash, cash equivalents and invested assets	$	61,449	100	%	$	59,976	100	%

For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for these line items under “—Consolidated Balance Sheets.” See note 4 in our unaudited condensed consolidated financial statements under “Item 1—Financial Statements” for additional information related to our investment portfolio.

We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of September 30, 2025 , approximately 6% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 6 in our unaudited condensed consolidated financial statements under “Item 1—Financial Statements” for additional information related to fair value.

Other invested assets

The following table sets forth the carrying values of our other invested assets as of the dates indicated:



	September 30, 2025				December 31, 2024
(Amounts in millions)	Carrying value		% of total		Carrying value		% of total
Bank loan investments	$	521	79	%	$	535	82	%
Derivatives	52		8		56		9
Short-term investments	26		4		4		1
Other investments	59		9		53		8
Total other invested assets	$	658	100	%	$	648	100	%

Short-term investments increased from net purchases in the current year. Bank loan investments decreased from principal repayments, partially offset by funding of additional investments.

122

Table of Contents

Derivatives

The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:


(Notional in millions)	Measurement	December 31, 2024		Additions		Maturities/ terminations		September 30, 2025
Derivatives designated as hedges
Cash flow hedges:
Interest rate swaps	Notional	$	8,757	$	—	$	(542)	$	8,215
Foreign currency swaps	Notional	144		12		—		156
Forward bond purchase commitments	Notional	2,639		425		—		3,064
Total cash flow hedges		11,540		437		(542)		11,435
Total derivatives designated as hedges		11,540		437		(542)		11,435
Derivatives not designated as hedges
Equity index options	Notional	604		355		(426)		533
Financial futures	Notional	1,102		3,192		(3,316)		978
Forward bond purchase commitments	Notional	500		—		—		500
Foreign currency forward contracts	Notional	—		521		—		521
Total derivatives not designated as hedges		2,206		4,068		(3,742)		2,532
Total derivatives		$	13,746	$	4,505	$	(4,284)	$	13,967


(Number of policies)	Measurement	December 31, 2024	Additions	Maturities/ terminations	September 30, 2025
Derivatives not designated as hedges
Fixed indexed annuity embedded derivatives	Policies	4,867	—	(526)	4,341
Indexed universal life embedded derivatives	Policies	717	—	(23)	694

The increase in the notional value of derivatives was primarily attributable to the addition of foreign currency forward contracts to mitigate foreign currency exchange risk and forward bond purchase commitments that support our long-term care insurance business. These increases were partially offset by decreases in interest rate swaps that support our long-term care insurance business and financial futures that support our variable annuity products.

The number of policies with embedded derivatives decreased as these products are no longer being offered and continue to run off.

Consolidated Balance Sheets

Total assets . Total assets increased $1,615 million from $86,871 million as of December 31, 2024 to $88,486 million as of September 30, 2025 .

• Invested assets increased $1,485 million primarily attributable to increases of $1,208 million in fixed maturity securities and $331 million in limited partnerships, partially offset by a decrease of $96 million in commercial mortgage loans. The increase in fixed maturity securities was predominantly related to lower interest rates, increasing the fair value of our fixed maturity investment portfolio, partially offset by net sales and maturities in the current year. Limited partnerships increased largely from capital calls in the current year. Commercial mortgage loans decreased mostly due to payments outpacing originations.

• Deferred acquisition costs decreased $147 million largely driven by amortization in our life and long-term care insurance products in the current year.

123

Table of Contents

• Reinsurance recoverable increased $257 million primarily due to a decrease in the single-A interest rate used to discount the reinsurance recoverable and the impact of actual variances from expected experience related to lower terminations in our long-term care insurance business, partially offset by the runoff of certain ceded products in the current year.

Total liabilities . Total liabilities increased $1,225 million from $77,440 million as of December 31, 2024 to $78,665 million as of September 30, 2025 .

• The liability for future policy benefits increased $1,754 million primarily from a decrease in the single-A interest rate used to discount the liability for future policy benefits. Our long-term care insurance reserves also increased largely driven by aging of the in-force block, including higher interest accretion, and unfavorable actual variances from expected experience, partially offset by benefit payments outpacing premiums collected in the current year. These increases were partially offset by the runoff of our fixed annuity and life insurance products.

• Policyholder account balances decreased $555 million largely driven by benefit payments, surrenders and withdrawals in our fixed annuity and universal and term universal life insurance products in the current year.

Total equity . Total equity increased $390 million from $9,431 million as of December 31, 2024 to $9,821 million as of September 30, 2025 .

• We reported net income available to Genworth Financial, Inc.’s common stockholders of $221 million for the nine months ended September 30, 2025 .

• Unrealized gains (losses) on investments increased total equity by $1,251 million primarily due to a decrease in interest rates in the current year.

• Derivatives qualifying as hedges decreased total equity by $139 million largely due to amortization of forward starting swap gains into net investment income in the current year.

• The change in the discount rate used to measure future policy benefits and related reinsurance recoverables decreased total equity by $880 million largely attributable to a decrease in the single-A interest rate in the current year.

• Treasury stock increased $153 million due to the repurchase of Genworth Financial’s common stock, at cost, including excise taxes and other associated costs, resulting in a decrease to total equity in the current year.

Liquidity and Capital Resources

Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs.

Overview of cash flows—Genworth and subsidiaries

Our principal sources of cash include premiums and other payments received on our insurance products and services, income from our investment portfolio and proceeds from sales and maturities of investments. Cash flows related to operating activities are affected by the timing of premiums, fees and investment income received and benefits, claims and expenses paid. Cash flows from operating activities have been invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flows, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the repurchase of common stock presented as treasury stock; and other capital transactions.

124

Table of Contents

The following table sets forth our unaudited condensed consolidated cash flows for the nine months ended September 30 :



(Amounts in millions)	2025		2024
Net cash from (used by) operating activities	$	127	$	61
Net cash from (used by) investing activities	468		641
Net cash from (used by) financing activities	(607)		(860)
Net increase (decrease) in cash and cash equivalents	$	(12)	$	(158)

We had higher net cash inflows from operating activities in the current year primarily driven by lower benefit payments in our long-term care insurance business resulting from lower settlement payments, as the implementation of the third legal settlement was materially completed in the fourth quarter of 2024.

Net cash inflows from investing activities were lower in the current year mainly due to an increase in commercial mortgage loan originations.

Net cash outflows related to financing activities were lower primarily due to lower net withdrawals from our investment contracts in the current year and repurchases of Genworth Holdings’ debt in the prior year that did not recur .

Genworth—holding company liquidity

In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding company for their respective subsidiaries and do not have any significant operations of their own. Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends and other returns of capital from Enact Holdings. Additional sources of cash have included subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. The primary uses of funds at Genworth Financial and Genworth Holdings include payments of principal, interest and other expenses on borrowings or other obligations, payment of holding company general operating expenses (including employee benefits and taxes), payments under guarantees (including guarantees of certain subsidiary obligations), payments to subsidiaries (or, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, investments in CareScout, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial.

Management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt. We manage our legacy U.S. life insurance subsidiaries on a standalone basis and accordingly, do not expect to receive any dividends or other returns of capital from them. Therefore, our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Genworth Financial has the right to appoint a majority of directors to Enact Holdings’ board of directors; however, actions taken by Enact Holdings and its board of directors are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. In addition, insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries.

Enact Holdings’ capital allocation strategy includes supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to its shareholders. On May 1, 2024, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $250 million of its common stock. Enact Holdings completed the repurchase of shares under this authorization in the second quarter of 2025. On April 30, 2025, Enact Holdings announced the authorization of a new share repurchase program that allows for the repurchase of up to an additional $350 million of its common stock. Genworth Holdings entered into an agreement with Enact Holdings to participate in the share repurchase program in order to maintain its current ownership interest in Enact Holdings. In addition to its share repurchase program, Enact Holdings pays a quarterly dividend. As the majority shareholder, Genworth Holdings received $280 million of capital returns from Enact Holdings during the nine months ended September 30, 2025 , comprised of share repurchases and quarterly dividends. Enact Holdings expects the timing and amount of any future share repurchases will be opportunistic and will depend on a variety of factors, including Enact Holdings’ stock price, capital availability, business and market conditions, regulatory requirements and debt covenant restrictions, among other factors. Future dividend payments will be subject to

125

Table of Contents

quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial and will also be dependent on a variety of economic, market and business conditions, among other considerations.

On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under Genworth Financial’s existing share repurchase program that began in May 2022. Pursuant to the program, during the nine months ended September 30, 2025 , Genworth Financial repurchased 19,815,615 shares of its common stock at an average price of $7.62 per share for a total of $151 million before excise taxes and other costs. On September 18, 2025, Genworth Financial announced that its Board of Directors had authorized a new share repurchase program under which Genworth Financial may purchase up to $350 million of its outstanding common stock. Under the new program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.

In October 2025, Genworth Financial repurchased 3,302,403 shares of its common stock through a Rule 10b5-1 trading plan at an average price of $8.76 per share, finalizing the repurchases under the July 2023 authorization and leaving approximately $325 million available for repurchase under the new program as of October 31, 2025. Future share repurchases will be funded from holding company capital, as well as future cash flow generation, including expected future capital returns from Enact Holdings.

Our future use of liquidity and capital will prioritize strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases. In addition, we also expect to repurchase or redeem outstanding debt from time to time (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise.

Genworth Holdings had $254 million and $294 million of unrestricted cash and cash equivalents as of September 30, 2025 and December 31, 2024 , respectively. The decrease was principally driven by repurchases of Genworth Financial’s common stock, capital contributions to CareScout and interest payments on Genworth Holdings’ debt, partially offset by capital returns from Enact Holdings. The $254 million of Genworth Holdings’ cash and cash equivalents included approximately $145 million of cash held for future obligations, including advance cash payments from our subsidiaries. We do not consider this cash held for future obligations when evaluating holding company liquidity for the purposes of allocating capital or computing our cash position relative to the cash management target discussed below. We believe Genworth Holdings’ unrestricted cash and cash equivalents provide sufficient liquidity to meet its financial obligations over the next twelve months as well as in the longer term. We expect Genworth Holdings’ liquidity to continue to be impacted by the amounts and timing of Genworth Financial’s share repurchases as well as future dividends and other forms of capital returns from Enact Holdings. In addition, we anticipate lower intercompany cash tax payments to be retained by Genworth Holdings from its subsidiaries going forward.

We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or as a result of planned future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant.

Capital resources and financing activities

Our current capital resource plans do not include any additional debt offerings by Genworth Holdings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends and other returns of capital therefrom.

On September 30, 2025, Enact Holdings entered into a five-year unsecured revolving credit facility with a syndicate of lenders in the initial aggregate principal amount of $435 million, which replaces the 2022 Credit Facility. Any borrowings under the 2025 Credit Facility will accrue interest at a floating rate tied to a standard short-term borrowing index selected at Enact Holdings’ option, plus an applicable margin, pursuant to the terms of the credit agreement. The applicable margin is based on Enact Holdings’ ratings established by certain debt rating agencies for its outstanding debt.

126

Table of Contents

Enact Holdings may use any future borrowings under the 2025 Credit Facility for working capital needs and general corporate purposes, including the execution of dividends to its shareholders and capital contributions to its insurance subsidiaries. The 2025 Credit Facility includes customary representations, warranties, covenants, terms and conditions. As of September 30, 2025 , Enact Holdings was in compliance with all covenants and the 2025 Credit Facility remained undrawn.

Regulated insurance subsidiaries

The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payments of principal and interest on their outstanding debt obligations and income taxes. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements. Our insurance subsidiaries’ principal cash inflows from operating activities are derived from premiums, annuity deposits and insurance and investment product fees and other income, including commissions, cost of insurance, mortality, expense and surrender charges, contract underwriting fees, investment management fees, investment income and dividends and distributions from their subsidiaries. We manage our legacy U.S. life insurance subsidiaries on a standalone basis. Accordingly, these subsidiaries will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and long-term care insurance in-force rate actions to satisfy policyholder obligations.

In our long-term care insurance business, we expect overall claims costs to continue to increase over time as our blocks age, with peak claim years over a decade away. For information on discounted and undiscounted expected future benefit payments, see note 8 in our unaudited condensed consolidated financial statements under “Item 1—Financial Statements.” We also expect renewal premiums on the in-force block of our legacy long-term care insurance business to decline over time as the block runs off and as policyholders elect benefit reductions in connection with our in-force rate actions and legal settlements; however, we expect this decline to be partially offset by future approved rate actions.

Given the challenging macroeconomic environment in 2024 and into the first three quarters of 2025, employee costs have increased driven in part by wage inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care due in part to elevated inflation. These inflationary pressures have not had a significant impact on our liquidity to date; however, if these conditions persist, they could have a material adverse impact on our liquidity, results of operations and financial condition.

The U.S. economy also faces uncertainty and volatility due to pending tariff negotiations taking place across global markets. The insurance industry and our insurance subsidiaries are not directly impacted by tariffs. However, if the ultimate outcome of the global tariff negotiations significantly impacts the U.S. and global economies and equity and fixed income markets, this could have an adverse impact on the housing industry, investment income, our results of operations and liquidity. We will continue to monitor macroeconomic trends, including inflation and any ancillary effects of the tariff negotiations, to help mitigate any potential adverse impacts to our liquidity.

Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are typically matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are typically matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of September 30, 2025 , our total cash, cash equivalents and invested assets were $61.4 billion . Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of September 30, 2025 .

Off-balance sheet commitments, guarantees and contractual obligations

As of September 30, 2025 , we were committed to fund $1,817 million in limited partnership investments, $ 379 million in private placement investments, $134 million of bank loan investments and $ 19 million in commercial mortgage loan investments.

127

Table of Contents

As previously disclosed, in connection with pending litigation between AXA and Santander related to the payment protection insurance (“PPI”) mis-selling losses, Genworth has certain rights to share in any recoveries by AXA to recoup payments it previously made to AXA for the underlying PPI mis-selling losses. Genworth is not a named party in the litigation with Santander, and, therefore, does not ultimately control the litigation. In order to better align the interests of AXA and Genworth in the litigation, in March 2025, Genworth agreed to provide AXA a guarantee for the recovery of certain of AXA’s PPI mis-selling losses not previously reimbursed by Genworth, regardless of the ultimate outcome of the litigation. The guarantee was provided through a stand-by letter of credit (“LC”) issued by a third-party financial institution for the benefit of AXA and a reimbursement agreement between Genworth and the third-party financial institution. Genworth could be required to pay an amount under the guarantee, through the reimbursement agreement, up to £80 million. Whether AXA may draw upon the LC is subject to the amount of any settlement between AXA and Santander, or certain milestones in the court proceedings. On July 25, 2025, the U.K. High Court issued a liability judgment in favor of AXA in the legal proceedings against Santander. The judgment finds Santander liable for AXA’s losses resulting from Santander’s mis-selling. The judge awarded AXA damages, interest and costs of approximately £680 million ( $911 million based on then current exchange rates). Santander subsequently applied for permission to appeal, and the U.K. Court of Appeal granted that request on October 21, 2025. The case will now proceed to a determination by the U.K. Court of Appeal. Under prior agreements between Genworth and AXA, Genworth is entitled to share in funds that AXA recovers from third parties related to the mis-selling losses. If the appeal is resolved in favor of AXA, Genworth could be entitled to recover approximately $750 million , depending upon the applicable exchange rate at that time. As of September 30, 2025, we have not recorded any amounts related to the guarantee or loss recoveries in connection with the liability judgment. In November 2025, AXA initiated the process to cancel the LC . Loss recoveries have not been factored into our capital allocation plans, including the sizing of the new share repurchase authorization discussed above. We would expect to deploy any loss recoveries in line with our stated capital allocation priorities, which are investing in growth through CareScout, returning cash to shareholders through our share repurchase program and opportunistically paying down debt.

Except as disclosed above, as of September 30, 2025 , there have been no material additions or changes to guarantees provided by Genworth Financial and Genworth Holdings or to our contractual obligations as compared to the amounts disclosed within our 2024 Annual Report on Form 10-K filed on February 28, 2025 .

Supplemental Condensed Consolidating Financial Information

Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes (registered securities under the Securities Act of 1933), on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures. Genworth Holdings is a direct, 100% owned subsidiary of Genworth Financial.

Excluding investments in subsidiaries, the assets, liabilities and results of operations of Genworth Financial and Genworth Holdings, on a combined basis, are not material to the consolidated financial position or the consolidated results of operations of Genworth. In addition, none of Genworth Financial’s direct or indirect subsidiaries, other than Genworth Holdings, are issuers or guarantors of any guaranteed securities. Therefore, in accordance with Rule 13-01 of Regulation S-X, we are permitted, and we elected, to exclude the summarized financial information for both the issuer and guarantor of the registered securities.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates, equity prices and foreign currency exchange rates. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. There were no material changes in our market risks since December 31, 2024 . See “—Business trends and conditions” and “—Investments and Derivative Instruments” in “Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussion of recent market conditions, including changes in interest rates.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of September 30, 2025 , an evaluation was conducted under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based

128

Table of Contents

on this evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2025 .

Changes in Internal Control Over Financial Reporting During the Quarter Ended September 30, 2025

During the three months ended September 30, 2025 , there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

129

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

See note 16 in our unaudited condensed consolidated financial statements under “Part 1—Item 1—Financial Statements” for a description of material pending litigation and regulatory matters affecting us.

Item 1A. Risk Factors

The discussion of our business and operations should be read together with the risk factors contained in Item 1A of our 2024 Annual Report on Form 10-K, which together describe various risks and uncertainties to which we are or may become subject. These risks and uncertainties have the potential to affect our business, financial condition, results of operations, cash flows, strategies or prospects in a material and adverse manner. There have been no material changes to the risk factors set forth in the above-referenced filing as of September 30, 2025 .

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Common Stock

The following table sets forth information regarding Genworth Financial’s share repurchases during the three months ended September 30, 2025 :


(Dollar amounts in millions, except per share amounts)	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced program	Approximate dollar amount of shares that may yet be purchased under the program (1)
July 1, 2025 through July 31, 2025	1,266,726	$	7.89	1,266,726	$	70
August 1, 2025 through August 31, 2025	3,829,071	$	8.33	3,829,071	$	38
September 1, 2025 through September 30, 2025	3,921,884	$	8.71	3,921,884	$	354
Total	9,017,681			9,017,681

______________

(1) On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial could repurchase up to $350 million of its outstanding common stock. On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under this existing program. On September 18, 2025, Genworth Financial announced that its Board of Directors had authorized a new share repurchase program under which Genworth Financial may purchase up to $ 350 million of its outstanding common stock. Under the new program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time. Genworth Financial completed the repurchase of shares under the July 2023 authorization in October 2025. For additional information on the share repurchase programs, including certain repurchases made subsequent to periods provided in the chart above, see “Part I—Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources.”

Item 5. Other Information

During the three months ended September 30, 2025 , no directors or officers of Genworth adopted or terminated any contract, instruction or written plan for the purchase or sale of Genworth’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 trading arrangement”) or any “non-Rule 10b5-1 trading arrangement” as defined under the securities laws.

130

Table of Contents

Item 6. Exhibits


Number						Description
31.1						Certification of Thomas J. McInerney (filed herewith)

31.2						Certification of Jerome T. Upton (filed herewith)

32.1						Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code— Thomas J. McInerney (filed herewith)

32.2						Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code— Jerome T. Upton (filed herewith)

101.INS						Inline XBRL Instance Document

101.SCH						Inline XBRL Taxonomy Extension Schema Document

101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document

104						Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)

131

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	GENWORTH FINANCIAL, INC. (Registrant)
Date: November 6, 2025

	By:	/s/ Darren W. Woodell
		Darren W. Woodell Vice President and Controller (Principal Accounting Officer)

132

TABLE OF CONTENTS

Part I Financial Information Item 1. Financial Statements Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operations Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures Part II Other Information Item 1. Legal Proceedings Item 1A. Risk Factors Item 2. Unregistered Sales Of Equity Securities and Use Of Proceeds Item 5. Other Information Item 6. Exhibits

Exhibits

31.1 Certification of Thomas J. McInerney (filed herewith) 31.2 Certification of Jerome T. Upton (filed herewith) 32.1 Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code Thomas J. McInerney (filed herewith) 32.2 Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code Jerome T. Upton (filed herewith)

GNW 10-Q Quarter ended Sept. 30, 2025

Exhibits